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The human body is composed of hundreds of different tissues, all containing same genetic 
information, yet defined by unique gene expression patterns. In order to achieve this, 
multicellular organisms evolved regulatory mechanisms that go beyond the mere DNA 
sequence. Unlike in prokaryotes, where DNA is freely accessible to the transcriptional 
machinery, DNA in eukaryotic cells is wrapped around histone proteins, forming a structure 
called chromatin. Importantly, chromatin can be regulated by various post-translational 
modifications of the histone proteins. Such modifications are generally assumed to directly 
affect the compaction of chromatin and/or act as a recruitment platform for chromatin factors 
that relax (activate) or condense (repress) chromatin. One of the repressive histone marks, 
histone 3 lysine 9 methylation (H3K9me), is recognised by members of the HP1 family 
and/or by other proteins that have the unique ability to spread along chromatin, compacting 
it, and ultimately forming large inaccessible domains referred to as heterochromatin. Over 
the past decade, however, the view of HP1s as rigid silencers has been gradually challenged, 
as it was found that heterochromatic regions produce RNA, and that HP1s are highly mobile 
molecules. In addition, HP1 proteins were shown to associate with RNAs, and to also 
associate with chromatin lacking the H3K9me mark. These findings raised several 
fundamental questions: Is HP1 activity regulated by RNA? How are HP1 proteins recruited 
to sites lacking H3K9me, and what is their role at those sites? 
One aim of my PhD project was to elucidate potential roles of RNA in modulating HP1 
activity. For this, I used biochemical methods to dissect RNA binding properties of 
mammalian HP1 proteins in vitro. My work revealed that one of the HP1 homologs, HP1, 
interacts with RNA when bound to H3K9me-marked nucleosomes. The physiological role of 
such interaction could be stabilisation of binding to heterochromatin, or alternatively, 
eviction from heterochromatin. The major goal of my PhD project, however, was to 
investigate the mechanism of HP1 recruitment to chromatin lacking the H3K9me mark. To 
do so, I was using mouse embryonic stem cells (mESCs) as a model system. I have exploited 
recent advances in genome editing/CRISPR-Cas9 to delete or endogenously tag individual 
HP1 homologs or various combinations thereof. Genome- and proteome-wide studies 
subsequently revealed a novel protein complex, which I dubbed “ChAHP”. ChAHP contains 
two HP1 homologs (HP1 and/or HP1), the transcription factor Adnp, and the chromatin 
remodeller Chd4. In collaboration with the group of Nicolas Thomä, we have reconstituted 
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the ChAHP complex in vitro from insect cells and dissected the individual interactions. 
Together with my proteomics experiments in mESCs, this revealed Adnp as a core bridging 
module interacting with Chd4 and HP1s. Using ChIP-sequencing, we identified over 15 000 
ChAHP-bound genomic sites. Importantly, these sites are devoid of H3K9me2 or H3K9me3. 
Instead, the complex is targeted via a highly conserved DNA motif recognized by Adnp, and 
deletion of Adnp or of the DNA motif depletes HP1 binding at the ChAHP sites. In addition, 
deletion of Adnp or HP1s leads to derepression of lineage-specifying genes bound by 
ChAHP. However, unlike in case of canonical HP1 silencing, which involves H3K9me and 
results in formation of a broad heterochromatic domain, ChAHP silencing occurs locally by 
restricting access to its sites. I propose that this prevents other regulators, including 
transcriptional activators, from accessing the corresponding DNA sites. Finally, my results 
provide first insights into the molecular mechanism of a disease that is associated with 
mutations in the ADNP gene, Helsmoortel-Van der Aa syndrome. Mutant Adnp found in 
Helsmoortel-Van der Aa patients fails to interact with HP1 proteins, and therefore cannot 
target HP1s to the chromatin. In summary, my work revealed that HP1 proteins can be 
recruited to genomic loci in a DNA sequence-specific, H3K9 methylation-independent, 
manner via an interaction with the transcription factor Adnp, and I demonstrated that H3K9 




























1. Milestones in the history of chromatin biology 
All the information necessary for an organism to build, maintain and replicate itself is 
encoded in its DNA sequence, the genome. The rise in complexity of organisms was 
accompanied by the expansion of their genomes. The prokaryotic genome of Escherichia coli 
encodes approximately 4 000 genes in 4.6 mega base pairs (Mbp), the unicellular eukaryotic 
genome of Schizosaccharomyces pombe encodes nearly 5 000 genes in 13.8 Mbp, and the 
human genome encodes 20 000 to 25 000 genes in 3 200 Mbp (Blattner et al., 1997; Venter 
et al., 2001; Wood et al., 2002). The expansion in genome size, however, does not linearly 
correlate with an increase in the number of the genes. The protein coding genes of S. pombe 
occupy 60% of its genome, 57% if we exclude introns, but only about 25% of the human 
genome comprises protein-coding genes, with only 1.1% encoding exons. Higher eukaryotes, 
and in particular mammals, accumulated large amounts of non-coding DNA consisting mostly 
from simple repeats, pseudogenes, tandem repeats like centromeres and telomeres, and 
transposon-derived repeats, with the last class alone taking up more than 45% of the human 
genome (Lander et al., 2001). The evolutionary benefits and roles of these elements are still 
under investigation, but what is clear is that organisms with such complex genomes also had 
to evolve complex regulatory mechanisms to control transcriptional noise. Uncontrolled 
integration of transposons across the genome would be detrimental to genome stability and 
survival of the organism, and potentially the whole species. In addition to preventing 
unwanted transcription, multicellular organisms must regulate differential expression in 
individual cells during development, and subsequently preserve the acquired tissue-specific 
expression pattern. How can this be achieved without changing the sequence of DNA in 
individual cells and tissues? How can a single genotype give rise to different phenotypes?  
In the 1940s, Conrad Waddington introduced the term epigenetics. He defined epigenetics 
as ‘‘the branch of biology which studies the causal interactions between genes and their 
products which bring the phenotype into being’’ (Waddington, 1942).  In the original sense 
of his definition, epigenetics referred to all changes in environment and pathways that 
modulated the interpretation of the genotype, and therefore lead to the development of the 
phenotype, e.g. the process of development of the fertilized zygote into the mature organism. 
During the following decades however, the rapid development of biological techniques 




gene expression, has led scientists to narrow down the original definition to “the study of 
mitotically and/or meiotically heritable changes in gene function that cannot be explained by 
changes in DNA sequence” (Riggs and Porter, 1996).  This definition was further refined 
when an additional requirement was added – the induced change has to be self-propagated 
even in the absence of the initial signal in order to be considered epigenetic (Berger et al., 
2009; Ptashne, 2007). 
What are those epigenetic changes? In 1950 Ellen Stedman and Edgar Stedman isolated 
small basic proteins, histones, from the nuclei of red blood and liver cells, finding that the 
histones varied between the two cell types. They proposed that histones could act as gene 
suppressors with cell specific variation in their composition (Stedman and Stedman 1950). It 
took another 24 years to find that histones form an oligomer around which about 200 bp of 
DNA is bound (Kornberg and Thomas 1974).  Based on this work, Roger Kornberg further 
hypothesized that a histone oligomer wrapped in DNA forms a repeating unit which is flexibly 
connected to the other units, like “beads on a string”, and that this is a general mechanism of 
DNA storage in eukaryotic cells (Kornberg, 1974). One can easily envisage that histones may 
act as a steric barrier making DNA transcriptionally less accessible. However, where does the 
regulation come from? At the turn of the 21st century, there were many publications 
identifying covalent posttranslational modifications of histones. To date, over a hundred 
distinct modifications have been described, and it became clear that certain modifications 
correlate with actively transcribed regions while others with silent regions  (review in Zhao 
and Garcia 2015). Nowadays, histone modifications and their corresponding modifiers and 
readers are widely referred to as “epigenetic”. This, however, does not necessarily satisfy the 
above definitions of epigenetics by Arthur Riggs and his colleagues, since we often cannot 
distinguish between DNA-sequence-independent propagation of histone marks over cell 
divisions, and reestablishment of marks after cell division by a DNA-sequence-dependent 
machinery. Consequently, there is a wide array of opinions in the field about the correct use 
of the term “epigenetic”. In 2007, Adrian Bird attempted to resolve this confusion by refining 
the definition of epigenetics to “the structural adaptation of chromosomal regions so as to 
register, signal or perpetuate altered activity states” (Bird, 2007). Nevertheless, many 
scientists, and amongst them Mark Ptashne, insist on the use of the term epigenetics only in 
the context of memory, arguing that histone modifications and their associated factors lack 




is up to individual scientists to choose the definition that fits them best; this work is going to 
respect the one by Adrian Bird. 
Another type of epigenetic mark, which seems to better satisfy all of the above definitions, 
is DNA methylation. It was first described in 1975 by two parallel works, both suggesting a 
repressive role of DNA methylation in X chromosome inactivation (Holliday, R. & Pugh, 
1975; Riggs, 1975). The epigenetic transmission of DNA methylation across the cell divisions 
was confirmed shortly after by another study (Bird, 1978), and today it is one of the best 
documented epigenetic marks (reviewed in (Bird 2002; Jones 2012)). It was later realised, 
however, that another epigenetic regulator – non-coding RNA – is responsible for the 
initiation and spreading of X chromosome inactivation. Permanent silencing of one of the two 
X chromosomes occurs early during female mammalian development. It is initiated by the 
expression of a long non-coding RNA, X-inactive-specific transcript (Xist). The Xist RNA 
then binds the whole X chromosome from which it is transcribed, acting as a recruiter of the 
silencing machinery, with the final repressive state being permanently maintained by DNA 
methylation and histone-modification mediated silencing (Lee et al. 1996; Penny et al. 1996; 
for review Galupa and Heard 2015).  
In summary, the establishment and maintenance of tissue specific gene expression patterns 
is achieved through the coordinated action of epigenetic regulators and DNA-sequence 
specific factors. It remains difficult, however, to make a general statement about the hierarchy 
of individual factors, as we are often faced with the “causality dilemma”. The further chapters 













2. Chromatin – structure and function  
The genome of eukaryotes is organized into a dynamic structure called chromatin – a 
complex of DNA, proteins and RNA. There are several benefits of storing genetic information 
in the form of chromatin: it mediates the spatially efficient storage of DNA, creates a steric 
barrier for the transcriptional machinery, and can be differentially modified helping to impose 
a silent or active state over the corresponding DNA (Bannister and Kouzarides, 2011; Lorch 
et al., 1987). Traditionally, chromatin has been divided into two subtypes based on different 
cytological staining characteristics, euchromatin and heterochromatin. Euchromatin becomes 
less compact during interphase, and its staining appears light; heterochromatin stays tightly 
compacted and, consequently, its staining appears much darker (Fig. 1). Today we know that 
euchromatin consists of transcriptionally active genes and their regulatory elements, and 
heterochromatin consists of transcriptionally silent regions. Heterochromatin is further 
subdivided into permanently silent “constitutive heterochromatin”, which mostly contains 
repetitive sequences, and temporarily silent “facultative heterochromatin”, with mostly 
repressed genes and their regulatory elements. The constitutive heterochromatin plays a 
crucial role in genome stability and organization, and secures proper chromosome segregation 
during cell division. (reviewed in Trojer and Reinberg 2007)  
 
Figure 1. Electron micrograph of a bone marrow 
plasma cell. 
Two distinct regions can be distinguished in the nucleus of 
eukaryotic cells, the compact heterochromatin – dark regions, 
and accessible euchromatin – light regions.  Source: UCSF, 









These historical definitions, however, do not sufficiently satisfy our increasing knowledge 
of the molecular signatures of different chromatin environments, and alternatives were 
therefore proposed. For instance, Filion and colleagues performed genome-wide mapping of 
53 chromatin-associated proteins in Drosophila melanogaster, and based on their analysis 
proposed five different chromatin types, three repressive and two active, each defined by a 
unique combination of chromatin factors (Filion et al., 2010).  
The basic repeating unit of chromatin is a nucleosome. The nucleosome consists of eight 
histone proteins that form an octamer, around which 146 bp of DNA is wrapped in 1.65 turns. 
The octamer consists of the core histones H3, H4, H2A and H2B, which form one tetramer 
H3-H4 and two heterodimers H2A-H2B (Kornberg and Thomas, 1974; Luger et al., 1997) 
(Fig. 2).  Comparative studies revealed that core histones are the most evolutionary conserved 
proteins in eukaryotes, with >90% sequence identity between the yeast and human orthologs 
(Malik and Henikoff, 2003). This is presumed to be due to the severe structural constraints 
associated with the assembly of histones into a nucleosome (Luger et al., 1997). 
 
 
Figure 2. The structure of the nucleosome. 
(A) A 2.8A structure of a core nucleosome reconstituted from Xenopus laevis solved by Karolin Luger and her 
colleagues (Luger et al. 1997). 
 (B) A schematic representation of a nucleosome depicting core octamer, consisting of H3-H4 tetramer and two 
H2A-H2B dimers, wrapped around 147bp of DNA. The globular domains of histones reside within the core of 
nucleosome, while N-terminal flexible tails of histones protrude from the surface of the nucleosome.  
(A, B) Structural images were adapted from (Luger et al., 1997), and reprinted from (Allis et al., 2015) with the 





In the most open form of chromatin, individual nucleosomes are connected by 10-80 bp of 
free linker DNA, forming the aforementioned “beads on a string” fibre (Fig. 3). The individual 
nucleosomes can be brought closer together, and therefore make DNA less accessible and 
transcriptionally inactive, if the linker DNA is bound by histone H1, with the resulting 
structure called the “30 nm” fibre (Fig. 3; Robinson and Rhodes 2006; Song et al. 2014). The 
level of compaction is also strongly affected by histone modifications; charged modifications 
alter the accessibility by counteracting the negative charge of DNA, while other modifications 
create specific binding sites for effector proteins that have the ability to compact or relax the 
fibre (Kouzarides, 2007). The chromatin fibre can be further folded and coiled, creating so 
called higher-order chromatin structures (300-700 nm). This seems to be facilitated by intra- 
or inter-chromosomal looping, and anchoring chromatin to the nuclear membrane, possibly 
even in a physiologically relevant organized manner – clustering either the silent or active 
chromatin together (Cavalli and Misteli, 2013; van Steensel and Belmont, 2017). The highest 
level of chromatin compaction, in which the entire chromosomes are organized into compact 
structures visible under the light microscope, occurs only during cell division (Fig. 3).   
Unlike core histones, histone H1 does not seem to display strong evolutionary 
conservation across eukaryotes. The fission yeast lacks H1 completely (Godde and Widom, 
1992), and the budding yeast has only a weakly conserved homolog, Hho1p (31% identical 
to human H1) (Harshman et al., 2013; Patterton et al., 1998). Hhop1 is not essential and its 
deletion has no significant effect on global chromatin organization or expression (Hellauer et 
al., 2001; Patterton et al., 1998). In Caenorhabditis elegans, the single H1 homolog is already 
required for proper germline development and silencing of reporter genes (Jedrusik and 
Schulze, 2001). Finally, mammals have multiple H1 isoforms and the deletion of single genes 
has no significant phenotype, most likely due to partial redundancy, but deletion of at least 







Figure 3.  The organization of chromatin – from nucleosomes to chromosome. 
The 11 nm chromatin fibre consists of individual nucleosomes connected by a free linker DNA. The 30 nm fibre 
is more compact structure, in which linker DNA is bound by histone H1. The 300-700 nm structure is further 
folded and looped form of chromatin, creating so called higher-order chromatin. The 1.5 um structure, the 
chromosome, is the most condensed form of chromatin present in the cell only during cell division. Adapted from 
(Felsenfeld and Groudine, 2003). 
 
2.1. Histone variants 
Metazoan genomes encode several histone isoforms. The genes encoding canonical 
histones, which act in general genome packaging, are clustered together in one array, and are 
transcribed during the S phase for rapid deposition on newly replicated DNA. Non-canonical 
histones, histone variants, are typically found individually in the genome, and neither their 
transcription nor their deposition is synchronised with replication. Variant histones exist for 
H3, H2A and H2B; they usually vary only in few amino acids compared to the canonical 
form, but these small differences significantly affect nucleosome assembly and impact the 




transcription regulation, DNA repair, chromosome segregation, X chromosome inactivation 
and sperm chromatin condensation (Talbert and Henikoff, 2010, 2016). 
The interplay between canonical histones and histone variants is well documented for H3. 
Mammals have two canonical H3 isoforms – H3.1 and H3.2, and three known variants – H3.3, 
cenH3 (in mouse and human called CENP-A), and H3t (Talbert and Henikoff, 2010). The 
canonical H3 is incorporated into chromatin during replication, or alternatively during DNA 
repair, by a histone chaperone complex called Chromatin assembly factor 1 (CAF1) (Polo et 
al., 2006; Tagami et al., 2004). When genes become transcriptionally active, canonical H3 is 
exchanged for H3.3 variants by another complex, Histone regulator 1 (HIRA) (Tagami et al., 
2004). Surprisingly, H3.3 can also be assembled into repressed regions like telomeres, 
mediated by Death-domain-associated-protein – Alpha-thalassemia/mental-retardation-
syndrome-X-linked complex (DAXX–ATRX) (Goldberg et al., 2010). The H3t variant is 
testis specific, and CENP-A is a centromere-specific variant. CENP-A is essential for 
kinetochore assembly and, consequently, chromosome segregation (Amor et al., 2004). 
Interestingly, CENP-A is deposited irrespectively of centromeric DNA sequence, as 
evidenced by so-called neocentromeres – spontaneously formed centromeres at ectopic sites 
that do not contain any centromeric sequences (Fukagawa and Earnshaw, 2014; Voullaire et 
al., 1993). 
The known mammalian variants for H2B are testis specific. H2A variants are H2A.X, 
macro-H2A, H2A.Z, H2A.B and H2A.L, and they govern a wide range of functions. The 
H2Y.X variant was shown to function in double-strand break repair, macro-H2A is a variant 
specific to inactivated X chromosome, and H2A.Z is often found at promoters of active genes 
(Bönisch and Hake, 2012; Talbert and Henikoff, 2010). In summary, histone variants provide 
an additional level of chromatin regulation and specification, and possibly help impose 
epigenetic states over the corresponding regions.  
 
2.2. Histone modifications 
Histones are small highly basic proteins consisting of an alpha helical globular domain and 
a flexible N-terminal “tail”. The globular domains of individual histones form the core of the 




are subject to extensive post-translational modification (PTM), and some PTMs occur at the 
globular domains as well. The most frequent and best characterized modifications are 
acetylation, methylation, phosphorylation and ubiquitination; the function and significance of 
many of the other PTMs remain to be further investigated (Fig. 3; Bannister and Kouzarides, 
2011; Tan et al., 2011; Zhao and Garcia, 2015). The tendency of histone modifications to 
occur at specific residues led David Allis and Brian Strahl to propose the concept of a “histone 
code” – a unique combination of distinct histone modifications acts as an information centre 
signalling to downstream factors and pathways, with a different code resulting in a different 
outcome (Strahl and Allis, 2000). As a result, PTMs can either solidify the inherently 
repressive nature of chromatin, or alternatively, overcome it and create transcriptionally 
permissive chromatin.  
The following chapters focus only on modifications of histone H3 as this is the most 
relevant to my PhD project. 
 
 
Figure 4. The posttranslational modifications of core histone tails 
The N-terminal tails of histones are subject to diverse posttranslational modifications (PTM); PTMs occur in the 
globular domain as well (boxed), some of which are indicated. In general, active marks include acetylation 
(turquoise Ac flag), arginine methylation (purple Me hexagon), and sometimes lysine methylation, such as H3K4 
(green Me hexagon) and H3K36 (yellow Me hexagon) Repressive marks include methylation at H3K9, H3K27, 
and H4K20 (red Me hexagon). Reprinted from (Allis et al., 2015) with the permission from Cold Spring Harbor 






2.2.1. Histone acetylation 
The fact that histones and their modifications do not simply serve as structural scaffolds 
was shown in 1964 in a pioneering study by Allfrey et al., which investigated the role of 
histone acetylation in the regulation of RNA synthesis (Allfrey et al., 1964). In this work, an 
in vitro transcription assay was used to test the effect of no histones, histones or increasingly 
acetylated histones on DNA-dependent-RNA polymerase activity. The simple presence of 
histones had a strong inhibitory effect on transcription that could be gradually overcome by 
an increase in acetylation levels. The most likely explanation, according to the authors, was 
that the specificity of DNA-histone binding was altered by acetylation, and it was proposed 
that this might serve as a transcriptional switch.  
The confirmation of the above hypothesis and the explanation of the role of histone 
acetylation in vivo came, however, only in 1990s. First, it was shown that histone tails are 
crucial for efficient transcription in yeast (Durrin et al., 1991). Shortly after it was found that 
the known yeast transcription regulator, Gcn5p, is homologous to the histone acetyltransferase 
(HAT) purified from Tetrahymena (Brownell et al., 1996), and in parallel work that the yeast 
repressor factor Rpdp3 is a histone deacetylase (HDAC) (Taunton et al., 1996). The 
identification of acetylated amino acids in histone tails followed, and Gcn5p was shown to 
specifically acetylate H3 at lysine 14 (H3K14Ac), and H4 at lysine 8 and 16 (H4K8Ac and 
H4K16Ac) (Kuo et al., 1996). Finally, it was demonstrated that histone lysine acetylation can 
be read by a specialized protein domain – the bromodomain – found in many of known 
transcriptional activators (Dhalluin et al., 1999).  
Over time many other HAT and HDAC enzymes were identified (Yang and Seto, 2007), 
and today we know that all four core histones can be acetylated at specific lysine residues 
(Fig. 3). Eventually, the genome-wide distributions of various histone lysine acetylations were 
mapped and found to globally overlap with active transcription (Wang et al., 2008). The 
HATs, HDACs and bromodomain-containing proteins became common therapeutic targets as 
it was found that many human diseases, like cancer and metabolic disorders, correlate with 






2.2.2. Histone phosphorylation 
At the time when David Allis proposed the idea of the histone code, acetylation had been 
the most studied and appreciated modification, yet it had been known for a long time that 
histone tails carry many other PTMs, including phosphorylation and methylation (Strahl and 
Allis, 2000). What was often lacking at that time, however, was a functional link between the 
modifications and their effect on gene expression. Phosphorylation, another negatively 
charged modification, came first in the spotlight of researchers. Luis Mahadevan and his 
colleagues used growth factors to induce early-response genes, c-jun and c-fos, and observed 
immediate phosphorylation of chromatin-associated protein “pp15”, which correlated with 
the activation of the above genes. Pp15 was identified as histone H3, with the main 
phosphorylation site at serine 10 (H3S10P) (Mahadevan et al., 1991). Not surprisingly, 
phosphorylation did not act alone in the activation of early-response genes, and acetylation 
on the same histones was observed, H3K9AcS10P (Clayton et al., 2000). In addition, the 
authors observed other unidentified PTMs present on the dual modified histones, suggesting 
an even more complex activation mechanism.  
 
2.2.3. Histone methylation 
 Histone methylation puzzled researches for a bit longer. It is electrostatically neutral, and 
therefore cannot alter histone-DNA interactions, suggesting that it rather serves as a recruiter 
of other nuclear regulators. The first breakthrough came in 1999, when two different groups 
isolated histone methyltransferase enzymes (HMTs). Chen and co-workers isolated a 
transcriptional coactivator with HMTase activity and specificity for H3 arginine residues – 
coactivator associated arginine methyltransferase 1 (CAMR1) (Chen et al., 1999). In the 
second work, Strahl et al. purified an HMTase from the transcriptionally active macronuclei 
of Tetrahymena, with preferential specificity for H3 lysine 4 (H3K4me). The authors also 
confirmed the conservation of this modification in yeast and mammalian cells (Strahl et al., 
1999). Both studies concluded that histone methylation acts in transcriptional activation.  
Shortly after, a mammalian HMTase was isolated, suppressor of variegation 3-9 homolog 
(Suv39h), this time with specificity for H3 lysine 9 (H3K9me) (Rea et al., 2000). 
Unexpectedly, the known homologs of Suv39h, S. pombe Clr4 and Drosophila Su(var)3-9, 




et al., 1994). Rea et al. confirmed that the Clr4 homolog is an active HMTase with H3K9 
specificity. Next, they used differentially modified H3 peptides as a substrate for an in vitro 
HMTase assay, and found that H3K9Ac and H3S10P block the ability of Suv39h to methylate 
K9. This result pointed towards the possibility of an in vivo regulation mechanism protecting 
active chromatin from deposition of repressive marks. Finally, based on the obtained data, 
they proposed that H3K9me acts as a key determinant of the histone code defining 
heterochromatin. Indeed, H3K9me was later shown to act as a binding platform for 
heterochromatin protein 1 (HP1) homologs (Bannister et al., 2001; Lachner et al., 2001), 
known heterochromatic factors acting in gene silencing and chromatin compaction 
(Eissenberg and Elgin, 2000; Platero et al., 1995). Interestingly, binding of the HP1 proteins 
to the H3K9me mark was found to be regulated by H3S10P (Fischle et al., 2005). Fischle et 
al. showed that phosphorylation of H3SP10 by kinase Aurora B during M-phase ejects HP1 
proteins from chromatin. At the end of the M-phase, phosphorylation is removed, and HP1 
binding can be restored. 
The next repressive HMTase that was discovered was the Extra-sex-combs and Enhancer-
of-zeste (ESC-E(Z)) complex, which was purified from fly embryos with methylation activity 
directed towards H3 lysine 27 (H3K27me) (Müller et al., 2002). Mutations in the catalytic 
subunit of the complex, E(Z), disrupted methyltransferase activity in vitro, and in vivo led to 
the derepression of known ESC-E(Z) targets, Homeobox (Hox) genes. Interestingly, the ESC 
component was found to be a H3K27me reader, with the ability to allosterically stimulate the 
HMTase activity of E(Z) (Hansen et al., 2008; Margueron et al., 2009). Disruption of the 
ability of ESC to bind H3K27me in flies led to a global reduction of methylation and defects 
in development. This elegant combination of H3K27me reader and writer factors within one 
complex allows for the epigenetic transmission of repressed state across cell divisions. 
Similarly to H3K9me, methylation of the H3K27 residue is inhibited by active marks that are 
already present on the H3 tail, thus restricting ESC-E(Z) activity to already silent chromatin 
(Schmitges et al., 2011). Note: the ESC-E(Z) complex is also known as Polycomb repressive 
complex 2 (PRC2). 
Unlike histone acetylation, where HATs deposit the mark and HDACs remove it, histone 
methylation was originally thought to be a permanent mark. This assumption was later 




different classes of HDMs, lysine specific demethylases  (LSD1 and LSD2) and Jumonji-C 
(JmjC)-domain-containing histone demethylases, were found (Karytinos et al., 2009; Klose 
et al., 2006; Shi et al., 2004). The LSD1 enzyme specifically demethylates the H3K4me mark. 
The knockdown of LSD1 leads to an increase of H3K4me and, consequently, to upregulation 
of gene expression  (Shi et al., 2004). Similarly, H3K9me is a reversible mark removed by 
JmjC domain-containing histone demethylation protein 2A (JHDM2A). The knockdown of 
JHDM2A results in the increase of H3K9me levels at a subset of genes, accompanied by a 
decrease in their expression (Yamane et al., 2006). More detailed analyses of HDMs revealed 
that they have a wider range of substrates than originally thought, for example LSD1 can 
demethylate H3K9me as well; eventually many other homologs of JmjC demethylases with 
specificity for other histone methylations were found (Højfeldt et al., 2013). 
Today we know that the most common methylation sites of histone H3 are lysines at 
position 4, 9, 27, 36, 79 and arginines at position 2, 17, 26 (Fig. 3; Bannister and Kouzarides, 
2011). Residues can be mono- (me1), di- (me2) or tri- (me3) methylated, allowing for yet 
another level of regulation (more in Chapter 5). In general, individual histone modifications 
show a discrete localization to active or silent chromatin regions, and in addition, they can 
have a specific distribution pattern within their chromatin region, e.g. different active marks 
in promoters and gene bodies. The distribution of the most important histone PTMs is further 
described in the next chapter (Fig. 5).  
 
2.3. Distribution of distinct histone marks  
The genome-wide mapping of histone modifications revealed that active genes associate 
with H3K4me1/2/3, H3K36me3 and hyperacetylated histones (Barski et al., 2007; Heintzman 
et al., 2007, 2009; Mikkelsen et al., 2007; Wang et al., 2008). The promoters of active genes 
show a high enrichment of RNA polymerase and H3K4me3, while active enhancers are 
marked by H3K4me1, p300 (HAT) and H3K27Ac (Creyghton et al., 2010; Heintzman et al., 
2009). The H3K4me2 mark is present in enhancers, promoters and to some extent gene bodies 
(Heintzman et al., 2009). Finally, H3K36me3 marks the gene bodies of transcribed genes 




The repressed chromatin regions are characterized by H3K9, H3K27 and H4K20 
methylation marks. H4K20me3 and H3K9me3 play a role in the silencing of constitutive 
heterochromatin, while H3K9me2 and H3K27me3 are associated with the silencing of 
facultative heterochromatin (Mikkelsen et al., 2007; Peters et al., 2003; Schotta et al., 2004). 
Interestingly, H3K27me3 can co-occur with H3K4me3 at the promoters of developmental 
genes in embryonic stem cells (ESCs), and this chromatin type is referred as bivalent 
(Bernstein et al., 2006). The proposed function of bivalent domains is to poise promoters for 
rapid activation upon developmental stimulation. The nucleosomes were originally thought 
to be modified in an asymmetric way, with one H3 tail carrying H3K4me3 and the other 
H3K27me3 (Voigt et al., 2012). More recently, however, Shema et al. used single molecule 
technologies to show that this bivalent mark can even occur on the same H3 tail (Shema et 
al., 2016). 
The different functional chromatin domains must be separated from each other to prevent 
spreading of epigenetic modifications or block unwanted interactions between regulatory 
elements, e.g. enhancers and promoters. The information about these “borders” is encoded in 
the DNA sequence, referred to as insulators or boundary elements.  In mammals, the CCCTC-
binding factor (CTCF) was shown to act as an insulator of neighbouring regions, forming so 
called topologically associating domains (TADs) (Dixon et al., 2012; Gaszner and Felsenfeld, 
2006; Nora et al., 2017). CTCF binds to more than 20 000 sites in the genome, and its binding 
was shown to relatively correlate with all three methylation states of H3K4me, H3K9me1 and 








Figure 5. Distribution of histone marks 
Enhancer, promoter and gene body are indicated in the scheme as an example of actively marked gene. H3K4me1, 
H3K27ac and HATase p300, marks active enhancers. H3K4me3 and hyperacetylation mark active promoters, and 
H3K36me3 marks gene bodies of actively transcribed genes. Repressed genes can be marked by H3K27me3, 
facultative heterochromatin, or alternatively by H3K9me3 in case of constitutive heterochromatin. Ctcf marks 
insulators creating boundaries between local chromatin domains. Altogether, creating a map of functional elements 
and chromatin domains. Reprinted from (Allis et al., 2015) with the permission from Cold Spring Harbor 




















3. Transcription factors 
Unlike in prokaryotes, where DNA is freely accessible to the transcriptional machinery, 
the DNA of eukaryotes is by default in a transcriptionally restricted state (Struhl, 1999). This 
state can be further reinforced or elevated by chromatin modifications and chromatin 
associated factors. The above chapters summarized how different histone modifications affect 
gene expression, and act as transmitters of the functional status across cell divisions. 
However, the initial signal for establishment of an active or inactive chromatin environment 
must come from regulatory factors that have the ability to recognize and bind specific DNA 
sequences. 
The power of DNA binding factors was first demonstrated by Davis et al., who showed 
that fibroblasts can be converted to myoblasts by overexpression of a single factor, Myoblast-
determination (MyoD) protein (Davis et al., 1987). Other examples followed; in one study the 
targeted expression of the Paired box 6 (Pax6) protein in developing Drosophila was shown 
to induce the growth of ectopic fully developed eyes on wings or legs (Halder et al., 1995). A 
decade ago, Shin Yamanaka and his group succeeded in converting mouse fibroblast into 
pluripotent stem cells by overexpressing four factors, Oct3/4, Sox2, c-Myc and Klf4 
(Octamer-binding transcription factor 3/4, Sex-determining-region-Y box 2, 
Myelocytomatosis-viral-oncogene homolog and Kruppel-like factor 4) (Takahashi and 
Yamanaka, 2006), a major discovery that started a whole new field.  
All of the above factors are so called “transcription factors”, a class of proteins with the 
ability to recognize and bind specific DNA sequences to activate or repress gene activity. The 
ability of most transcription factors (TFs) to bind their cognate DNA motif is regulated by 
nucleosome distribution, epigenetic modifications and higher-order chromatin organization. 
Indeed, genome-wide mapping studies of TF binding have shown that most TFs bind only a 
minority of their consensus target sites in the genome, mostly in already accessible or active 
regions (Li et al., 2011; Slattery et al., 2014). Yet, there is a subgroup of TFs, pioneer factors, 
which are able to recognize and bind their specific DNA motif irrespective of nucleosomes  
(Cirillo et al., 1998). The forkhead box A (FoxA) possesses a DNA binding domain that is 
very similar to the nucleosome-binding domain of linker histone H1. This is a rather unusual 
resemblance, considering that H1 acts in compaction and thus repression, whereas FoxA acts 




bind its full DNA motif on the nucleosome, displace H1, and using its C-terminus to interact 
with the core histones, opening chromatin and making it accessible for other co-factors or 
downstream regulators (Cirillo et al., 1998; Iwafuchi-Doi et al., 2016). Three of the four 
proteins previously mentioned as having a capacity to reprogram (Oct3/4, Sox2 and Klf4 
(OSK)) were also found to act as pioneer factors (Soufi et al., 2012, 2015). Interestingly, the 
fourth factor, c-Myc, prefers to bind to active chromatin on its own, but can bind inaccessible 
chromatin in cooperation with the OSK pioneer factors (Soufi et al., 2012, 2015). Analogously 
other transcription factors were found to cooperate with pioneer factors to bind inaccessible 
chromatin (Zaret and Carroll, 2011; Zaret and Mango, 2016). It is important to note that even 
pioneer factors cannot efficiently access epigenetically repressed chromatin like H3K9me-
marked heterochromatic domains (Soufi et al., 2012). 
Nevertheless, some transcription factors were found to access their sites on nucleosomes 
independently of pioneer factors. TFs that cannot bind their targets on nucleosomes 
individually were shown to be able to do so simultaneously, implying that cooperative binding 
might be a general mechanism (Adams and Workman, 1995). Other models propose that 
Adenosine triphosphate (ATP)-dependent chromatin remodelling complexes, remodellers, 
constantly scan the genome, loosen chromatin, and thus create access points for transcription 
factors (Erdel et al., 2010; de la Serna et al., 2006). Alternatively, TFs can couple with 
remodellers, accessing their sites together (Cosma et al., 1999). 
In general, transcription factors that bind DNA in a sequence-specific manner contain one 
of the following DNA binding domains: helix-turn-helix (HTH), zinc-coordinating or zipper-
type (Luscombe, Austin, Berman†, & Thornton, 2000).  The zinc-coordinating type is the 
most frequently occurring class in the genome of Homo sapiens. Transcription factors are 
usually classified based on their DNA binding domains or, alternatively, according to their 
hierarchy in binding to chromatin (e.g. pioneer factors). The following chapter is going to 








3.1. Activity dependent-neuroprotective protein 
The Activity-dependent neuroprotective protein (Adnp) is a putative transcription factor 
that is highly conserved in human, rat and mouse (Bassan et al., 1999; Sigalov et al., 2001; 
Zamostiano et al., 2001). Adnp was originally discovered as a protein associated with 
neuroprotection (Bassan et al., 1999), but later was found to be required during mouse 
development – its deletion is embryonically lethal (Pinhasov et al., 2003). This implicates that 
Adnp functions beyond the nervous system, yet its molecular function is not understood. The 
following paragraphs summarize current knowledge about the Adnp protein. 
 
3.1.1. Domain organization 
Adnp contains nine N-terminal zinc fingers, a C-terminal homeodomain, a C-terminal 
Proline-X-Valine-X-Leucine (PxVxL) pentapeptide motif, and a histone H3K9 mimic 
sequence (Fig. 6; Bassan et al., 1999; Mandel et al., 2007; Mosch et al., 2011; Zamostiano et 
al., 2001). All of the zinc fingers (ZF) in Adnp are the cysteine-cysteine-histidine-histidine 
(C2H2) type. The C2H2 motif is characterized by a tetrahedral coordination of one or two 
zinc ions (Zn) (Luscombe et al., 2000). ZFs are usually found in multiple copies within one 
protein, and are frequently accompanied by another DNA binding domain (Bateman et al., 
2017). Adnp contains two conserved (6, 7), three atypical (5, 8, 9) and four degenerate (1-4) 
ZFs; atypical ZFs deviate from the consensus sequence but can coordinate Zn, while 
degenerate ZFs are too different from the original C2H2 motif and have thus lost the ability 
to bind Zn (Bateman et al., 2017). The homeodomain shows the closest homology to the 
homeobox domain of the Hox protein family. Homeodomains contain a HLH motif, which 
consists of two α-helices connected by a flexible linker. The HTH motif invariably binds in 
the DNA major groove; the first helix helps stabilize the structure, and the second helix, 
commonly known as the recognition helix, is inserted in the groove forming a number of 
hydrogen bonds and hydrophobic interactions with DNA (Luscombe et al., 2000). The C-
terminal PxVxL pentapeptide, where x can be any amino acid, is a protein interaction motif 
that can be read by HP1 proteins (Thiru et al., 2004), and similarly the H3 mimic was shown 





Figure 6. Domain architecture of the mouse Activity-dependent neuroprotective protein 
(Adnp). 
The Adnp protein consists of nine N-terminal zinc fingers (ZFs) - two typical ZFs (6, 7), three atypical ZFs 
(5, 8, 9) and four degenerate ZFs (1, 2, 3, 4); followed by C-terminal DNA binding motif, homeobox domain. 
Two additional motifs are adjacent to homeobox domain, histone H3 mimic and PxVxL; both of these motifs 
can facilitate interaction with HP1 homologs.   
 
3.1.2. Interacting partners 
The Adnp protein was found to co-immunoprecipitate one of the three HP1 homologs, 
HP1α, from the embryonic carcinoma cell line P19 as well as from differentiated P19 cells 
(Mandel et al., 2007). This interaction was further supported by another work that showed 
HP1α- or HP1β-dependent Adnp association with heterochromatin (Mosch et al., 2011). The 
presence of the PxVxL motif in Adnp suggests that this is a direct interaction, but this has not 
been confirmed biochemically. In another study, immunoprecipitation of ADNP from human 
embryonic kidney 293 (HEK293) cells followed by mass spectrometry identified Brahma-
related gene 1 (BRG1), BRG1-associated factor 250a and 170 (BAF250a, BAF170), as co-
immunoprecipitating proteins, all components of the Switch/sucrose non-fermentable 
(SWI/SNF) chromatin-remodelling complex (Mandel and Gozes, 2007). To date, there are no 
other publications describing Adnp interactors, although Adnp was found in several works as 
a “prey”. For example, Adnp was identified as an interactor of HP1 homologs (Nozawa et al., 
2010; Rosnoblet et al., 2011; Vermeulen et al., 2010), and the mutation of a residue crucial 
for PxVxL motif recognition in HP1 abolished its interaction with ADNP in HEK293 cells 
(Nozawa et al., 2010). Large-scale interactome profiling of various transcription factors found 
Adnp in Forkhead box (Fox) homologs, Nuclear factor of activated T-cells 1 (Nfatc1) or 
TEF1-abaA (TEA)-domain transcription factor 2 (Tead2) purifications (Li et al., 2015), 






The association of Adnp with chromatin was confirmed by chromatin 
immunoprecipitation (ChIP) and immunofluorescence assays (Mandel et al., 2007; Mosch et 
al., 2011). ADNP was proposed to act as a regulator of gene expression in association with 
HP1 and/or the SWI/SNF complex, and the knockdown of ADNP in HEK293 cells induced 
distinct morphological changes and reduced viability (Mandel and Gozes, 2007). Moreover, 
complete deficiency in Adnp during mouse development results in general organogenesis 
defects, and failure in neural tube closure resulting in death at days 8.5-9.5 of gestation (E8.5-
9.5) (Pinhasov et al., 2003). The in situ hybridization of the pluripotency marker Oct4 and the 
neuronal marker Pax6 in control and mutant E8.2 embryos revealed that mutants failed to 
downregulate Oct4 or induce Pax6 expression. In the follow-up work from the same 
laboratory, Mandel et al. analysed gene expression by microarrays in Adnp-deficient mouse 
embryos (Mandel et al., 2007). The embryos exhibited upregulation of transcripts associated 
with lipid metabolism and extra-embryonic tissues, and downregulation of organogenesis, and 
in particular neurogenesis, related transcripts.  
ADNP is abundantly expressed in different human adult tissues with highest expression 
levels in cerebellum, cortex, heart, skeletal muscles, kidney, placenta and testis (Zamostiano 
et al., 2001). The levels of ADNP are often elevated in malignant cells, and the knockdown 
of Adnp in intestinal cancer cells reduced their viability by 90%, which was accompanied by 
upregulation of the tumour suppressor protein p53 (Zamostiano et al., 2001). More recently, 
de novo mutations in the ADNP gene were found to underlie ADNP syndrome (also known 
as Helsmoortel-Van der Aa syndrome/HVDAS), an extremely rare complex 
neurodevelopment disorder (Helsmoortel et al., 2014). This syndrome is commonly 
associated with neurological, cardiovascular, musculoskeletal, gastrointestinal, endocrine 
and immune defects, as well as vision, hearing, growth, feeding and sleep impairment. 
Additionally, patients exhibit delays in speech and intelligence, and many develop 
behavioural conditions such as autism spectrum disorders (ASD). It is estimated that at least 
0.17% of ASD patients have an ADNP mutation, making it one of the most frequent ASD-






4. Chromatin remodellers 
Although chromatin generally restricts access of proteins to DNA, the degree to which 
individual nucleosomes inhibit transcription factors from interacting with their specific sites 
is quite variable, and can be further modulated by altering the nucleosome positioning via 
chromatin remodellers (Workman and Kingston, 1998). Genome-wide mapping of 
nucleosome positioning in S. cerevisiae has revealed a stereotyped Pol II promoter 
organization in which a nucleosome-free region (NRF) is present within approx. 200 bps 
upstream of the start codon flanked on both sides by well positioned nucleosomes (Yuan et 
al., 2005). This suggests that transcriptional activation requires exposure of DNA, which in 
turn means that access of transcription factors to regulatory elements, and therefore gene 
expression, can be regulated by remodellers and nucleosome positioning. 
Remodellers use ATP hydrolysis as an energy source to slide, space, eject or assemble 
nucleosomes; or to replace individual histones within the nucleosome. In mammals, approx. 
30 genes encoding for chromatin-remodelling ATPase subunits have been identified (Ho and 
Crabtree, 2010). The vast majority of remodelling ATPases appears to be genetically 
nonredundant as their deletions result in early embryogenesis phenotypes, suggesting specific 
biological roles. Phylogenetic and functional analyses have grouped all remodeling ATPases 
into the RNA/DNA helicase superfamily 2 (Clapier et al., 2017). Based on the sequence and 
the structural conservation of individual ATPases, the chromatin remodellers can be further 
divided into four subfamilies: Imitation switch (ISWI), INO80, SWI/SNF and Chromodomain 
helicase DNA-binding (CHD) (Clapier and Cairns, 2014). These subfamilies are conserved 
from yeast to human and all contain their subtype ATPase domain, but differ in additional 
domains and features. Furthermore, higher eukaryotes evolved multiple remodeller subtypes 
within each subfamily, often with cell-type or developmentally specific functions (Ho and 
Crabtree, 2010; Kadoch and Crabtree, 2015).   
ISWI remodellers act mostly as repressors, assembling and regularly spacing nucleosomes 
in a way that limits DNA accessibility (Clapier et al., 2017). An exception in this subfamily 
is the Nucleosome-remodelling-factor (NURF) complex, which, with the help of additional 
subunits, randomizes spacing and facilitates transcriptional initiation (Xiao et al., 2001). Apart 




(HSS) domain that can bind the unmodified H3 tail and the linker DNA (Boyer et al., 2004; 
Dang and Bartholomew, 2007; Grüne et al., 2003). 
INO80 members mostly function in nucleosome editing that is associated with 
transcriptional activation and DNA repair (Clapier et al., 2017). They can remove individual 
histones within an octamer and replace them with canonical or variant histones. For instance, 
the SWR1 complex replaces canonical H2A for its H2A.Z variant in gene promoters 
(Mizuguchi et al., 2004), and so does E1A binding protein p400 (EP400), which can in 
addition exchange H3.1 with its H3.3 variant in promoters and enhancers (Pradhan et al., 
2016). Interestingly, another family member, INO80c, prevents H2A.Z depositioning outside 
of gene promoters (Papamichos-Chronakis et al., 2011). 
SWI/SNF type remodellers are the best described subfamily. They typically provide 
chromatin access by repositioning and/or ejecting nucleosomes, which can facilitate either 
activating or repressive functions and DNA repair (Clapier et al., 2017).  SWI/SNF 
remodellers contain an N-terminal helicase SANT-associated (HAS) domain, which can bind 
actin and actin-related proteins (Schubert et al., 2013), and a C-terminal bromodomain 
accompanied by a pair of DNA binding motifs, AT-hooks (Clapier et al., 2017).  
CHD family members are versatile remodellers providing chromatin access by 
nucleosome sliding, but also performing nucleosome assembly and editing (Clapier et al., 
2017). They are characterised by two N-terminal tandemly arranged chromatin organization 
modifier (chromo) domains (Delmas et al., 1993; Woodage et al., 1997). The family is further 
divided into three subtypes based on the presence of additional domains (Marfella and 
Imbalzano, 2007). Subtype 1 (CHD1/CHD2) contains a C-terminal DNA binding domain 
consisting of a SANT-SLIDE motif similar to ISWI (Ryan et al., 2011), subtype 2 
(CHD3/CHD4/CHD5) contains a paired plant homeodomain (PHD) zinc-finger-like domain 
at the N-terminus (Woodage et al., 1997), and subtype 3 (CHD6-CHD9) contains two C-
terminal domains, SANT and BRK (Brahma and Kismet) (Shur and Benayahu, 2005). 
CHD3/CHD4 ATPases are fundamental subunits of the Nucleosome remodelling and 
histone deacetylase (NuRD) complex. This complex functions in transcriptional activation 
and repression, in replication-coupled chromatin assembly, and in DNA repair (Basta and 
Rauchman, 2017; Lai and Wade, 2011). NuRD contains another enzymatic subunit, histone 




enzymatic subunits: metastasis-associated gene 1 (MTA1), MTA2 and MTA3, methyl-CpG-
binding domain 2 (MBD2) and MDB3, retinoblastoma-binding protein 4 (RBBP4; also 
known as RBAP48) and RBBP7 (RBAP46), and GATAD2A (p66α) and GATAD2B (p66β) 
(Denslow and Wade, 2007; Lai and Wade, 2011). The complex is possibly targeted across the 
genome by MTA and MBD subunits; MTA by associating with transcription factors (Fujita 
et al., 2004), MBD2 by binding to methylated DNA (Hendrich and Bird, 1998), and MBD3 
by binding to a product of active DNA demethylation, 5-hydroxymethylcytosine (Yildirim et 
al., 2011). In addition, the CHD4 subunit can bind DNA by its chromodomain (Bouazoune et 
al., 2002), and differentially modified H3 tails via its PHD fingers (Musselman et al., 2009). 
CHD4 seems to have NuRD independent functions, and it is possible that some of the assigned 
NuRD functions are in fact CHD4 specific (Basta and Rauchman, 2017). Biochemically, 
CHD4 does not require other NuRD components for its remodelling activities (Wang and 
Zhang, 2001), and Chd4 mouse knockout embryos die preimplantation, while other NuRD 


















5. Chromatin readers - HP1 proteins  
HP1 was originally discovered in Drosophila, by Sarah Elgin’s laboratory, as a non-
histone chromosomal protein associating with heterochromatin (James and Elgin, 1986). 
Shortly after, the same group identified HP1 as a dominant suppressor of position-effect 
variegation (PEV), a phenomenon of mosaic silencing observed when a euchromatic gene is 
placed near or within heterochromatin (Eissenberg et al., 1990). The family of HP1 proteins 
quickly expanded as other homologs were identified in Drosophila and other organisms 
(Singh et al., 1991). Today, we know that the HP1 family is evolutionary conserved with 
members across nearly all eukaryotes, ranging from fission yeast to plants to mammals. For 
instance, the fission yeast homolog shows overall 20% amino-acid sequence identity with 
mammalian homologs, and its chromo domain can be functionally replaced by the mouse 
HP1 chromo domain (Canzio et al., 2014; Wang et al., 2000). In mammals, the HP1 proteins 
are encoded by the Chromobox (Cbx) genes. The Cbx superfamily is defined by a conserved 
N-terminal domain, the chromatin organization modifier (chromo) domain (CD) (Paro and 
Hognesst, 1991). Both mice and humans possess three HP1 homologs, HP1, HP1 and 
HP1which are encoded by the Cbx5, Cbx1 and Cbx3 genes in mice, and the CBX5, CBX1 
and CBX3 genes in humans, respectively. The murine and human genes are located on 
syntenic chromosomal regions, and the proteins show an extremely high level of sequence 
identity – 98% for HP1, 100% for HP1, and 99.5% for HP1 (Bateman et al., 2017; 
Lomberk et al., 2006a).  
 
5.1. Domain organization  
Apart from the N-terminal chromo domain, HP1 proteins contain another structured 
module, the C-terminal chromo-shadow domain (CSD). Both domains have flexible 
extensions, N-terminal (NTE) and C-terminal (CTE), and are connected to each other by a 
flexible linker called the hinge (Fig. 7). The HP1 chromo domain specifically recognizes 
methylated lysine in the ARKS motif (ARKmeS), which is present in the H3 histone (H3K9) 
(Bannister et al., 2001; Jacobs et al., 2001; Lachner et al., 2001), but also in other proteins, 
such as the Eukaryotic HMTase 2 (Ehmt2) (Sampath et al., 2007). The chromo domain was 




H3K9me1, with the unmodified peptide showing the weakest affinity (Fischle et al., 2005; 
Yamada et al., 2005). The binding constants are rather weak, in the mol.L-1 (M) range; 
however, the affinity seems to be further fortified in vivo by additional mechanisms like the 
unspecific interaction of the hinge with nucleosomal DNA (Mishima et al., 2013) or by PTMs 
– the phosphorylation of tandem serines in the NTE of HP1 increases its affinity 
approximately fivefold (Hiragami-Hamada et al., 2011). Interestingly, this array of serines is 
not present in the other two homologs. The structure of the HP1 chromo domain resolved by 
nuclear magnetic resonance (NMR) revealed an N-terminal three-stranded antiparallel -sheet 
folded against a C-terminal -helix (Ball et al., 1997), but it did not provide any explanation 
for the specificity towards the ARKmeS motif.  The answer came from the structure of the 
chromo domain bound to the H3K9me2/3 peptide that revealed an aromatic cage, serving as 
a hydrophobic pocket for K9me2/3 (Jacobs and Khorasanizadeh, 2002; Nielsen et al., 2002). 
The other residues of the peptide form bonds with the -sheet of the chromo domain, and are 
equally important in establishing a stable specific interaction. A point mutation of alanine 
from the ARKS motif to methionine reduces the affinity of the CD for H3K9me2 25-fold 
(Jacobs and Khorasanizadeh, 2002). Similarly, substitution of the CD residue creating contact 
with the ARKS alanine, valine (V26 in Drosophila), leads to the mislocalisation of HP1 and 
impaired silencing in vivo (Platero et al., 1995).  
 
Figure 7. A schematic representation of HP1 proteins.  
HP1 proteins consist of two conserved domains, chromo and chromo-shadow, connected by a less conserved 
linker, hinge. In addition, there are N-terminal and C-terminal flexible extensions (NTE and CTE). The chromo 
domain serves as a recognition and binding module for the H3K9 methylation mark. The chromo-shadow acts as 
an interaction platform – mediating formation of HP1 homo- or heterodimers, and/or interaction with other 




The chromo-shadow domain adopts a very similar structure to the CD, consisting of a 
three-stranded antiparallel -sheet followed by two -helices (Brasher et al., 2000; Cowieson 
et al., 2000).  The second a-helix, which is missing in the CD, mediates the CSD dimerisation. 
The fold of the CSD dimer creates a nonpolar binding pocket, which serves as a protein 
interaction platform that can be bound by proteins containing a PxVxL motif (Thiru et al., 
2004). The protein interactions can, in addition, be regulated by the CTE residues (Mendez et 
al., 2013). Interestingly, the CSD can form homo- and heterodimers, both in vitro and in vivo 
(Nielsen et al., 2001). 
The hinge linker is the least conserved region in the HP1 family, both within and across 
species. It contains a nuclear localisation signal, and carries multiple PTMs, with 
phosphorylation and SUMOylation being the best functionally characterised (LeRoy et al., 
2009; Maison et al., 2011; Shimada et al., 2009; Zhao et al., 2001). The hinge contains a high 
number of KR residues that give it an overall positive charge, and has been implicated in 
nucleic acid binding (Keller et al., 2012; Maison et al., 2011; Mishima et al., 2013; Muchardt 
et al., 2002). 
 
5.2. Interacting partners  
Mammalian HP1s interact with a wide range of proteins, with BioGRID, a protein 
interaction database, listing nearly 200 HP1-specific interactions. Many of these, however, 
were not verified biochemically, and therefore are not necessarily direct. For the purpose of 
this thesis, I am going to list only the best-characterised and/or most relevant ones. In general, 
the HP1 interactors can be divided into three groups: (1) transcriptional regulators and 
chromatin-related proteins, (2) DNA replication and repair factors, (3) nuclear structure 
proteins (Table 1) (Lomberk et al., 2006a). Not surprisingly, group (1) contains histones and 
histone modifying enzymes. HP1s interact with two HKMTases that create their binding 
substrate, H3K9me, the Ehmt1/2 and Suv39h1/2 proteins (Aagaard et al., 1999; Melcher et 
al., 2000; Nozawa et al., 2010; Rosnoblet et al., 2011; Sampath et al., 2007). Ehmt1 and Ehmt2 
form a heterodimeric complex that acts as the primary enzyme for H3K9me1 and H3K9me2 




redundant paralogs depositing H3K9me3 in pericentric heterochromatin1 (Maksakova et al., 
2013; Peters et al., 2003; Rea et al., 2000; Rice et al., 2003; Tachibana et al., 2002, 2005). 
HP1s interact with another factor involved in retrotransposon silencing, tripartite motif 
containing 28 (Trim28).  Trim28 contains the PxVxL motif that mediates direct interaction 
with HP1s, and acts as a corepressor mediating transcriptional silencing via interaction with 
Krüppel-associated box (KRAB) domain-containing zinc-finger proteins (Friedman et al., 
1996; Lechner et al., 2000; Rowe et al., 2010; Sripathy et al., 2006). The HP1 proteins were 
shown to associate with the nuclear envelope by interacting with its structural components 
Lamin B and Lamin B receptor (LBR) (Kourmouli et al., 2000; Lechner et al., 2005; Ye and 
Worman, 1996). This coincides with the localisation of heterochromatin to the nuclear 
periphery (Fig. 1; (Akhtar and Gasser, 2007)).  
 
Table 1. Summary of the mammalian HP1-interacting proteins 
Interactor               HP1 homolog Reference 
  
(1)  Transcriptional regulators and chromatin-related proteins 
H1  (Hale et al., 2006; Nielsen et al., 2001) 
Core histones  (Nielsen et al., 2001; Rosnoblet et al., 2011) 
Dnmt1/3   (Fuks et al., 2003; Lehnertz et al., 2003; Smallwood et al., 2007) 
Suv39h1/2  (Aagaard et al., 1999; Melcher et al., 2000; Nozawa et al., 2010) 
Ehmt1/2  (Nozawa et al., 2010; Sampath et al., 2007) 
Brg1  (Lechner et al., 2005; Nozawa et al., 2010) 
Chd4   (Rosnoblet et al., 2011) 
Atrx1  (Lechner et al., 2005) 
Trim28  (Lechner et al., 2000; Nozawa et al., 2010; Rosnoblet et al., 2011) 
Adnp  (Mosch et al., 2011; Nozawa et al., 2010; Rosnoblet et al., 2011) 
   
(2)  DNA replication and repair factors 
Caf1*  (Lechner et al., 2005; Nozawa et al., 2010; Rosnoblet et al., 2011) 
Rbb4*  (Nozawa et al., 2010; Rosnoblet et al., 2011) 
Ku70  (Lomberk et al., 2006b; Rosnoblet et al., 2011) 
ORC  (Prasanth et al., 2010) 
   
                                                          
Pericentric heterochromatin is a region of chromatin that is found juxtaposed to the centromere. It consists of 




(3)  Nuclear structure proteins 
Lamin B  (Kourmouli et al., 2000) 
Lbr  (Lechner et al., 2005; Ye and Worman, 1996) 
 
(Trim28; Tripartite Motif Containing 28), (LBR; Lamin B receptor), (ORC, Origin recognition complex), (Rbb4 
Retinoblastoma-binding protein 4), (Dnmt1/3 DNA methyltransferase 1 and 3 ), (*Caf1 and Rbb4 form a Caf 
complex) 
 
5.3. Role of mammalian HP1s 
The most common role of HP1is the silencing of chromatin. For this, HP1s use their two-
domain structure to physically link their substrate histone mark, H3K9me, with the repressive 
non-histone proteins that they interact with. In this model, silencing involves an iterative self-
sustaining loop, in which HP1 is recruited by H3K9me and/or by the HKMTase depositing 
the mark. In turn, HP1 recruits more HKMTases, which leads to propagation of the H3K9me 
mark along the locus, and consequently, to spreading of HP1 binding. The HP1 association 
with constitutive heterochromatin is greatly reduced in Suv39h double-null (dn) cells (García-
Cao et al., 2004; Lachner et al., 2001), and similarly, deletion of the Ehmt2 gene leads to 
depletion of HP1 binding within silent euchromatin (Tachibana et al., 2005). Alternatively, 
HP1s can be recruited by Trim28, which also interacts with an H3K9me3-depositing 
HKMTase, SET (Suv39, E(z), Trithorax)-domain bifurcated 1 (SETDB1) (Schultz et al., 
2002).  
Artificial targeting of Trim28 to a reporter gene is sufficient to induce silencing, but it 
requires an intact interaction with HP1 and Setdb1 (Sripathy et al., 2006). Equivalently, 
tethering of HP1 or HP1 is sufficient to recruit Trim28 and Setdb1, and to repress the target 
reporter gene (Ayyanathan et al., 2003; Verschure et al., 2005). A later study by Hathaway et 
al., studying the dynamics of heterochromatin formation and maintenance, found that 
transient targeting of HP1upstream of the promoter of the endogenous Oct4 allele in mouse 
ES cells, leads to the erasure of the active marks, H3K4me3 and H3K27ac, and to the 
deposition of H3K9me3. The H3K9me3 mark is first deposited at the tethering site but 
continues to spread, eventually forming a domain spanning across approx. 10 kilo base pairs 
(kbp) (Hathaway et al., 2012). The acquired repressed state can be inherited over multiple 




Verschure et al., 2005). It is important to say, however, that the propagation of the silent state 
and the presence of H3K9me3 was accompanied by the deposition of the DNA methylation 
at the target locus (Hathaway et al., 2012). This is consistent with the silencing mechanism 
observed at naturally repressed chromatin sites. Both HP1s and HKMTases were shown to 
interact with the de novo DNA methyltransferase 3 homologs (Dnmt3a and/or Dnmt3b) 
(Table 1; Fuks et al., 2003; Lehnertz et al., 2003; Li et al., 2006). The study by Lehnertz et al. 
revealed that the Suv39h-mediated H3K9 methylation, and the HP1 binding, precede the 
establishment of the DNA methylation at the pericentric heterochromatin. In addition, the 
HP1 proteins co-immunoprecipitate the maintenance DNA methyltransferase 1 (Dnmt1) 
(Table 1; (Fuks et al., 2003; Smallwood et al., 2007)). All of the above-mentioned factors – 
Dnmt1, HKMTases and HP1s, were shown to, directly or indirectly, associate with the 
replication fork, contributing to the propagation of the silent state across the cell divisions 
(Table 1; Chuang et al., 1997; Loyola et al., 2009; Sarraf and Stancheva, 2004; Talbert and 
Henikoff, 2016).  
Tethering of one of the HP1 homologs, HP1, results in the recruitment of the endogenous 
homologs, HP1 and/or HP1, and analogously, tethering of HP1 results in the recruitment 
of HP1 (Hathaway et al., 2012; Verschure et al., 2005). The ability of individual HP1s to 
recruit each other and to form heterodimers suggests their cooperative, and perhaps redundant, 
action in gene silencing. The three mammalian HP1 homologs share a high level of sequence 
identity (Fig. 8). However, homolog-specific localisation patterns were also observed (Minc 
et al., 2000), and domain-swapping experiments between different HP1 homologs pointed 




Figure 8. Sequence identity of the 
mammalian HP1 homologs.  
The domain map of the mammalian HP1, 
HP1 and HP1, illustrating the level of 
conservation between the individual 
homologs. The percentage represents 
sequence identity of HP1 and HP1 
compared to HP1. (Adopted from 





Cbx5 deficient mice are viable and fertile, showing no distinguishable phenotype 
compared to wild-type littermates (Aucott et al., 2008; Brown et al., 2010). The Cbx1 null 
mutation, however, leads to perinatal lethality in mice, which is most likely caused by defects 
in brain development (Aucott et al., 2008). The in vitro culture of Cbx1 null neurospheres 
uncovered a severe genomic instability, indicating defects in centromere functions. Finally, 
Cbx3 mutants exhibit high postnatal lethality (99%), with the surviving animals being infertile 
(Brown et al., 2010; Naruse et al., 2007). The analysis of the mutant embryos and the 
surviving adult animals revealed an early loss of germ cells, impaired cell cycle progression, 
an increase in the transcription levels of retrotransposons, and defects in energy homeostasis 
(Abe et al., 2011; Aydin et al., 2015; Brown et al., 2010). Altogether, the above-presented 
data suggest that HP1s have redundant but also homolog-specific non-redundant functions. 
However, detailed mechanistic analysis of their redundancy and homolog-specialised roles 




















1. H3K9me-independent targeting of mammalian HP1 homologs  
HP1 proteins constitute a fundamental component of heterochromatin, recognizing and 
binding the hallmark of heterochromatin H3K9me via their chromo domain and consequently 
mediating silencing of the bound regions. Interestingly, the chromo domain is required for 
H3K9me-mediated silencing (Platero et al., 1995), but is not sufficient for the initial HP1 
targeting and heterochromatin formation (Smothers and Henikoff, 2001), suggesting that 
additional mechanisms and/or factors are involved in the de novo targeting. Furthermore, 
HP1 and HP1 were shown to localise not only to heterochromatin but also to euchromatin, 
possibly in a H3K9me-independent manner (Mattout et al., 2015; Minc et al., 2000; 
Smallwood et al., 2012). Several studies even proposed the role of HP1 in the activation of 
gene expression, transcription or pre-mRNA splicing (Huang et al., 2017; Lomberk et al., 
2006b; Skourti-Stathaki et al., 2014; Smallwood et al., 2012). This is quite striking 
considering that mammalian HP1 homologs are highly conserved and share nearly identical 
domains. The flexible regions, however, are not as conserved, and their diversification 
between the individual homologs could explain the different localisation patterns and 
functions. Indeed, the flexible regions were described to carry homolog-specific 
posttranslational modifications (LeRoy et al., 2009; Lomberk et al., 2006b; Maison et al., 
2011), to modulate the affinity for H3K9me (Hiragami-Hamada et al., 2011), to affect protein 
interactions (Lomberk et al., 2006b), and to mediate RNA binding (Maison et al., 2011; 
Muchardt et al., 2002). Most importantly, these modifications and/or interactions were shown 
to influence the chromatin localisation of individual HP1s.  
The aim of my PhD was to investigate the mechanisms that target HP1 proteins to specific 
sites in the genome. On the one hand, I focused on the role of RNA binding in this process, 
and my most significant findings are highlighted in chapter 1.1. In Chapter 1.2, I briefly 
summarize my second line of research, which resulted in the discovery of a novel HP1-
containing protein complex that is targeted to euchromatin by a transcription factor. A 
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The conventional view of heterochromatin as a silent rigid structure inaccessible to the 
transcriptional machinery has been gradually challenged over the two last decades. Firstly, 
the rapid development of genome-wide sequencing technologies revealed that transcription 
of the genome is more widespread than originally expected (Birney et al., 2007; Djebali et al., 
2012; Kapranov et al., 2007), and secondly, findings from different organisms revealed that 
heterochromatic transcripts can, in fact, be required for efficient silencing (Aravin et al., 2001; 
Deng et al., 2009; Matzke et al., 2009; Volpe et al., 2002). The process of RNA-mediated 
heterochromatin silencing has been most extensively studied in S. pombe, where it was found 
that deletion of RNA interference (RNAi) components results in the loss of H3K9 methylation 
and HP1 binding, and consequently, upregulation of centromeric transcripts (Volpe et al., 
2002). In addition, it was discovered that silencing need not occur at the transcriptional level 
by restricting access of RNA polymerase, or post-transcriptionally by degradation of 
transcripts in the nucleoplasm, but can also occur co-transcriptionally. In co-transcriptional 
gene silencing RNA degradation is induced by the chromatin context from which the 
transcript is produced, and the transcript itself is required for silencing (Bühler et al., 2006).  
Most recently, a heterochromatin-dependent transcriptional machinery was described in 




silencing (Andersen et al., 2017). The study revealed that the core transcription machinery 
can be recruited to heterochromatin by the HP1 paralog, Rhino/HP1d, which results in the 
initiation of transcription at Rhino bound regions instead of at TSSs that are transcriptionally 
inaccessible. Moreover, the HP1 proteins, which were assumed to act as a static “glue” of 
heterochromatin, were found to be highly mobile (Cheutin et al., 2003, 2004; Festenstein et 
al., 2003). The dynamic nature of HP1s was further reinforced by the finding that HP1s bind 
centromeric and telomeric transcripts, and that abolishing these interactions impairs HP1 
localisation patterns (Deng et al., 2009; Keller et al., 2012; Maison et al., 2011; Muchardt et 
al., 2002).  
Mammalian HP1 homologs were shown to be recruited by RNA transcripts to specific 
heterochromatic loci. All three homologs, HP1, HP1 and HP1, were shown to bind RNA 
by an RNA-immunoprecipitation assay (RIP), an electrophoretic mobility shift assay (EMSA) 
and/or North-western assay, but only the HP1-RNA interaction, which appears to be the 
strongest, has been characterised further (Maison et al., 2011; Muchardt et al., 2002). The 
study by Muchardt et al. found that the hinge region and its positive residues are required for 
RNA binding in vitro, and that this interaction is necessary for HP1 localization to 
pericentric heterochromatin in mouse fibroblast cells. The more recent work by Maison et al. 
made very similar observations, but in addition found that the SUMO-modified HP1 protein 
can specifically bind to the major satellite transcripts, which then guide de novo targeting of 
HP1 to the pericentric domains.  
A previous study from our laboratory focusing on the S. pombe HP1 homolog, Swi6, 
revealed that Swi6 binds heterochromatic RNAs through its positively charged hinge region, 
and hands them over to the RNA degradation machinery (Fig. 9; Keller et al., 2012). 
Interestingly, RNA binding changes the conformation of the Swi6 chromodomain, affecting 
its ability to bind to the H3K9me mark, and eventually leads to the eviction of Swi6 from the 
heterochromatin (Fig. 9). The follow up study by Keller et al. found that abolishing the RNA 
binding of Swi6 in vivo results in the spreading of Swi6 and H3K9me into neighbouring 













Because the above findings depict different roles of RNA in modulating HP1 functions 
between mammals and fission yeast (recruitment to and eviction from chromatin, 
respectively) we decided to revisit the RNA-mediated regulation of the mammalian HP1 
homologs. The objective of this project was to dissect the RNA binding properties of the 
mammalian HP1 proteins in vitro with the help of the methods established in our laboratory 
for Swi6, and in the following step, apply the results we obtained to study mouse embryonic 
stem cells, investigating the roles of HP1-RNA interactions genome wide. The following 






Figure 9. Model for HP1Swi6-mediated 
degradation of heterochromatic RNAs.  
HP1Swi6 (dark blue) dynamically exchanges 
within H3K9me nucleosomes (grey). 
Transcribed RNAs (red) associate with HP1Swi6 
and cause a conformational change (light blue), 
which evicts HP1Swi6 from heterochromatin due 
to the competition between RNA and H3K9me. 
The RNA is passed on to the RNA decay 
pathway (Cid14 (red)), and the HP1 
conformation is restored. This mechanism serves 
as a checkpoint at the borders between 
heterochromatin and euchromatin, preventing 
heterochromatin spreading into euchromatic 






First, I set out to recapitulate the previously published RNA binding by HP1 proteins in 
vitro. To do so, I overexpressed N-terminal Glutathione-S-transferase (GST)-fusions of 
mouse HP1, HP1 and HP1, respectively, in Escherichia coli, and captured the fusion 
proteins on Glutathione sepharose. I cleaved off the GST tag, and purified the recombinant 
HP1 proteins by anion exchange chromatography (AEC) and size exclusion chromatography 
(SEC). Finally, I used the recombinant HP1 proteins to perform EMSA assays with 
fluorescently labelled RNA probes. In these assays, the recombinant HP1 proteins did not 
bind RNA at the expected protein:RNA ratios (data not shown). RNA probes of a different 
sequence and length were assayed as well, but with the same result. Therefore, I decided to 
use NMR spectroscopy, which is a more sensitive method to test RNA binding. We purified 
15N labelled HP1s and measured 1H-15N-HSQC (2D) NMR spectra, followed by the titration 
of unlabelled RNA. However, this method was also unable to detect any significant RNA 
interaction (data now shown). To tackle the discrepancy between our observations and the 
previously published data, I thoroughly investigated the methodology of the prior 
publications, and found that their results were obtained using recombinant GST-HP1 fusion 
proteins (Maison et al., 2011; Muchardt et al., 2002). The GST tag has a similar size as HP1 
proteins and on its own forms a dimer (Parker et al., 1990); it is, therefore, foreseeable that it 
can significantly influence the biophysical properties of HP1s.  
In the next experiment, I decided to test in parallel the RNA binding of the untagged and 
GST-tagged HP1 proteins, and compare the observed binding affinity, if any, with the Swi6 
ortholog. For this, I purified recombinant HP1α, HP1β, HP1γ and Swi6 (Fig. 10A), their GST 
fusions (Fig. 10B), and the GST tag as a control (Fig. 10C). For Swi6, the mutation of the 
positively charged hinge residues, R and K, to alanine (A) drastically reduced the RNA 
binding as compared to the wild-type protein (Keller et al., 2012). I designed the same mutants 
for the HP1 proteins, HP1-KR13A, HP1-KR12A, HP1-KR11A, and purified their GST 









Figure 10. Recombinant mammalian HP1 proteins.  
(A) Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) of the recombinant mouse HP1, 
HP1, HP1, and fission yeast Swi6. (B) SDS-PAGE of the recombinant N-terminal Glutathione-S-transferase 
(GST) fusions of HP1, HP1, HP1 and Swi6. (C) SDS-PAGE of the recombinant GST-HP1-KR13A, GST-
HP1-KR12A, GST-HP1-KR11A mutants (all positively charged residues in hinge, K and R, mutated to alanine, 
A), and GST tag. 
(A-C) All proteins were overexpressed in Escherichia coli, and captured on Glutathione sepharose. The GST tag 
was cleaved off (A) or left intact (B, C), proteins were subsequently purified by anion exchange chromatography 
(AEX) and size exclusion chromatography (SEC).  
The above-purified recombinant proteins were assayed for RNA binding by EMSA using 
a fluorescently labelled AU-rich RNA probe. In accordance with our previous observations, 
the untagged HP1 proteins did not bind the RNA probe (Fig. 11A-C), although RNA mobility 
was slightly affected by HP1 at the highest protein:RNA ratios (200:1 to 400:1) (Fig. 11A). 
For comparison, Swi6, which has a rather weak RNA binding constant of approx. 40 M 
(Keller et al., 2012), interacted with RNA already at a 5:1 ratio, and fully bound at a 50:1 ratio 
(Fig. 11D). The second step was to assay the GST-tagged HP1 proteins. The GST-tag had no 
effect on HP1 but slightly enhanced the HP1-RNA interaction, and most importantly, it 
induced RNA binding by HP1 (Fig. 11A-C, second lane). Interestingly, the GST tag reduced 
the affinity of Swi6 to RNA, and on its own had no influence on RNA mobility (Fig. 3D, 
second and third lane). Next, I wanted to test whether this is a GST-induced artefact or an 
HP1-specific interaction. To do so, I assayed the RNA binding of the GST-HP1-KRxA 
mutants. The previously observed RNA binding by GST-HP1 was greatly reduced in the 
GST-HP1-KR13A mutant (Fig. 3A, third lane). Not surprisingly, the GST-HP1-KR12A 
and GST-HP1-KR11A mutants showed similar behaviour as their wild-type proteins (Fig. 
11B, 11C; third lane). In summary, these results demonstrated that HP1 has the potential to 





Figure 11. Recombinant GST-HP1 fusion protein binds AU-rich RNA. 
(A) Electrophoretic mobility shift assay (EMSA) of the fluorescently labelled AU-rich RNA probe and 
recombinant HP1, GST-HP1 or GST-HP1-KR13A. 
(B) EMSA of the fluorescently labelled AU-rich RNA probe and recombinant HP1, GST-HP1 or GST-HP1-
KR12A. 
(C) EMSA of the fluorescently labelled AU-rich RNA probe and recombinant HP1, GST-HP1 or GST-HP1-
KR11A. 
(A-C) RNA probe was labelled with fluorescein-UTP by in vitro transcription. Protein-RNA mixtures were 
separated on 1.6% TB agarose gels, and the fluorescent signal was detected using a typhoon scanner. All wells 
contained constant amounts of the RNA probe. First wells, np, had no recombinant protein. Second to seventh 
wells contained increasing concentrations of the recombinant proteins; protein:RNA ratio of 5:1, 25:1, 50:1, 100:1, 
200:1, 400:1.   
Since both, the GST tag and the HP1 chromoshadow domain, can independently dimerise 
(Cowieson et al., 2000; Parker et al., 1990), I hypothesized that the GST-HP1 fusions can 
form alternative dimers or oligomers, which change the conformation of HP1 allowing the 
RNA interaction. In this theoretical conformation, the GST dimerisation connects two 
chromodomains, while their chromoshadow domains interact together, forming a closed 
dimer. Alternatively, the chromoshadow domains from one GST-HP1 dimer can interact 
with the chromoshadow domains from the neighbouring GST-HP1 dimers, forming an 
oligomer.  Interestingly, this is the exact description of the proposed HP1 binding to the 
nucleosomes (Canzio et al., 2014). In this analogy, the GST dimer represents the two 
H3K9me-tails of a single nucleosome. I had, in fact, considered the effect of the H3K9me3 
binding previously, and measured the RNA affinity of the untagged HP1 bound to the 




significant RNA binding (data not shown), possibly because a nucleosome with two HP1 
binding sites is required to stimulate the RNA interaction. Therefore, I aimed to reconstitute 
the H3K9me nucleosomes in vitro in collaboration with the laboratory of Dr. Beat Fierz from 
EPFL.  
 
Figure 12. Schematic representation of reconstitution of semisynthetic H3K9me3 nucleosomes.  
(A) H3 histone lacking its N-terminus (H3d1-14) is produced recombinantly, by overexpression and purification 
from E. coli. The H3 N-terminal tail (H31-14) is chemically synthesised, including the trimethylation at the lysine 
9 (red dot). The two components are then chemically ligated together, forming H3K9me3 histone. 
(B) Unmodified histones, H2A, H2B and H4, are produced recombinantly from E. coli, and in combination with 
H3K9me3, used to form a histone octamer. In the last step, the 601 DNA is introduced to the octamer, ultimately 
forming H3K9me3 nucleosome.  
We followed the general reconstitution protocol established by Luger et al. for the 
production of unmodified nucleosomes (Fig. 12B; Luger et al., 1997), but used a 
semisynthetic approach for the reconstitution of H3K9me3 nucleosomes established by the 
Fierz laboratory (Fig. 12A-B). In the first step, we produced recombinant core histones and 
synthetic H3K9me31-14 peptide (Fig. 13A-B). The K9me3-modified H3 histone was 
synthesised by the chemical ligation of H3K9me31-14 and the N-terminally truncated 
recombinant H3d1-14 histone. Next, we combined the individual core histones at equimolar 
ratios, and purified the resulting histone octamers by SEC (Fig. 13C). In the last step, 601 
DNA was assembled on octamers with the help of salt gradient dialysis, resulting in the 
formation of nucleosomes (Fig. 13D). The purity and size of the H3K9me3 nucleosomes was 
confirmed by the SEC-MALLS method (multiangle light laser scattering), which detected a 
uniform protein mixture of the approx. size of 205 kDa (Fig. 13E). This is in agreement with 




et al., 1997). In summary, we produced highly purified H3K9me0 and H3K9me3 
nucleosomes. 
 
Figure 13. Reconstitution of the H3K9me0 and H3K9me3 nucleosomes. 
(A) SDS-PAGE of the recombinant H2A, H2B, H3d1-14 and H3 proteins. Commercial H3 histone was used as a 
loading control. B. Analytical HPLC trace of the synthetically produced H3K9me3 peptide used for synthesis of 
the H3K9me3 histone.  
(C) SDS-PAGE of the SEC-purified histone octamers containing unmodified H3 (H3K9me0) or K9me3-modified 
H3.  
(D) DNA agarose gel of the final H3K9me0 and H3K9me3 nucleosomes. Free 601 DNA was loaded as a control. 
(E) SEC-MALLS (Multiangle light laser scattering) profile of the reconstituted H3K9me3 nucleosome.  
Next, we tested the RNA binding by HP1 in the context of nucleosomes by the EMSA 
assays. The recombinant HP1 protein bound to nucleosomes induced an RNA shift at similar 
protein:RNA ratios as the GST-HP1 fusion (Fig. 14, Fig. 11A); we did not observe the same 
RNA shift with HP1 alone or with HP1 bound to the H3K9me3 peptide (Fig. 14). 
Interestingly, HP1 RNA binding was enhanced by nucleosomes irrespectively of the K9 
methylation status (Fig. 14). The RNA interaction was abolished in the HP1 hinge mutant, 
HP1-KR13A (Fig. 14). Because we did not observe the same RNA shift by HP1, we 




In agreement with the previously published data, the affinity of Swi6 to RNA was reduced in 
the context of nucleosomes due to the competition between the RNA and nucleosome binding 
(Fig. 14; Keller et al., 2012).  
 
Figure 14. Enhancement of the HP1 RNA binding in the context of the nucleosome. 
EMSAs assaying the binding of the fluorescently labelled AU-rich RNA probe by the recombinant HP1, HP1-
KR13A, HP1, Swi6 or Swi6-KR25A proteins in the context of H3K9me3 peptide, H3K9me0 nucleosome or 
H3K9me3 nucleosome. RNA probe was labelled with fluorescein-UTP by in vitro transcription. Protein-RNA 
complexes were separated on 1.6% TB agarose gels, and the fluorescent signal was detected using a typhoon 
scanner; the typhoon scanner also detected unlabelled nucleosomal DNA signal. All wells contained constant 
amounts of the RNA probe. First wells, np, had no recombinant proteins; all the second to forth wells contained 
increasing concentrations of the recombinant proteins, peptides or nucleosomes. First column, protein:RNA ratio 
of 5:1, 50:1 and 250:1. Second column, protein:peptide:RNA ratio of 5:5:1, 50:50:1 and 250:250:1. Third and 
fourth column, protein:nucleosome:RNA ratio of 5:2.5:1, 50:25:1, 250:125:1. Control EMSA contains only 
nucleosomes and RNA at the ratio of 2.5:1, 25:1 and 125:1. 
Our next goal was to further characterise the nucleosome-HP1-RNA interaction by 
NMR. We purified 15N labelled HP1 and unlabelled H3K9me3 nucleosomes, and attempted 




combined HP1 with H3K9me3 nucleosomes, we observed massive protein precipitation, 
which made it impossible to measure NMR spectra. Instead, we inspected our sample by EM. 
This revealed uniformly shaped structures, which are suggestive of a phase separation of the 
nucleosome-HP1complex (data not shown). Indeed, DNA was recently shown to promote 
the phase separation of HP1 (Larson et al., 2017). However at that point, we were not able 
to continue with the biochemical characterisation of the nucleosome-HP1-RNA interaction. 
Therefore, I considered creating the endogenous HP1-KR13A mutation in mouse ES cells, 
comparing its behaviour with the wild-type protein. However, before initiating this 
experiment, I wanted to perform one last control in vitro experiment, to measure the affinity 
of the HP1-KR13A mutant to the H3K9me3 peptide by SPR. This revealed that the affinity 
of the HP1-KR13A mutant is about 60-fold weaker compared to the wild type protein (Fig. 
15A, 15B). The difference in the binding constants is most likely even more severe in the 
context of the nucleosomes, as it was previously shown that the hinge linker contributes to 
the nucleosome binding in vitro (Mishima et al., 2013).  
 
Figure 15. Intact HP1 hinge is required for efficient H3K9me3 binding. 
(A) Surface plasmon resonance (SPR) measurement of recombinant HP1 affinity to the immobilised H3K9me3 
peptide. (B) SPR measurement of recombinant HP1-KR13A mutant affinity to the immobilised H3K9me3 
peptide.  
(A, B) Equilibrium dissociation constants (KD) were determined by the SPR software (GE Healthcare). Relative 
R.U. – relative response units. 
 
The above result discouraged us from creating the endogenous HP1-KR13A mutation 
because we would not be able to separate the phenotypes caused by the loss of RNA binding 




residues by NMR to identify the ones affected by RNA, and eventually use this information 
for designing an RNA binding-specific mutant. Unfortunately, the instability of HP1 at 
higher concentrations, which is a requirement for such an experiment, prevented us from 
determining the exact residues affected by RNA. Finally, we decided to postpone this project 
until new evidence helping to tackle the HP1-RNA interaction arises. 
In summary, our data confirm that HP1 does interact with RNA, while the other two 
homologs, HP1 and HP1 do not. The affinity of the interaction is extremely weak in vitro, 
but can be further reinforced in the context of the nucleosome. The HP1-RNA affinities are 
similar for GC- or AU-rich substrates (data not shown), which suggests that this is a rather 
unspecific interaction. RNA binding is mediated by the positively charged hinge linker, and 
mutation of the KR residues abolishes the interaction. The above results, their implications 
and possible follow-up experiments, are further discussed in the last chapter (Discussion and 
Outlook).  
 
1.1.4. Collaborations  
The NMR measurements were carried out in collaboration with the group of Dr. Sebastian 
Hiller, namely by Ricardo Adaixo and Dr. Morgan Callon, and in later stages with Dr. Antoine 
Clery. Dr. Morgan Callon did the EM analysis. The nucleosome reconstitution and the 
following experiments with nucleosomes were performed in collaboration with Dr. Claudia 
Keller, Dr. Beat Fierz, and Dr. Mauro Zurini.  
 
1.1.5. Methods  
Expression and purification of HP1 proteins, EMSA assays, NMR experiments, and SPR 
measurements were carried out according to (Keller et al., 2012). Nucleosome reconstitution 
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Prevailing models suggest that HP1 proteins are targeted to chromatin via their chromo 
domain, which recognizes and binds the H3K9me mark. However, the affinity of the chromo 
domain to H3K9me is rather low (Canzio et al., 2014), and HP1s show distinct localization 
patterns in the nucleus (Minc, Courvalin and Buendia, 2000). In addition, previous works 
have demonstrated that HP1 and HP1 can also localise to euchromatic regions (Mattout et 
al., 2015; Smallwood et al., 2012; Vakoc et al., 2005). It is not clear, however, how the 
homolog-specific targeting is achieved, or what factors and/or mechanisms act as a recruiter 
of HP1s to euchromatic regions. In this project, I set out to investigate whether the HP1 
proteins can be targeted to euchromatic regions by homolog-specific protein interactors. To 
test this, I exploited the recent advances in genome editing to endogenously tag individual 
HP1 homologs, and determined their interactomes (Fig. 16, 17). Interestingly, the majority of 
highly enriched HP1 interactors we observed were DNA-binding proteins (Fig. 17, green).  
 
 
Figure 16.  
Scheme depicting the endogenous 
tagging of the individual HP1 genes 
in mouse ES cells with the FLAG-
Avi tag (FLAvi), followed by 
tandem affinity purification of HP1-
containing protein complexes for 
LC-MS/MS (Liquid 
chromatography followed by 




Next, I inspected the individual HP1 interactors to find the one that is (1) a DNA-binder, 
(2) HP1- and/or HP1-specific, (3) highly enriched, and (4) has a PxVxL HP1-interaction 
motif. The best candidate, fulfilling all of the above criteria, was a transcription factor, Adnp. 
I endogenously tagged Adnp, and confirmed its interaction with HP1 and HP1. More 
importantly, the tandem affinity purification (TAP) of tagged Adnp in 500mM NaCl did not 
disturb its interaction with HP1s or with another highly enriched protein, chromatin 
remodeller Chd4 (Fig. 18). This indicates that Adnp, HP1 and/or HP1, and Chd4 form a 
stable complex in mouse ES cells – which we named the ChAHP complex. 
 
 
Figure 17. The HP1 interactome of mouse embryonic stem cells.  
Heat map showing the variation in co-purifying (Z-score) proteins across HP1 isoform-specific TAP-LC-MS/MS 
experiments. Proteins that were significantly enriched in at least one of the individual HP1 purifications were 
included in the analysis.  
 
We reconstituted the ChAHP complex in vitro from insect cells and dissected the 
individual interactions. Together with proteome studies from mouse ESCs, this revealed Adnp 
as a core bridging module interacting with Chd4 and HP1s. Using ChIP-sequencing, we 
identified over 15 000 ChAHP-bound genomic sites. Unexpectedly, these sites are devoid of 
H3K9me2 or H3K9me3. Instead, the complex appears to be targeted via a highly conserved 
DNA motif recognized by Adnp, and deletion of Adnp leads to the depletion of HP1 binding 
at the ChAHP sites (Fig. 19A). Similarly, deletion of the Adnp binding motif at the 






Additionally, deletion of Adnp or HP1s (triple knock-out) leads to the derepression of 
lineage specification factors bound by ChAHP, suggesting that ChAHP acts as a 
transcriptional repressor in mES cells. Indeed, we have found that ChAHP binding renders 
chromatin inaccessible. Ultimately, we investigated the role of ChAHP in Helsmoortel-Van 
der Aa syndrome, a disease caused by mutations in the ADNP gene. We discovered that 
patient Adnp protein (AdnpMut) fails to interact with HP1s and, consequently, cannot assemble 
functional ChAHP complexes. The DNA binding of AdnpMut to the ChAHP genomic sites 
was not affected, suggesting that the most likely primary cause of Helsmoortel-Van der Aa 
syndrome is the inability of AdnpMut to form a functional complex. Finally, we were able to 
rescue the AdnpMut defect pharmacologically, restoring complex formation.  
In summary, my work revealed that HP1 proteins can be recruited to genomic loci in a 
DNA sequence-specific, H3K9 methylation-independent, manner via an interaction with the 
transcription factor Adnp. In addition, I demonstrated that H3K9 methylation is not required 
for repression of ChAHP target genes, and finally yet importantly, I uncovered the most likely 
primary cause of the Helsmoortel-Van der Aa syndrome, and based on my results, propose a 
potential pharmacological treatment. 
 
Figure 18. Adnp, HP1 and/or HP1, and Chd4 
form a novel complex – ChAHP.  
TAP-LC-MS/MS of endogenously FLAG/Avi-tagged 
Adnp. Protein purification was performed in the presence 
of 500mM NaCl. Parental mES cell line serves as 
background control. n=3 biological replicates (i.e. 3 






Figure 19. DNA sequence specifies ChAHP association with euchromatin.  
(A) Heatmap of HP1ChIP-seq enrichment in ChAHP peaks (top) or heterochromatic HP1-bound sites (bottom) 
in Adnp+/+ and Adnp-/- mES cells. Each row represents a 6-kb window centered on the respective peak signal. 
Rows are sorted by mean ChIP enrichment. Average of n=3 biological replicates (i.e. 3 independent mES cell 
lines).  
(B) Schemes depicting the location of Adnp binding motifs in the Bmp1 and Igfbp4 genes (left, middle) and the 
Igfbp4 locus with the motif deletion  Igfbp4Δmotif/ Δmotif (right).  
(C) ChIP-qPCR measuring Adnp enrichments over Igfbp4 and Bmp1 promoters in Igfbp4Δmotif/Δmotif cells compared 
to parental line. n=3 independent biological replicates.  
(D) ChIP-qPCR measuring Chd4 enrichments over Igfbp4 and Bmp1 promoters in Igfbp4Δmotif/Δmotif cells compared 
to parental line. n=6 independent biological replicates used. (E) HP1ChIP-qPCR enrichments over Igfbp4 and 
Bmp1 promoters in Igfbp4Δmotif/Δmotif cells compared to parental line. n=3 independent biological replicates.  
 
1.2.1. Collaborations 
The proteomic experiments were carried out in collaboration with the FMI Protein 
Analysis Facility, namely with Dr. Daniel Hess and Dr. Vytautas Iesmantavicius. The ChAHP 
complex reconstitution experiments were performed in collaboration with the group of Dr. 
Nicolas Thomä, namely by Dr. Anja Basters. The bioinformatic analysis of the genome-wide 
data was performed by Dr. Sarah H. Carl and Dr. Fabio Mohn. Dr. Fabio Mohn performed 
the chromatin accessibility experiments. All experiments related to AdnpMut were performed 
with the help of Lisa Lampersberger, Dr. Yukiko Shimada, Dr. Matyas Flemr and Dr. Fabio 
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Traditionally, HP1 homologs, as their name suggests, are perceived as fundamental 
constituents of heterochromatin, to which they are recruited via the H3K9me mark. Their role, 
based on the widely accepted model, is to facilitate spreading of H3K9me along the locus, 
and to compact heterochromatin, rendering it physically inaccessible. This static perception 
of HP1s holds true although the general view of heterochromatin is being reshaped by 
emerging evidence about its highly dynamic nature. HP1 proteins themselves were found to 
be highly mobile molecules with the ability to interact with RNA, and to bind to euchromatin 
in a homolog-specific manner. HP1 binding to euchromatin is usually explained by the 
presence of the H3K9me mark, but the mark itself, as it lacks specificity, cannot act as a 
primary targeting mechanism; if it would, all three homologs would be recruited to the same 
sites across the genome, which is not the case. In addition, HP1 was detected at sites lacking 
H3K9me (Smallwood et al., 2012). These findings raise several questions about HP1 
recruitment and function. What determines HP1 targeting to chromatin? What gives 
specificity to individual homologs? What is the extent of their redundancy? What is their role 
in euchromatin that is not marked by H3K9me?  
During my PhD, I focused on H3K9me-independent pathways of HP1 recruitment to 
chromatin, which appears to use the hinge and chromo-shadow domains. Notably, the chromo 
domain, which is required for H3K9me binding, is on its own insufficient for targeting to 
constitutive heterochromatin (Muchardt et al., 2002; Smothers and Henikoff, 2001). This 
indicates that even H3K9me-dependent recruitment requires other HP1 domains and/or 
additional factors.  
All three HP1 domains (the N-terminal extension with the chromo domain, the hinge, and 
the chromo-shadow with the C-terminal extension) were shown to play a functional role in 
determining the chromatin-binding patterns of HP1s. In the following chapters, I describe and 
discuss the roles of the individual domains and their targeting mechanisms based on the 
current literature, using this as a foundation for the discussion of the main findings of my 
PhD.  
In the first chapter, I concentrate on H3K9me-dependent recruitment, which was not my 
primary focus, yet I believe that my work contributes to our understanding of this pathway. 
In the second chapter, I discuss the role of the hinge domain and RNA in regulating HP1 
function and chromatin binding, which I investigated using biochemical approaches. In the 
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third chapter, I focus on the main finding of my PhD – transcription factor-mediated 
recruitment of HP1s to euchromatin, a novel recruitment pathway that is independent and not 
associated with the H3K9me mark. In the last chapter, concluding remarks, I summarise this 
discussion, and present my perspective on HP1 recruitment to chromatin. 
 
 
1. H3K9-methylation dependent recruitment of HP1s  
In the following chapters, I am going to review H3K9-methylation dependent targeting of 
HP1s, and provide literature-based evidence, indicating that CD-mediated HP1 binding to 
H3K9me-marked chromatin depends also on other HP1 domains and on additional factors. 
In later chapters, I focus on mammalian HP1 homologs and their redundancy, and discuss 
my results that are relevant to this pathway.  
 
1.1. Contributions of HP1 domains in mediating the H3K9me interaction 
The targeting of HP1s to H3K9-methylation-marked chromatin requires the cooperative 
action of all three HP1 domains. The chromo domain binds the N-terminal H3 tail carrying 
K9 methylation and the C-terminal histone-fold domain of H3 (Bannister et al., 2001; Jacobs 
et al., 2001; Lachner et al., 2001; Nielsen et al., 2001). The hinge region contacts nucleosomal 
DNA (Canzio et al., 2013; Mishima et al., 2013), and the chromo-shadow domain interacts 
with HKMTases (Nozawa et al., 2010; Schotta et al., 2002; Yamamoto and Sonoda, 2003). 
Mutation of V22 in the HP1 chromo domain, which reduces its affinity for the ARKS motif, 
abolishes interactions with the nucleosome in vitro (Nielsen et al., 2001). This indirectly 
indicates that the role of the hinge is to stabilise the binding mediated by the CD, and on its 
own, it cannot form a stable interaction with the nucleosome. Similarly, the CSD creates 
stabilising contacts with the nucleosome, but on its own is not sufficient for the interaction 
(Canzio et al., 2013; Mishima et al., 2013; Nielsen et al., 2001).  
The cumulative power of the individual domains in stabilising the interaction with H3K9 
methylation is especially apparent when we compare the affinity of the isolated CD for the 
H3K9me peptide with the affinity of the full-length (FL) HP1 for the nucleosome. In vitro the 
stability of the FL-HP1-nucleosome complex is 100-fold stronger than of the CD-H3K9me3-
Discussion and Outlook 
64 
 
tail complex, with the affinity of FL-HP1 for the nucleosome being 100 nM (Canzio et al., 
2013).  
In addition, we should not omit the interaction with HKMTases that can potentially 
increase the affinity for H3K9 methylation-marked chromatin. Indeed, in vitro binding of the 
fly HP1 ortholog, HP1a, to nucleosomes is stimulated by the presence the of HKMTase, 
Su(var)39 (Eskeland et al., 2007). This effect is independent of the enzymatic activity of 
Su(var)39, but depends solely on the interaction between HP1 and Su(var)39. 
1.2. Interdependency of HP1 and HKMTases 
Based on the above presented data, it is not surprising that HP1 recruitment to 
heterochromatin requires the presence of the corresponding HKMTase, and this dependency 
is highly conserved across different systems, from fission yeast (Bannister et al., 2001; 
Nakayama et al., 2001), to flies (Schotta et al., 2002), to mammals (Lachner et al., 2001; 
García-Cao et al., 2004; Tachibana et al., 2005). What is surprising, however, is that the 
proper localisation of HKMTases also depends on HP1 proteins. Deletion of HP1a results in 
mislocalisation of Su(var)39 outside of the pericentric heterochromatin into the euchromatic 
regions, where it ectopically methylates H3K9 (Schotta et al., 2002). Similarly, in S. pombe 
deletion of its HP1 ortholog, Swi6, results in the spreading of H3K9 methylation into 
euchromatin (Stunnenberg et al., 2015). 
These results imply that the interaction of HKMTases with the HP1 chromo-shadow 
domain restricts their binding to heterochromatin. Such an interdependency model of the HP1-
HKMTase association is further supported by domain swapping experiments, in which the 
HP1a chromo domain was replaced by the chromo domain of Polycomb (Pc) (HP1a-Pc) 
(Schotta et al., 2002). The Pc chromo domain has specificity for H3K27me3, and 
consequently, binds different chromatin regions than HP1s (Fischle et al., 2003). The chimeric 
HP1a-Pc protein binds to both, HP1 and Pc chromatin sites (Fischle et al., 2003; Platero et 
al., 1995), and more importantly, it has the ability to recruit Su(var)39 and endogenous HP1s 
to Pc sites (Platero et al., 1995; Schotta et al., 2002). This indicates that CSD-mediated 
interactions are strong enough to recruit HKMTases to ectopic sites.  
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1.3. Mammalian HP1 homologs  
All three mammalian HP1s, HP1, HP1 and HP1, bind H3K9me in vitro, and in cells 
localise to H3K9me-marked chromatin (García-Cao et al., 2004; Lachner et al., 2001; 
Tachibana et al., 2005). Biochemical experiments and microscopic observations, however, 
point towards certain differences between the homologs. Unlike HP1, the HP1 CSD does 
not form any contacts with the methylated nucleosome, which results in similar affinities of 
HP1 for the H3K9me peptide and the nucleosome (both in µM range); suggesting it may 
have a weaker affinity compared to HP1 in vivo (Mishima et al., 2013; Munari et al., 2012). 
The NTE of HP1 contains a tandem array of serines, which upon phosphorylation increase 
the affinity of HP1 to H3K9me (Hiragami-Hamada et al., 2011), while phosphorylation of 
HP1 reduces its affinity to H3K9me-marked chromatin (Lomberk et al., 2006b). This clearly 
demonstrates that the affinity of the CD to H3K9me can be modulated, which allows for 
differential regulation of individual homologs in vivo. 
More recently, the phosphorylation (P) of the NTE of HP1 was shown to promote 
formation of phase-separated droplets (Larson et al., 2017). The P-NTE-HP1 protein has the 
ability to sequester H3K9-methylated nucleosomes in these droplets without an effect on 
solvation, which means that reactions and interactions can take place in the HP1 phase. 
Larson et al. also tested the oligomerisation potential of P-NTE-HP1 compared to HP1 or 
HP1, finding that only the P-NTE-HP1 can form higher order oligomers, a feature required 
for heterochromatin compaction. It would be intriguing to test if the other two HP1 homologs 
can be phase-separated by P-NTE-HP1. Finally, the authors proposed that in vivo this could 
serve as a repressive mechanism in which heterochromatin is physically sequestrated in an 
environment permissive only for repressive machinery or alternatively, for factors responsible 
for dissolving the phase droplets. 
Microscopic analyses of HP1 localisation patterns in mouse and human cells revealed 
homolog-specific differences as well. HP1 and HP1 predominantly bind to the pericentric 
heterochromatin, yet some staining in euchromatin was also observed (Lachner et al., 2001; 
Minc et al., 1999; Tachibana et al., 2005); while HP1 appears to be mostly dispersed in 
euchromatin (Minc et al., 2000; Tachibana et al., 2005). Interestingly, deletion of Ehmt2, 
which results in a loss of H3K9me2 in silent euchromatin, leads to delocalisation of all HP1 
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homologs to pericentric heterochromatin (Tachibana et al., 2005). In addition, all three 
homologs were detected by ChIP at other H3K9me-marked regions, telomeres and 
retrotransposons (García-Cao et al., 2004; Matsui et al., 2010).  
Altogether, this suggests that despite differences in the HP1 localisations, they all have the 
potential to bind to H3K9 di- and tri-methylated chromatin, with specificity arising from the 
interactions with HKMTases or other associated factors, and the affinity being modulated by 
the small differences in HP1 sequence and PTMs.  Support of this model, in addition to the 
already discussed findings, also comes from the fact that in Suv39h dn cells the H3K9me3 
mark is depleted from pericentric regions while H3K9me2 persists, yet HP1 binding is lost. 
The requirement of additional factors, however, does not diminish the importance of the mark; 
it rather demonstrates the versatility and complexity of the underlying regulation.  
The above findings suggest that HP1 has the strongest affinity to H3K9me and has a non-
redundant function in heterochromatin compaction, but surprisingly Cbx5-/- mice, unlike Cbx3 
or Cbx1 mutants, have no observable phenotype (Aucott et al., 2008; Brown et al., 2010). This 
can indicate that (a) HP1and HP1 may have H3K9me-independent roles that are essential 
for mouse development; (b) HP1 and/or HP1 use alternative mechanisms in 
heterochromatin compaction in vivo, and this is sufficient to compensate for the lack of HP1; 
(c) the unique HP1 properties in H3K9me binding and oligomerisation are not essential; or 
(d) combination of the previous options. In this regard, it would be interesting to test if double 
knock-out mice, e.g. Cbx5-/- Cbx1-/- have more severe, or earlier, phenotypes than Cbx1 single 
KO mice.  
 
1.3.1. Redundancy of mammalian HP1 homologs in mouse ES cells 
As apparent from the previous paragraphs, our understanding of HP1 function comes 
mostly from biochemical experiments and genetic studies combined with 
immunofluorescence or single locus studies (e.g. ChIP). Genome-wide experiments are 
therefore required to further expand our knowledge about the roles of HP1s, and especially to 
study their redundancy. During my PhD, I took advantage of the recent developments in 
genome editing to endogenously tag individual HP1 homologs in mouse ES cells, and 
determined their genome-wide occupancy. Our analysis focused on the ChAHP-bound 
regions, which is discussed separately in chapter 3 of this section, and we have not yet fully 
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exploited the potential of our datasets. Therefore, I propose to compare the profiles of all three 
HP1s to determine homolog-specific and redundant binding sites across the whole genome, 
and in the second step, determine the binding of individual homologs in the absence of the 
other two to study their redundancy. Up to now, I created FLAvi-HP1in Cbx3-/-, and FLAvi-
HP1 in Cbx1-/- and performed ChIP-seq in these cell lines. My results are very encouraging, 
as we see complementation of binding in the corresponding cell lines. 
Next, I propose to perform ChIP-seq of H3K9me2 and H3K9me3 in wild-type and HP1 
conditional/straight KO cells that I generated during my PhD (Table 2); testing if methylation 
spreads outside of the normal regions or alternatively, if it is lost, and what is the extent of 
HP1 redundancy in this process. 





Thus far, we analysed only expression profiles of these cell lines by RNA-seq, and the 
results point towards significant redundancy of the HP1 homologs in mouse ES cells. This is 
especially evident when looking at transcript levels of endogenous retrovirus (ERVs), a 
subclass of long terminal repeat (LTR) retrotransposons occupying approximately 10% of the 
mouse genome (Chinwalla et al., 2002). Based on their similarity, ERVs are divided into three 
classes: I, II and III, which are all repressed by the known HP1 interactors. Classes I and II 
are silenced by the H3K9me3-depositing Trim28-Setdb1 pathway, and class III is silenced by 
the H3K9me2-depositing Ehmt1-Ehmt2 pathway (Maksakova et al., 2013).  
Unexpectedly, the HP1 proteins were previously shown to be dispensable for the silencing 
of class I and II (Maksakova et al., 2011), and cause only mild derepression of the class III 
elements (Maksakova et al., 2013). Our datasets, however, reveal that HP1 proteins are 
essential for the silencing of ERVs. The single HP1 KOs and double KOs indeed have no 
effect, but loss of all three HP1s results in the upregulation of class II and III ERVs (Fig. 20). 
The functional redundancy of the HP1 homologs explains the discrepancy with the above-
mentioned reports, in which single HP1 KOs or triple HP1 short interfering (si) RNA-induced 
Single KOs Double KOs Triple KO 
Cbx5fl/fl Cbx5fl/fl  Cbx1-/- Cbx5fl/fl  Cbx3fl/fl  Cbx1-/- 
Cbx1-/- Cbx5fl/fl  Cbx3fl/fl  
Cbx3fl/fl Cbx3fl/fl  Cbx1-/-  
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knock-downs (KD) were tested. For the triple HP1 KD, we have to take into account that the 
residual levels of the individual homologs can have a cumulative effect, and that this can be 
potentially sufficient for silencing, as is the case for the double KOs. In addition, the 
redundancy of the HP1 homologs can be seen from the effects of their depletion on the 
proliferation of mES cells. Single and double KOs do not show significant changes in growth 
while triple KO cells stop proliferating 6-8 days after treatment with 4-hydroxytamoxifen 
(data not shown).  
Lastly, I propose to differentiate ES cells, and map the changes in HP1 behaviour during 
this process. Apart from the experiments focusing on the HP1 redundancy, it would be 
interesting to differentiate the single KOs into lineages corresponding to their mouse KO 
phenotypes: germ cell like cells (PGCL) for HP1 deficient cells (Hayashi et al., 2011; Ohta 
et al., 2017), and neurons for HP1 deficient cells (Bibel et al., 2004). These experiments can 
contribute to our understanding of the homolog-specific roles, and potentially explain the 
striking differences in the mouse phenotypes of the individual HP1 KOs. 
 
Figure 20. Redundant role of HP1 proteins in the silencing of ERV elements. 
Bar graph displaying RNA-seq reads mapping to the ERV class I, II, and III elements. Counts were normalized to 
1 million genome-mapping reads per library. Cbx1, Cbx3, and Cbx5 genes encode for HP1, HP1, and HP1 
proteins, respectively. All mutant cell lines were derived from the same parental mES cell line through direct 
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2. RNA-mediated regulation of HP1 binding to chromatin 
The HP1 hinge region acts as a flexible linker of the CD and the CSD, as a carrier of a 
NLS signal, and as a stabiliser of the interaction with the nucleosome. In addition, the positive 
charges of the basic hinge residues mediate RNA binding. The RNA interaction is best 
documented for the fission yeast HP1 homolog, Swi6 (Keller et al., 2012), followed by 
findings about the mammalian HP1 homolog, HP1 (Maison et al., 2011; Muchardt et al., 
2002). Although RNA binding via the hinge seems to be evolutionary conserved, the role of 
this interaction could not differ more. RNA binding to the hinge of Swi6 triggers eviction 
from heterochromatin, while RNA interaction with the HP1 hinge promote targeting to 
heterochromatin. How can two opposite mechanisms be used by proteins with the same 
domain composition? 
 
2.1. Sequence divergence of Swi6 and HP1 predicts different RNA-binding 
properties 
The structured domains, CD and CSD, are well conserved between Swi6 and HP1, but 
the NTE region and the hinge show only 10% sequence identity (Canzio et al., 2014). The 
Swi6 hinge is 83 amino acids long and contains 25 positively charged residues (KR25), while 
the HP1hinge is 43 amino acids long with 13 positive residues (13KR). Despite the variation 
in length, the frequency of the KR residues is conserved between the two homologs. Examples 
of RNA binding facilitated by the KR-rich basic patches of unstructured domains have been 
previously documented, and proteome wide studies of mammalian RNA-binding proteins 
(RBP) revealed that such motifs are abundant amongst “unorthodox” RBPs (Castello et al., 
2012; Järvelin et al., 2016; Kwon et al., 2013). RNA binding is typically mediated by the 
hydrogen bonds formed between RNA (phosphates, 2’-OH groups of ribose, and bases) and 
the -NH2 groups of KR-residues and the -NH- groups of a side chain (Bahadur et al., 2008). 
Analogous disordered KR-patches were also found in DNA-binding proteins (DBPs), in 
which interaction with DNA largely depends on the phosphates and appears to be sequence-
independent, serving rather as an affinity tuner of the main DNA-binding domain (Vuzman 
and Levy, 2012). It is not clear, however, how basic patches distinguish between RNA and 
DNA, or if and how they can recognise specific sequences.  
Discussion and Outlook 
70 
 
The Swi6 hinge shows similar affinities for different RNA sequences but does not bind 
DNA (Keller et al., 2012). Similarly, HP1was found to be a sequence-unspecific RNA 
binder with a very weak affinity for DNA (Muchardt et al., 2002). The preference of RNA 
over DNA can potentially originate from the higher stabilisation of the RNA:hinge complex 
due to the 2’-OH ribose groups, which are missing in DNA. Given the unspecificity of RNA 
binding by the hinge, it is possible that the affinity of the interaction linearly correlates with 
the number of basic patches. If so, we would expect the affinity of shorter linkers, like in 
HP1, to be lower.  
The NTE of Swi6 is about four times longer compared to the NTE of HP1, and due to its 
length, it can fold back on the chromo domain, affecting its conformation. This property 
appears to be crucial in regulating the RNA-mediated eviction of Swi6 from chromatin. In the 
first step, RNA binding to the hinge triggers NTE folding to the chromo domain. In the second 
step, the NTE interaction with the CD outcompetes H3K9me3, resulting in the ejection of 
Swi6 from chromatin (personal communication, Claudia Keller). It is rather unlikely that 
HP1 with its short NTE can eject H3K9me3 in the same way. However, alternative 
mechanism may exist, including additional cofactors or PTMs.  
 
2.2. Regulation of HP1 nucleic acid binding by PTMs  
Immunofluorescence studies determined that the HP1 hinge region is required for proper 
localisation to heterochromatic foci. Mutation of the hinge KR residues results in dispersed 
HP1 binding across the nucleus (Muchardt et al., 2002), and so does the treatment of cells 
with RNase (Maison et al., 2002). These findings indicate RNA-dependent targeting of HP1 
to heterochromatin rather than eviction. Indeed, SUMOylated HP1 was shown to interact 
specifically with major satellite repeats, guiding the recruitment of HP1 to pericentric 
chromatin (Maison et al., 2011). In this model, de novo recruitment of the SUMO-HP1-
RNA complex to pericentric regions is the initiating step of heterochromatin formation. In the 
following step, Suv39h is recruited and deposits H3K9 methylation, which creates a binding 
interface for unmodified HP1s, ultimately resulting in the spreading and compaction of 
heterochromatin. More recently, Suv39h1 was found to directly stimulate SUMOylation of 
HP1, accelerating its targeting to de novo sites (Maison et al., 2016). This result indicates 
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that Suv39h1 recruitment is rather a parallel than a subsequent step in heterochromatin 
establishment, and further supports the paradigm of the interdependency of HP1s and 
HKMTases discussed in chapter 1.2. 
The SUMO protein is half the size of HP1, and it is quite conceivable that deposition of 
such a large modification will have a significant impact on the biophysical properties of the 
hinge region and surrounding domains. In addition, SUMO contains several basic patches that 
can potentially contribute to the specific RNA binding. Therefore, it is possible for HP1 to 
accommodate both RNA binding modes – unspecific binding by the unmodified hinge, and 
specific RNA binding by the SUMO-modified hinge.  
 The second PTM that is known to modulate the hinge is the phosphorylation of the NTE 
of HP1 introduced in chapter 1.3. (Larson et al., 2017). The unique behaviour of P-NTE-
HP1, oligomerisation and phase separation, can be abolished by mutation of the hinge KR 
residues. In addition, the chimeric HP1 protein that has P-NTE from HP1 cannot induce 
oligomerisation despite having a hinge region with 12 KR residues. However, the chimeric 
HP1 with P-NTE and hinge from HP1, can form higher order oligomers. This is rather 
unexpected finding given the similarity of the hinge KR patches between the HP1 homologs, 
and suggests that certain KR residues might be essential and/or that other residues of the hinge 
are functionally equally important.  
 The P-NTE mediated oligomerisation followed by phase separation at higher 
concentrations was explained by the ability of phosphates on the NTE to make bridging 
contacts with the KR patch in the hinge region of a neighbouring dimer. Mechanistically, this 
is analogous to the nucleic acid binding described in chapter 2.1: the backbone phosphates of 
a nucleic acid create hydrogen bonds with the -NH2 groups of KR residues. Indeed, 
oligomerisation and phase separation of unphosphorylated HP1 can be induced by DNA, 
and mutation of positive hinge residues or CSD dimerisation impairs this HP1 property.  
Somewhat surprisingly, Larson et al. did not test if RNA can induce oligomerisation, or 
alternatively, if it can outcompete HP1 oligomerisation on DNA. In the latter case, higher 
local concentrations of RNA could trigger the release of HP1 dimers bound to RNA, inhibiting 
HP1 oligomerisation on chromatin and thus preventing phase separation. This could serve as 
a mechanism maintaining heterochromatin in a semi-permissive state as opposed to the 
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restricted state in phase-separated droplets, and/or as a mechanism preventing 
heterochromatin spreading into the neighbouring active regions, as is the case for Swi6. 
 
2.3. HP1 binding to nucleosomes promotes RNA interaction and phase 
separation 
During my PhD, I employed the biochemical methods to dissect the interaction of HP1 
and other HP1 homologs with RNA. My work confirmed that HP1 interacts with RNA in 
vitro, but its affinity is extremely weak, approximately 40- to 80-fold weaker than that of 
Swi6. The weaker affinity of HP1is not that surprising given the shorter length of its hinge 
accompanied by the smaller number of KR residues. Interestingly, RNA binding by HP1 
can be stimulated by the GST tag, possibly due to a change in HP1 conformation, with the 
resulting affinity being about 5-fold stronger compared to untagged HP1. As previously 
published, mutations of the hinge KR residues (KR13A) abolished the interaction with RNA 
(Muchardt et al., 2002). I also reproduced the unspecificity of RNA binding by the GST-
HP1protein, as I did not observe any preference between GC- or AU-rich substrates 
(Muchardt et al., 2002). In the next step, it would be interesting to test RNA affinity and 
specificity of the recombinant SUMO-HP1. Is SUMO indeed promoting specific RNA 
binding? 
In accordance with the previously published work, I did not observe RNA binding by the 
other two homologs, HP1 and HP1 (Maison et al., 2011; Muchardt et al., 2002). The fact 
that HP1 and HP1 cannot bind RNA is somewhat puzzling as their hinges contain similar 
number of KR residues as HP1. HP1 and HP1 where shown to associate with telomeric 
RNAs by RIP (Deng et al., 2009), but this does not prove a direct binding. A similar 
“uniqueness” of the HP1 hinge was also observed in the DNA oligomerisation experiments 
performed by Larson et al. (discussed above in 2.2.).  
Next, I hypothesised that the nucleosome changes the conformation of HP1 in the same 
way as the GST tag, and I tested the RNA binding of untagged HP1 in a complex with the 
nucleosome. Indeed, HP1 bound to the nucleosome interacted with RNA with a similar 
affinity as to GST-HP1, and this interaction was specifically abolished by the KR13A 
mutation. Interestingly, Larson et al. proposed in their work that unmodified HP1 (unHP1) 
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alone in solution forms a closed dimer, in which the hinge is inaccessible. This would support 
my observations that unHP1 rarely interacts with RNA, unless I disrupt its conformation 
using a GST tag or binding to the nucleosome. Similarly, modification of the hinge region by 
SUMO most likely distorts the HP1 conformation, and thus, promotes hinge exposure and 
RNA binding. 
 What could be a possible physiological role of the HP1 protein binding to RNA on 
chromatin? Stabilisation of the binding or ejection? To test this, we designed an NMR 
experiment consisting of three steps: (1) recording the spectrum of HP1 alone, (2) titrating 
nucleosomes, and identifying chromo domain resonances that are affected upon binding, and 
(3) titrating RNA to the complex, detecting changes in the CD resonances responsible for the 
interaction with the nucleosome. This would allow me to distinguish between stable RNA 
interaction on the nucleosome and RNA-binding induced ejection. However, in the second 
step phase separation occurred, preventing me from finding the answer.  
Larson et al. did not test if unHP1 can phase separate in the presence of nucleosomes, 
but they tested a DNA template, which indeed induced oligomerisation and phase separation 
(OPS). Why did I not see a similar effect in the EMSA assays? According to Larson et al. 
there is a critical protein concentration that is required for OPS to happen, and during the 
EMSA assays the concentrations are too low. A possible way to overcome the OPS effect and 
still be able to perform my desired experiment would be to immobilise nucleosomes on the 
surface, for example by the SPR method, and then measure the interaction with HP1 and 
RNA.  
Interestingly, three independent studies reported just recently that satellite transcripts 
associated with pericentric heterochromatin stabilise the binding of Suv39h enzymes at these 
sites (Johnson et al., 2017; Shirai et al., 2017; Velazquez Camacho et al., 2017). These 
findings support the RNA-mediated stabilisation of HP1 binding at heterochromatin.  
However, for now based on my data I can only conclude that unHP1 binding to 
nucleosomes promotes the RNA interaction and OPS. In order to explain the functional 
importance of these observations and deepen our understanding of the underling mechanisms 
e.g., the different effects of RNA and DNA, we and/or others, have to perform additional 
experiments, some of which are proposed in the next chapter. 
 




I propose to focus on investigating the roles of RNA binding by HP1 in mouse ES cells, 
and to use biochemistry rather as a complementary tool. First, we have to find an HP1 RNA 
binding mutant that does not affect affinity to H3K9me as is the case for the HP1-KR13A 
mutant. For this, I would perform photo-cross-linking followed by mass-spectrometry for the 
recombinant GST-HP1 bound to RNA in order to identify the exact residues forming bonds 
with RNA (Kramer et al., 2014). I would use this information to design new RNA binding 
mutants, and test their affinity for RNA and H3K9me, at the end selecting the ones which 
impair only RNA binding. At this point, we could also test unHP1 and the newly generated 
mutants in EMSA assays with nucleosomes, and possibly with SPR as proposed in chapter 
2.3. 
In the second step, I propose to ectopically express HP1 and various RNA binding 
mutants in the triple HP1 KO cell line (tKO; Table 2). The use of the tKO has several benefits. 
For example, in this background the mutant HP1 proteins cannot be recruited to chromatin 
via an interaction with endogenous HP1 homologs. We can also use the growth defect of the 
tKO as an easy readout allowing us to test the rescue potential of different HP1 mutants. 
Ultimately, I would use genome-wide approaches to identify the binding and expression 
profiles of HP1 and HP1 RNA binding mutants. Next, I would try to identify cellular RNA 
binding substrates of HP1 by CLIP-seq. However, this method is known to work better for 
strong RNA binders. Thinking beyond RNA binding, it would also be interesting to include 
other HP1 mutants. What happens when we mutate the tandem array of serines in the NTE, 
CD binding to H3K9me, CSD dimerisation, or if we remove the CTE? I believe that these 
experiments combined with the experiments already performed or proposed in the chapter 
1.3.1 would deepen our understanding of HP1s and their roles in the establishment and 
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3. DNA-sequence-dependent recruitment of HP1s 
The chromo-shadow domain mediates homo- and hetero-dimerisation of HP1s, and 
interactions with the other proteins. The HP1 domain dissection study revealed that the vast 
majority of the protein interactions requires chromo-shadow dimerisation, and in some cases, 
like for the Ehmt1/Ehmt2 interaction, also the intact chromo domain (Nozawa et al., 2010; 
Sampath et al., 2007). The information presented in the previous chapters underlines the 
importance of CSD-mediated interactions in the recruitment of HP1 proteins to chromatin. 
HP1 binding to H3K9me-marked chromatin depends on interactions with the corresponding 
HKMTases, which restrict HP1 binding patterns. At first sight, the interaction with 
HKMTases may seem to provide specificity for HP1 binding, but HKMTases themselves lack 
specificity.  
Where does the specificity of all chromatin-modifiers, -readers, -erasers, or -remodellers 
originate from? Initially, it has to come from the DNA and/or RNA sequence. This, of course, 
is not a new concept, even for the HP1s themselves. HP1 homologs can be targeted to specific 
sites in the genome via interaction with Trim28-KRAB-ZFs, an example of DNA-mediated 
specificity; or by interaction with major satellite transcripts in the case of SUMOylated HP1, 
an example of RNA-mediated specificity. In both cases, HKMTases are recruited as well, 
methylating H3K9 residues, and thus, mediating the spreading of HP1s across the locus.  
The existence of specificity factors in the heterochromatin recruitment pathways prompted 
me to investigate whether HP1 homologs could be recruited to euchromatin in a similar 
manner, especially as HP1 was shown to bind to sites lacking H3K9me2/3 (Smallwood et 
al., 2012). Indeed, my PhD work revealed that HP1 proteins can be recruited to genomic loci 
in a DNA sequence-specific, H3K9 methylation-independent, manner via an interaction with 
the transcription factor Adnp. In the following chapters, I am going to discuss my proteomic 
analysis of HP1s in mouse ES cells, which uncovered several potential targeting factors, and 
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3.1. Identification of potential HP1 targeting factors 
To test my hypothesis of DNA-binding protein-mediated recruitment of HP1s to 
euchromatin, I had to first determine the interactomes of the individual HP1 homologs. Our 
analysis revealed a large number of DNA binders and transcription factors, some of which 
were specific to individual homologs. Interestingly, HP1 and HP1 interactomes were more 
similar to each other than to that of HP1. This was a bit unexpected given the previously 
reported localization patterns of the HP1 homologs. HP1 and HP1 were shown to 
predominantly bind to the pericentric heterochromatin with some staining in euchromatin 
(Lachner et al., 2001; Minc et al., 1999; Tachibana et al., 2005), while HP1 was shown to be 
mostly dispersed in euchromatin (Minc et al., 2000; Tachibana et al., 2005). However, we 
have to take into account that immunofluorescence only provides a very broad overview of 
binding patterns, which do not necessarily reflect all functional states of HP1s, and in addition 
that there may be differences between pluripotent and differentiated cells. Indeed, Mattout et 
al. observed more dispersed binding of HP1 in mouse ES cells as compared to retinoic acid 
differentiated cells (Mattout et al., 2015). This, in combination with the interactome similarity, 
suggested that in mouse ES cells HP1 and HP1 may both bind to euchromatic regions.  
The second surprising finding was the low levels of Suv39h1 HKMTase I recovered in my 
TAP purifications. This is most likely due to the low solubility of the compacted 
heterochromatin and its associated factors, which require a more elaborate protein purification 
protocol than we used, e.g. including benzonase digestions. It is, therefore, likely that my 
proteomic experiments enriched for proteins associated with less compacted chromatin, which 
given my main interest in euchromatin-associated interactors was not an issue. Nevertheless, 
overall my proteomic experiments reproduced many previously identified HP1 interactors, 
and in addition, identified several new ones (see Introduction; (Nozawa et al., 2010; Rosnoblet 
et al., 2011)). Moreover, this is the first HP1-interactome dataset determined using the 
endogenously tagged proteins. Previous studies relied on protein overexpression or on 
potentially non-specific antibodies. 
Ultimately, I proceeded to identifying potential HP1 targeting factors. I looked for proteins 
that bound to DNA, contained a PxVxL HP1-interaction motif, and had a high enrichments 
in the HP1 or HP1/HP1 purifications. The proteins best satisfying these criteria were: 
Adnp, Adnp2, and Mga (Max gene-associated). Because out of these three factors Adnp was 
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the only one linked to HP1 localisation in chromatin (Mosch et al., 2011), I selected it as the 
best candidate, and moved on to tackle its role in HP1 targeting, which I summarise and 
discuss in the next chapter. In the later chapters, I introduce other two prospective candidates, 
Adnp2 and Mga, and discuss their potential roles in HP1 recruitment. 
 
3.2. Adnp-mediated recruitment of HP1s to euchromatin 
In the next steps, I focused on the characterisation of the Adnp-HP1 interaction, which 
eventually resulted in the discovery of a novel protein complex consisting of Adnp, HP1 
and/or HP1, and the chromatin remodeller Chd4. Our consequent analysis of the genome-
wide binding profiles of the individual components revealed over 15 000 ChAHP-bound sites 
that are devoid of H3K9me2/me3. Given my interest in histone mark-independent 
recruitment, this was a particularly exciting finding as we have two unspecific chromatin 
factors, a reader and remodeller, binding to chromatin in a complex with a DNA-specificity 
factor. 
To test if Adnp is responsible for the recruitment of HP1, I performed HP1 ChIP-seq in 
Adnp KO cells. My result confirmed my hypothesis, as I observed depletion of HP1binding 
at the ChAHP sites. The following question was whether it is indeed the DNA sequence 
recognised by Adnp that is targeting HP1 and Chd4. For this, we computationally identified 
the Adnp binding motif, and I deleted it at one of the ChAHP target sites, at the promoter of 
the Igfbp4 gene. As a result of the DNA motif deletion, all three subunits, Adnp, HP1 and 
Chd4, failed to bind to the Igfbp4 promoter, which was, as for the Adnp-KO, accompanied by 
the upregulation of Igfbp4 mRNA levels. Note: Igfbp4, Insulin-like growth factor binding 
protein 4. 
Interestingly, deletion of Cbx1 and Cbx3 was not sufficient to derepress the ChAHP 
targets, while deletion of all three HP1-encoding genes resulted in upregulation of the target 
genes. This suggests that HP1, which is not a member of ChAHP under wild type conditions, 
can join the complex in the absence of the other two homologs. To ultimately verify this 
redundancy of HP1s within the complex, I propose to perform ChIP experiments, comparing 
HP1 binding to ChAHP sites in wild type and Cbx1Cbx3 KO cells.  
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In summary, these results establish a novel DNA sequence-specific, H3K9 methylation-
independent pathway for HP1 recruitment to chromatin, and demonstrate that H3K9 
methylation is not required for repression of ChAHP target genes. 
 
3.2.1. Silencing mechanism of the ChAHP complex 
The canonical HP1-mediated silencing mechanism involves HKMTase depositing H3K9 
methylation, which mediates the spreading of HP1 homologs along the locus, resulting in the 
formation of a broad heterochromatic domain that is sterically inaccessible to the 
transcriptional machinery. How can ChAHP mediate silencing independently of H3K9 
methylation? Based on our ATAC-seq experiments, ChAHP binding to chromatin renders 
these sites inaccessible. This implies that ChAHP can locally restrict access to its sites, 
preventing other regulators, including transcriptional activators, from binding to DNA. 
Furthermore, my single step Adnp purifications, which are less stringent, identified additional 
Adnp interactors: H3K4me-demethylase Lsd1 and histone deacetylases Hdac1 and Hdac2. 
Recruitment of these enzymes to the ChAHP sites might contribute to silencing by keeping 
nucleosomes in a hypoacetylated state, and protected from the H3K4me-activatition mark. 
Bioinformatic analysis of Lsd1 and Hdac1/2 genome-wide binding profiles should reveal if 
these enzymes indeed associate with ChAHP sites. We can use already published datasets 
from mouse ES cells by Whyte and his colleagues (Whyte et al., 2012). 
However, we should not fully exclude a potential role of H3K9me methylation later in 
development. The ChAHP sites might be in a temporary silent state, allowing for rapid 
induction when activating signals are strong and outcompete ChAHP, or alternatively, for 
rapid silencing in tissues where the corresponding genes have to be silenced permanently. In 
the latter case, HKMTase could be recruited, and together with HP1s create typical 
heterochromatin domains. I could test this hypothesis by differentiating my cells to a neuronal 
lineage, and performing H3K9me-ChIP on ChAHP-bound endodermal genes. If I do observe 
deposition of H3K9me, it would be interesting to induce HP1 depletion at the beginning of 
the differentiation, and test if the heterochromatisation of the corresponding loci fails in the 
absence of HP1s.  
Finally, in addition to characterising ChAHP, I propose to investigate potential existence 
of alternative targeting complexes, which is discussed in the next chapters. 
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3.3. Adnp2 as a prospective targeting factor of HP1s 
As the name suggests Adnp2 is a homolog of Adnp, and thus, it is my next top candidate 
for TF-mediated recruitment of HP1s. In the following paragraphs, I am going to summarise 
what is known about Adnp2, and later, I am going to discuss its possible roles and its 
redundancy with Adnp, ultimately speculating about the existence of an alternative ChAHP 
complex, ChAHP2. In parallel, I am going to propose experiments that can help us to verify 
those ideas. 
The Adnp2 homolog shows 20% sequence identity compared to Adnp, which may seem 
low at first sight, yet the majority of major features are conserved between the two proteins 
(Fig. 21). Adnp2 contains a conserved N-terminus, nine N-terminal zinc fingers, a C-terminal 
homeodomain, and a C-terminal PxVxL pentapeptide motif; however, it lacks an H3K9 
mimic found in Adnp, and instead contains an additional C-terminal extension of unknown 
function. Similarly to Adnp, all of the Adnp2 ZFs are the C2H2 type but they show different 
levels of conservation, which might affect their sequence specificity compared to Adnp; three 
ZFs are conserved (1, 8, 9), and six degenerate (2, 3, 5, 6, 7) (Bateman et al., 2017). Despite 
variation in the conservation of the individual ZFs between the two homologs, they appear to 
be distributed in a similar manner, a cluster of four at N-terminus and a cluster of five closer 
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Figure 21. Uniprot clustal aligment of Adnp and Adnp2 homologs.  
The two homologs show 20% sequence identity, and share N-terminal cluster of four zinc fingers (grey), followed 
by the second cluster of five zinc fingers (grey), a C-terminal homeodomain (green), and a PxVxL motif (orange). 
Adnp2 homolog lacks an H3K9 mimic (red), but contains C-terminal extension missing in Adnp. 
 
Literature studying Adnp2 and its roles is extremely sparse. One of the few available 
studies tested Adnp2 expression levels in mouse tissues, finding it to be ubiquitously 
expressed in distinct tissues with the highest expression levels in brain, and cerebral cortex in 
particular (Kushnir et al., 2008). The upregulation of Adnp2 in neuronal tissues appears to 
already be induced during embryonic development. Similar expression patterns were 
observed for Adnp mRNAs (see Introduction). In addition, a de novo mutation in the ADNP2 
gene was identified in whole-genome sequencing in one of the patients with the behavioural 
disorder (Chung et al., 2015), and ADNP2 mRNA levels appear to be upregulated in patients 
with schizophrenia (Dresner et al., 2011). Altogether, this suggest a possible role of Adnp2 in 
neurogenesis as is the case for Adnp, but given the limited information it is impossible to 
make any conclusions about Adnp2 function.  
 
3.3.1. Potential redundancy of Adnp homologs and the existence of ChAHP2 
The homeodomains of both homologs appear to be highly conserved, which suggests 
similar DNA motif recognition, but our data show that Adnp does not require a functional 
homeodomain for binding to ChAHP sites. Adnp binding to ChAHP sites appears to be 
dependent on the ZFs, which are not as highly conserved between the two homologs. ZFs can 
be in theory provide specificity driving the two homologs to distinct/partially overlapping 
sites, while the homeodomain might be important rather for stabilisation of DNA binding. I 
can compare the genome-wide binding of the two homologs, if I endogenously tag the Adnp2 
gene and perform ChIP-sequencing. Will I see separate, partly overlapping or overlapping 
binding? This would already indicate to what extent the two homologs are redundant in mouse 
ES cells.  
My data show that Adnp is not essential for the survival of mESCs but its depletion leads 
to upregulation of a subset of lineage specifying genes, and to changes in morphology of the 
cells accompanied by a reduction in alkaline phosphatase staining. This is consistent with the 
effects seen in Adnp KO mice, where embryos fail to express the correct lineage markers 
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(Pinhasov et al., 2003). However, it is surprising that the Adnp KO embryos die only at E8.5-
E9.5 if the phenotype is, at least to some extent, present already in the pluripotent state. It is 
possible that Adnp and Adnp2 are partly redundant in the early stages of development, and 
their roles become essential in later stages. Thus, I propose to delete Adnp2 in wild type and 
Adnp KO mESCs. This, in combination with the proposed ChIP-seq experiment, will provide 
a good basis for investigation of their redundancy in mESCs. 
Moreover, I can already draw some conclusions about the two homologs based on my 
proteomics data, which would, in my opinion, rather suggest partial redundancy. As 
mentioned above, HP1 and HP1 both co-purify Adnp and Adnp2, which is not that 
surprising given that both homologs contain a PxVxL motif. However, HP1 seems to favour 
Adnp2, while HP1 shows higher enrichments of Adnp. In addition, HP1 binds preferentially 
to the genomic ChAHP sites compared to HP1, and the recruitment of HP1 can be 
stimulated by deleting Cbx3. What sites does HP1 favour in the wild type condition? 
Perhaps in wild type cells, HP1 might be preferentially targeted to Adnp2 genomic sites? 
And if so, can Chd4 join Adnp2 and HP1, forming a ChAHP2 complex? Again, I can look 
for some clues in my data. First, I know that a single step purification of heterozygously 
tagged Chd4 recovers Adnp, Adnp2, HP1 and HP1 (Fig. 22). Second, from our in vitro 
complex reconstitution we know that HP1s do not directly interact with Chd4, and that the N-
terminus of Adnp is required for the interaction with Chd4. My preliminary ChAHP 
crosslinking-MS/MS experiments point towards the N-terminal 60aa of Adnp as a site of the 
Chd4 interaction (data not shown). Interestingly, looking at the alignment of Adnp with 
Adnp2 we can see that this N-terminal part is one of the best conserved regions in the two 
proteins (Fig. 21). Third, from my Adnp TAP experiments I know that Adnp does not interact 
with Adnp2, meaning they cannot co-purify each other. These three points in combination 
with the very high Adnp2 enrichments in Chd4 TAPs indicate that Chd4 could indeed directly 
interact with Adnp2. But in order to get an ultimate answer we have to perform high 
stringency TAP purifications with the endogenously tagged Adnp2 protein, followed by in 
vitro reconstitution. For a start, we can use my ChIP-seq data to search for the Chd4-HP1 co-
bound sites that are independent of Adnp. 
In summary, I speculate that there are two partially redundant ChAHP complexes in mouse 
ES cells. ChAHP consisting of Chd4, Adnp and HP1, and ChAHP2 consisting of Chd4, 
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Adnp2 and HP1 HP1 and HP1 are promiscuous components, which is a reason why I 
recover both Adnp and Adnp2 in their corresponding TAPs. The close similarity of both 
complexes suggests partial redundancy, and would explain why in Adnp KO cells low levels 
of HP1 persist at ChAHP sites. Those could be redundant targets of the ChAHP2 complex, 
to which HP1 can be recruited as well. This would also explain why I see rather a small 
subset of ChAHP bound genes being upregulated in Adnp KO. Of course, I can test all of 
those assumptions performing the experiments I proposed in the previous paragraphs.   
 
Figure 22. Chd4 interactome in mouse ES cells.  
AP-LC-MS/MS of endogenously FLAG/Avi-tagged Chd4. Protein purification was performed in the 
presence of 350mM NaCl. Parental mES cell line serves as background control. n=3 biological 
replicates (i.e. 3 independent Chd4FlagAvi/-  mES cell lines).  
 
 
3.4. Mga as a prospective recruiter of HP1s 
Another transcription factor highly enriched in my TAP-LC-MS/MS experiments that 
could act as a specific HP1 recruiter is Mga. Mga is a 330kDa protein with a basic helix-loop-
helix DNA binding domain and a PxVxL motif, PQVFL at position 1593aa-1597aa (Bateman 
et al., 2017). Mga is known to form a heterodimer with another transcription factor recovered 
in my purifications, although at much lower levels, Max (Myc-associated factor X) (Hurlin et 
al., 1999). Mga/Max heterodimer (MMh) is a known component of the previously identified 
non-canonical PRC1 complex, PRC1.6. In addition to MMh, PRC1.6 consists of Ehmt1/2, 
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HP1, HP1, E2f6 (E2 factor 6), Pcgf6 (Polycomb group ring finger 6), Ring2 (Ring finger 
protein 2), L3mbtl2 (Lethal 3 malignant brain tumour-like protein 2), and Tfdp1 
(Transcription factor dimerisation partner 1), all of which I co-purified; plus several other 
variable components, which do not appear in my purifications (Gao et al., 2012; Ogawa et al., 
2002; Qin et al., 2012; Trojer et al., 2011).  
MMh could act as a sequence specifier of HP1 binding in the context of the PRC1.6 
complex. The presence of HKMTases in the complex also indicates the presence of H3K9me2 
at those sites. I hypothesise that this is another example of HKMTase-HP1 binding specified 
by DNA sequence, as in the case of Setdb1-Trim28-KRAB-ZFs.  
 Indeed just recently, MMh was shown to be responsible for the sequence specific 
recruitment of several PRC1.6 components, Pcgf6, Ring2 and L3mbtl2, to the TSS of meiosis- 
and germ cell-related genes in mouse ES cells; and depletion of Pcgf6, Ring2 or Max resulted 
in derepression of the bound genes (Endoh et al., 2017). Endoh et al. did not test if HP1 and/or 
Ehmt1/2 binding is lost upon MMh depletion. However, they looked at the expression profiles 
of Cbx1Cbx3 double KO mouse ES cells, and did not observe any upregulation of meiosis- 
or germ cell-related genes, concluding that HP1s are not required for silencing.  
These findings are quite intriguing considering the Cbx3 KO mice phenotype in the 
germline. It would be interesting to test if Ehmt1/2 and HP1/ binding to PRC1.6 sites is 
dependent on MMh, and if I see upregulation of meiosis- and germ cell-related genes in my 
tKO cell line. The redundancy of HP1s I have observed so far in ES cells (ERV silencing and 
within ChAHP) could also apply in the context of the PRC1.6 complex, especially as HP1 
also interacts with Mga in my TAP experiments. A homolog-specific function of HP1 may 
be required only at the later stages of differentiation of germ cells during mouse development; 
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4. Concluding remarks 
The generally accepted canonical pathway of HP1 recruitment via H3K9me neither 
explains different localisation patterns of the HP1 homologs, nor how they can distinguish 
between H3K9me2 and H3K9me3, nor how they are recruited to sites lacking H3K9me. In 
this final chapter, I present my personal perspective on HP1 recruitment, based on my work 
and the literature discussed in this thesis. I propose that the role of the H3K9 methylation 
mark is not to recruit HP1 proteins, but to increase affinity of binding after recruitment, and 
to mediate HP1 spreading along the locus. HP1s can be recruited via interactions with RNA 
and/or other proteins: (a) major satellite transcripts providing specificity to pericentric 
chromatin, (b) already bound HP1s and HKMTases, and (c) DNA-binders and transcription 
factors targeting HP1s based on their DNA-sequence specificity. In case of the last option, 
the interaction is not necessarily direct, which is further discussed in chapter 4.2.  
 
4.1. RNA-regulated binding of HP1 to pericentric chromatin 
I postulate that there are two modes of HP1-RNA interaction, both affecting binding to 
chromatin (Fig. 23). The first is RNA-mediated recruitment of HP1 to pericentric chromatin 
that depends on SUMOylation of the hinge, which facilitates specific RNA-binding, and 
ultimately results in de novo recruitment of SUMO-HP1 and Suv39h1 to pericentric 
chromatin (Fig. 23A) (Maison et al., 2011, 2016). This is followed by recruitment of 
additional unmodified HP1s and Suv39h1 enzymes, and results in spreading and, ultimately, 
establishment of pericentric heterochromatin (Fig. 23B). Suv39h1 interacts with major 
satellite transcripts that associate with pericentric heterochromatin, and this stabilises its 
retention at the locus (Johnson et al., 2017; Shirai et al., 2017; Velazquez Camacho et al., 
2017). Similarly, HP1 bound to nucleosomes can interact with major satellite transcripts, 
but the effect of such an interaction is unclear (my work, Fig. 23B). There are two options: 
(1) stabilisation of binding to nucleosomes, and/or (2) eviction of HP1 from chromatin (as 
in case of Swi6 (Keller et al., 2012)). I speculate that low levels of RNA stabilise 
HP1binding, but high levels (e.g. at the borders of heterochromatin) could induce eviction. 
A similar effect of RNA concentration was, in fact, observed for Swi6 itself (Keller et al., 
2012).  
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Interestingly, this pathway appears to be unique to the HP1 homolog, which is neither 
essential during mouse development nor in the later adult stages. This indicates that there are 
alternative mechanisms of pericentric heterochromatin establishment and maintenance, which 
require further investigation. Another open question that remains to be investigated is whether 
similar RNA-mediated regulation of HP1 binding to pericentric heterochromatin also exists 
in different chromatin contexts, for example in ERV repeats that are found spread across the 
euchromatic regions. 
 
Figure 23. Simplified model of HP1 targeting to pericentric heterochromatin. 
(A) A scheme depicting RNA-mediated de novo targeting of HP1 to pericentric chromatin. Top left, the 
nucleoplasmic HP1 dimer is in a closed conformation that is incompatible with RNA binding. Suv39h1-
stimulated SUMOylation of the HP1 hinge induces a change in conformation, which exposes the hinge and 
facilitates RNA binding (open HP1 dimer). Specific binding of the major satellite (pericentric) transcripts targets 
the SUMO-HP1-Suv39h1 complex to the pericentric chromatin. Suv39h1 deposits H3K9 trimethylation to which 
HP1 binds, and this initiates heterochromatin formation and spreading (B).  
(B) A scheme depicting HP1binding to pericentric heterochromatin. Suv39h1-deposited H3K9me3 increases the 
affinity of HP1 binding and mediates HP1 spreading along the locus. Nucleoplasmic HP1 and Suv39h1 can 
bind directly to chromatin via interactions with already bound HP1 and/or Suv39h1. Major satellite transcripts 
stabilise Suv39h1 association with pericentric heterochromatin. HP1 bound to nucleosomes is in an open 
conformation, and can interact with major satellite transcripts, but the effect of this interaction is not clear. It can, 
as in the case of Suv39h1, stabilise retention on chromatin or it can lead to eviction of HP1 to the nucleoplasm. 
This model is based on (Johnson et al., 2017; Keller et al., 2012; Larson et al., 2017; Maison et al., 2011, 2016; 
Shirai et al., 2017; Velazquez Camacho et al., 2017), and my work presented in this thesis. Scales are approximate. 
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4.2. DNA-sequence-specific targeting of HP1s to silent euchromatin  
HP1 proteins can be recruited to distinct loci in euchromatin where they contribute to 
silencing. For the sites associated with H3K9 methylation, it is, indeed, tempting to conclude 
that the histone mark acts as a recruiter. However, if we take a closer look at figure 24, we 
see that in almost all cases HP1s closely interact with DNA specificity factors. What would 
be an evolutionary purpose of these interactions if not recruitment?  
For the ERV class I-II, HP1s interact directly with Trim28, which gains its specificity from 
KRAB-ZFs (Fig. 24A). For the ChAHP sites, HP1s interact directly with the transcription 
factor Adnp, which is essential for HP1 recruitment (Fig. 24C). The importance of HP1 
targeting to the Adnp sites is underlined by my work, which revealed that Adnp with 
mutations found in Helsmoortel-Van der Aa syndrome patients fails to interact with HP1s, 
and thus, target them to chromatin. For the PRC1.6 sites, HP1s interact with the recruiting 
transcription factor Mga, which contains a PxVxL motif, indicating it is a direct interaction 
(Fig. 24D). Finally for the ERV class III, there is no known recruiter of the Ehmt1/2 
heterodimer, and therefore, it would be unfair to make any conclusions about HP1 recruitment 
or the order of binding (Fig. 24B). However, my proteomic datasets uncovered multiple zinc 
finger proteins, some of which were also shown to interact with Ehmt2 (Maier et al., 2015; 
Zhang et al., 2016). ZFs that have especially high enrichments in my experiments are Zfp462, 
Zfp518b, and Zfp280c/d. Out of these, Zfp518b appears to be the most interesting candidate 
for targeting Ehmt2 to the ERVs class III: (1) it is one of the top enriched proteins in all HP1 
TAPs, and all three homologs bind to ERVs, and (2) Zfp518b KD was shown to reduce the 
levels of H3K9me2 (Maier et al., 2015). It would be interesting to test if Zfp518b or other 
ZFs recruit HP1s and Ehmt1/2 to the specific sites in the genome. 
Finally, coming to the role of H3K9me, my PhD work demonstrated that HP1 homologs 
do not require H3K9me for silencing of the ChAHP sites. The only effect we see as a 
consequence of lacking HKMTase and H3K9me at those loci, is that HP1s cannot spread (Fig. 
24C). This is apparent from my ChIP-seq data where we see narrow HP1 peaks at the ChAHP 
sites, and wide HP1 peaks at the H3K9me3-marked sites. As discussed in chapter 3.2 of this 
section, the difference between the H3K9me-HP1- and ChAHP-silenced chromatin could be 
the stability of the repressed states - permanent and temporary silencing, respectively. 
 




Figure 24. Simplified model of HP1 targeting to silent euchromatin. 
(A) HP1 homologs are recruited to the ERV class I and II via direct interaction with Trim28-KRAB-ZFs. Trim28 
recruits Setdb1, which deposits H3K9me3, and mediates HP1 spreading.  
(B) HP1 homologs can be recruited to the ERV class III, which is silenced by an Ehmt1/2 heterodimer that deposits 
H3K9 dimethylation. The mechanism of the Ehmt1/2 and HP1 recruitment is not clear, but HP1s interact with 
Ehmt1/2 via the chromo-shadow domain and/or chromo domain.  
(C) HP1 homologs are recruited by the transcription factor Adnp in a DNA-sequence-specific, H3K9me-
independent, manner. HP1, Adnp, and the chromatin remodeller Chd4 form a complex named ChAHP. HP1 
associates preferentially with the complex. The complex may also associate with additional repressive enzymes 
such as Lsd1 and/or Hdac1/2. The lack of H3K9me at these sites prevents HP1 spreading, but does not affect 
silencing. 
(D) HP1s and Ehmt1/2 are components of the PRC1.6 complex, which is recruited to meiosis- and germ cell-
related genes. PRC1.6 appears to be targeted by two transcription factors, Mga and Max, which form a 
heterodimer. The Mga/Max-dependency of HP1 or Ehmt1/2 binding to the PRC1.6 sites has not been tested. Mga 
contains a PxVxL-HP1 interaction motif. 
(A), (B), (D) The presence of HKMTases and, thus, H3K9 methylation mediates spreading of HP1 along the locus, 
while in (C) HP1 binding is locally restricted.  
This model is based on (Endoh et al., 2017; Maksakova et al., 2011, 2013; Ogawa et al., 2002), and my work 
presented in this thesis. Scales are approximate. 
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Activity-dependent neuroprotective protein recruits 
HP1 and CHD4 to control lineage-specifying genes
Veronika Ostapcuk1,2, Fabio Mohn1, Sarah H. Carl1,3,5, Anja Basters1,5, Daniel Hess1, Vytautas Iesmantavicius1,  
Lisa Lampersberger1,4, Matyas Flemr1, Aparna Pandey1,2, Nicolas H. thomä1, Joerg Betschinger1 & Marc Bühler1,2*
De novo mutations in ADNP, which encodes activity-dependent 
neuroprotective protein (ADNP), have recently been found 
to underlie Helsmoortel–Van der Aa syndrome, a complex 
neurological developmental disorder that also affects several other 
organ functions1. ADNP is a putative transcription factor that is 
essential for embryonic development2. However, its precise roles 
in transcriptional regulation and development are not understood. 
Here we show that ADNP interacts with the chromatin remodeller 
CHD4 and the chromatin architectural protein HP1 to form a 
stable complex, which we refer to as ChAHP. Besides mediating 
complex assembly, ADNP recognizes DNA motifs that specify 
binding of ChAHP to euchromatin. Genetic ablation of ChAHP 
components in mouse embryonic stem cells results in spontaneous 
differentiation concomitant with premature activation of lineage-
specific genes and in a failure to differentiate towards the neuronal 
lineage. Molecularly, ChAHP-mediated repression is fundamentally 
different from canonical HP1-mediated silencing: HP1 proteins, in 
conjunction with histone H3 lysine 9 trimethylation (H3K9me3), 
are thought to assemble broad heterochromatin domains that are 
refractory to transcription. ChAHP-mediated repression, however, 
acts in a locally restricted manner by establishing inaccessible 
chromatin around its DNA-binding sites and does not depend on 
H3K9me3-modified nucleosomes. Together, our results reveal 
that ADNP, via the recruitment of HP1 and CHD4, regulates the 
expression of genes that are crucial for maintaining distinct cellular 
states and assures accurate cell fate decisions upon external cues. 
Such a general role of ChAHP in governing cell fate plasticity 
may explain why ADNP mutations affect several organs and body 
functions and contribute to cancer progression1,3,4. Notably, we 
found that the integrity of the ChAHP complex is disrupted by 
nonsense mutations identified in patients with Helsmoortel–Van 
der Aa syndrome, and this could be rescued by aminoglycosides 
that suppress translation termination5. Therefore, patients might 
benefit from therapeutic agents that are being developed to promote 
ribosomal read-through of premature stop codons6,7.
ADNP contains nine N-terminal zinc-fingers and a C-terminal 
homeobox domain, strongly suggesting transcription factor activity8. 
Although originally associated with neuronal function9, ADNP is 
essential for embryonic development in mice: Adnp-deficient mouse 
embryos exhibit neural tube closure defects and die at days 8.5–9.5 of 
gestation. Two studies in knockout mouse embryos identified potential 
ADNP target genes that are implicated in cell differentiation and the 
maintenance of stem cells2,10.
To dissect the molecular activity of ADNP, we exploited mouse 
embryonic stem (ES) cells11. We first inserted a Flag-AviTag at the 
endogenous Adnp gene12 (Extended Data Fig. 1a–c) and performed 
chromatin immunoprecipitation coupled to next-generation sequenc-
ing (ChIP–seq) to interrogate putative ADNP–DNA interactions 
genome-wide. This revealed 15,026 sites that are significantly enriched 
for ADNP (Fig. 1a, b and Supplementary Table 1). Notably, most (61%) 
of the peaks were found in introns or proximal of annotated transcrip-
tion start sites. The remaining peaks were located promoter distal in 
intergenic regions (Extended Data Fig. 1d, e). To analyse the func-
tion of ADNP, we generated homozygous Adnp knockout mouse ES 
cells (Extended Data Fig. 2a, b). Compared with wild-type ES cells, 
Adnp−/− cells displayed gross morphological changes and appeared 
to differentiate spontaneously as they started spreading out of char-
acteristically densely packed ES cell colonies (Fig. 1c, d). In addition, 
Adnp−/− cells displayed heterogeneous activity of the pluripotency 
associated marker alkaline phosphatase (Fig. 1d). Transcriptome pro-
filing by RNA sequencing (RNA-seq) revealed that most of the genes 
with altered mRNA levels in Adnp−/− cells were upregulated (Extended 
Data Fig. 2c). Many genes bound by ADNP and displaying increased 
expression in the absence of ADNP encode known lineage specification 
factors, such as GATA4, GATA6, BMP1 or SOX17 (Supplementary 
Table 2). For example, Gata4 is expressed predominantly in mesoderm- 
and endoderm-derived tissues13, and forced Gata4 expression in mouse 
ES cells induces differentiation towards extra-embryonic endoderm14. 
Moreover, genes upregulated in Adnp−/− cells were enriched for Gene 
Ontology terms related to differentiation and development (Extended 
Data Fig. 2d and Supplementary Table 3). We also observed a group 
of genes that were upregulated both in Adnp−/− cells as well as in 
extra-embryonic endoderm stem-cell lines, which can be differentiated 
from mouse ES cells15 (Extended Data Fig. 2e). To gain further insight 
into the biological role of ADNP, we differentiated wild-type and 
Adnp−/− ES cells towards neuronal precursor cells (Fig. 1c, d) using an 
established differentiation protocol16. Adnp−/− ES cells formed smaller 
embryoid bodies and showed increased cell death after differentiation 
when compared to wild-type cells (Fig. 1d). Nanog and Oct4 (also 
known as Pou5f1) expression was downregulated in both wild-type and 
Adnp−/− cells, indicating successful exit from pluripotency (Fig. 1e). 
However, whereas Adnp+/+ cells started expressing neural markers 
such as Pax6 and Ngn2 (also known as Neurog2) over the course of 
differentiation, Adnp−/− cells failed to induce neural genes (Fig. 1f). 
Instead, the expression of Gata4 and Sox17 was specifically induced 
in Adnp−/− cells (Fig. 1g), indicating misspecification towards the 
endodermal lineage under conditions that normally induce neuronal 
fate. This ES cell phenotype is reminiscent of Adnp−/− mouse embryos, 
which show a developmental delay, fail to induce Pax6 and suffer from 
defective neural tube closure2. Thus, ADNP is required to restrain the 
expression of lineage-specifying genes in ES cells and for specification 
towards the neuronal lineage upon external differentiation cues.
These results are consistent with previously reported repressive 
activity of ADNP when artificially targeted to a reporter gene17. 
Furthermore, ADNP was shown to co-immunoprecipitate with the 
SWI/SNF chromatin remodelling complex18 or with proteins of the 
heterochromatin protein 1 (HP1) family10,19. To unambiguously iden-
tify ADNP-interacting proteins in mouse ES cells, we subjected ADNP 
tagged endogenously with a Flag-AviTag to tandem-affinity purifica-
tion coupled to liquid chromatography tandem mass spectrometry 
1Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland. 2University of Basel, Basel, Switzerland. 3Swiss Institute of Bioinformatics, Basel, Switzerland. 4University of Vienna, 
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(TAP–LC–MS/MS). Besides ADNP, we observed highly notable enrich-
ment of HP1β, HP1γ and CHD4, but not SWI/SNF complex subunits. 
These interactions were preserved under 500 mM NaCl, showing that 
ADNP stably interacts with CHD4 and the HP1β and HP1γ proteins 
in ES cells (Fig. 2a). To corroborate this, we inserted a Flag-AviTag 
into the endogenous Cbx1, Cbx3 and Cbx5 genes, which encode the 
three mammalian HP1 isoforms HP1β, HP1γ and HP1α, respectively12 
(Extended Data Fig. 3a). Both ADNP and CHD4 were highly enriched 
in HP1β and HP1γ purifications (Fig. 2b and Extended Data Fig. 3). By 
contrast, CHD4 did not co-purify with HP1α (Extended Data Fig. 3b, 
e), and ADNP was 100-fold and 235-fold less abundant than in HP1β 
and HP1γ purifications, respectively (Extended Data Fig. 3g).
To verify that ADNP, HP1 and CHD4 form a stable complex via 
direct protein–protein interactions, we set out to reconstitute complex 
formation in vitro with recombinant human ADNP, HP1γ and CHD4 
(Extended Data Fig. 4). Co-lysis of cells expressing HP1γ, ADNP and 
CHD4 resulted in the formation of a trimeric complex, which was pre-
served after streptavidin affinity purification, anion-exchange chro-
matography, and size-exclusion chromatography (SEC) (Fig. 2c, d). 
Subsequent experiments with full-length and truncated variants of the 
proteins (Extended Data Fig. 4) revealed that ADNP is at the core of 
the complex and interacts with CHD4 via its N terminus and with 
the chromoshadow domain (CSD) of HP1 via its C-terminal domain 
(Fig. 2e), probably through the PXVXL (in which X denotes any amino 
acid) motif17. In conclusion, CHD4, ADNP and HP1β/γ form a stable 
protein complex, which we refer to as ChAHP.
Next we performed ChIP–seq with endogenously tagged HP1α, 
HP1β and HP1γ and consulted a published dataset20 for CHD4. 
Corroborating the biochemistry, all of the ADNP peaks (n = 15,026, 
Fig. 1) showed enrichment for CHD4 and HP1β/γ (Fig. 2f). Of the 
HP1 isoforms, the average HP1γ occupancy was the highest, HP1β 
was moderately enriched, and HP1α was barely detectable at those 
sites (Fig. 2f and Extended Data Fig. 5a–d). This confirms our 
TAP–LC–MS/MS results and indicates that HP1γ is the dominant 
isoform in ChAHP, whereas HP1β is present in a minor fraction of 
ChAHP complexes or forms sub-stoichiometric heterodimers with 
HP1γ. In line with a partial redundancy of HP1β and HP1γ, we 
observed that the average HP1β occupancy on all ChAHP-bound 
sites was greatly increased in the absence of HP1γ, whereas HP1γ 
occupancy remained similar in the absence of HP1β (Extended Data 
Fig. 5c). Thus, HP1γ is the predominant member of ChAHP in ES cells.
HP1 proteins recognize and bind to methylated H3K9 through the 
chromodomain21,22, indicating that HP1 might target ChAHP to H3K9 
methylated nucleosomes. Consistent with previous immunostaining 
experiments17, we observed slight ADNP and CHD4 association with 
H3K9me3-marked chromatin. However, most of the highly enriched 
ADNP, and respective ChAHP peaks, were located in euchromatin 
(Fig. 2f). Consistent with repressive activity of ChAHP, histone modifi-
cations associated with active transcription were also absent (Extended 
Data Fig. 5e, f). In line with an H3K9me3-independent recruitment 
of ChAHP, HP1γ with mutations in the chromodomain that abolish 
H3K9me binding still bound to ChAHP target genes (Extended Data 
Fig. 5g). By contrast, the binding of HP1γ was lost at all ChAHP-bound 
sites in the absence of ADNP, whereas HP1γ bound to genomic regions 
with H3K9me3-modified nucleosomes remained largely unaffected 
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Fig. 1 | ADNP binds and represses lineage-specifying genes. a, Heat map 
of ADNP ChIP–seq enrichment across all significant peaks (n = 15,026) in 
the mouse genome. Each row represents a 6-kb window centred on peak 
midpoints, sorted by the ADNP ChIP signal. Input signals for the same 
windows are shown on the right. Average peak intensity of n = 3 biological 
replicates. RPM, reads per million. b, UCSC genome browser shots of 
three endoderm specification factors (Igfbp4, Bmp1 and Gata4). ChIP–
seq profiles for ADNP and input, and RNA-seq profiles for wild-type 
(Adnp+/+) and ADNP-knockout (Adnp−/−) mouse ES cells. Both ChIP–seq 
and RNA-seq profiles are normalized for library size. The experiment 
was repeated three times. c, Wild-type ES cells differentiate to neural 
progenitors (NP) in response to external cues. Consecutive withdrawal 
of 2i and leukaemia inhibitory factor (LIF) results in the formation of 
cellular aggregates (embryoid bodies, EB), which further differentiate into 
neural progenitors by the addition of retinoic acid (RA) at day 4. d, Phase-
contrast images (original magnification, ×5) of Adnp+/+ and Adnp−/− 
mouse ES cells stained with alkaline phosphatase when grown in 2i,  
serum and LIF (day 0), and during differentiation towards the neuronal 
lineage (days 2, 4 and 8). The experiment was repeated three times.  
e–g, mRNA expression profiles of genes specifying pluripotent cells  
(e; Nanog and Oct4), or cells of the neural (f; Pax6 and Ngn2) or the 
endodermal (g; Gata4 and Sox17) lineages from two independent 
differentiation experiments (light and dark coloured dots). Values normalized 
to Tbp mRNA are shown relative to the Adnp+/+ parental cell line (in 2i/
serum/LIF medium) for each replicate. Biological replicates were performed 
using independent mouse ES cell lines for each tagged protein. d, day.
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the complex to euchromatic sites in a sequence-specific manner. Motif 
analysis of ADNP-bound loci revealed several significant DNA motifs. 
The highest-enriched motif (CGCCCYCTNSTG) was present in 63% 
of peaks (P = 1 × 10−10,538), and several motifs often co-occurred at 
bound genomic loci (Extended Data Fig. 6). To prove that ChAHP is 
indeed recruited via sequence-specific binding of ADNP, we deleted 
the predicted ADNP-binding motif (Δmotif) at the endogenous Igfbp4 
locus (Fig. 3b). Validating GCCCCCTGGAG as an ADNP-binding 
site, ADNP enrichment was specifically lost at the Igfbp4 locus in 
Igfbp4Δmotif/Δmotif cells, whereas another ChAHP target gene (Bmp1) 
remained unaffected (Fig. 3c). Importantly, the binding of CHD4 
and HP1γ was also depleted at the Igfbp4 but not the Bmp1 locus in 
Igfbp4Δmotif/Δmotif cells (Fig. 3d, e). Consistent with ChAHP-mediated 
target repression, we observed significantly increased Igfbp4 but not 
Bmp1 mRNA levels in Igfbp4Δmotif/Δmotif cells (Fig. 3f).
Identification of ChAHP strongly suggests that ADNP 
exerts its repressive function with the help of HP1. Indeed, 
Cbx1−/−Cbx3−/−Cbx5−/− triple-knockout cells revealed a distinct 
group of genes that was also upregulated in Adnp−/− cells. This was not 
evident in Cbx single- or double-knockout cells (Extended Data Fig. 7 
and Supplementary Table 4). This suggests functional replacement by 
HP1α in the absence of HP1β and HP1γ, even though it only weakly 
interacts with ADNP and is not highly enriched at ChAHP target genes 
(Extended Data Figs. 3g, 5d). The fact that overall gene expression was 
not greatly affected if at least one HP1 isoform was present provides a 
general indication that HP1 isoforms can act partially redundantly to 
repress target genes in ES cells (Extended Data Fig. 7b).
The requirement of HP1 for ChAHP-mediated repression prompted 
us to revisit ADNP mutations found in patients with Helsmoortel–Van 
der Aa syndrome. Most are frameshift or nonsense mutations that result 
in C-terminally truncated ADNP that lacks the homeobox domain and 
the HP1 interaction motif1 (Extended Data Fig. 1b). This suggests that 
mutant ADNP fails to assemble functional ChAHP and/or to bind its 
target genes. To test this, we introduced a patient-specific nonsense 





































































































































































































Fig. 2 | ADNP mediates ChAHP complex 
formation. a, TAP–LC–MS/MS of ADNP 
endogenously tagged with Flag-AviTag. 
Protein purification was performed in the 
presence of 500 mM NaCl. Parental mouse ES 
cell line serves as background control. n = 3 
biological replicates. FDR, false discovery 
rate. b, TAP–LC–MS/MS of HP1α, HP1β 
and HP1γ endogenously tagged with Flag-
AviTag. Protein purification was performed 
in the presence of 350 mM NaCl. Proteins that 
interact predominantly with HP1α (left), or 
HP1β or HP1γ (right) are indicated by UniProt 
names. n = 3 biological replicates. Statistical 
analysis was done with Perseus (see Methods). 
Mass spectrometry raw data are deposited with 
ProteomeXchange. c, d, In vitro reconstitution 
of the ChAHP complex. ADNP, CHD4 and 
HP1γ were expressed in Hi5 insect cells. Strep-
tagged HP1γ (S–HP1γ) was pulled down with 
co-purifying ADNP and CHD4, followed by 
separation on size-exclusion chromatography 
(SEC) (Extended Data Fig. 4b, c). The fraction 
containing purified ChAHP was loaded on 
SDS–PAGE (c) and reinjected on SEC (d). 
For gel source data, see Supplementary Fig. 1. 
All experiments were performed at least 
twice. e, Scheme depicting ChAHP subunit 
interactions (see Extended Data Fig. 4). ADNP 
N-terminal zinc-fingers are necessary for 
the interaction with yet-to-be-determined 
CHD4 residues. The PXVXL motif in ADNP 
mediates the interaction with the CSD of HP1. 
Protein domains as predicted by InterPro. CD, 
chromodomain. f, Heat map of ADNP, CHD4, 
HP1γ, HP1β, HP1α and H3K9me3 ChIP–seq 
enrichment across all euchromatic sites bound 
by ChAHP (top) or heterochromatic sites 
bound by HP1γ (bottom). Each row represents 
a 6-kb window centred on the ADNP or HP1γ 
peak midpoint, respectively. Rows are sorted 
by ADNP (top) or HP1γ (bottom) ChIP 
enrichment. Average peak intensity of n = 3 
biological replicates. Biological replicates were 
performed using independent mouse ES cell 
lines for each tagged protein.
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mutation upstream of the homeobox domain at amino acid position 
718 (AdnpPTC718; Extended Data Fig. 8a; corresponds to Tyr719 in 
human ADNP). ADNPPTC718 failed to co-purify with HP1β and HP1γ, 
whereas the interaction with CHD4 remained preserved (Extended 
Data Fig. 8b). Consistent with the requirement of HP1 for silencing, 
we observed increased expression of ADNP-target genes in cells that 
express ADNPPTC718 (Extended Data Fig. 8c). The ADNPPTC718 protein 
still bound its target site at the Igfbp4 locus (Extended Data Fig. 8d), 
indicating that the homeobox domain is dispensable for DNA binding 
but might assist in target repression. These results demonstrate that 
patients with nonsense mutations in the ADNP gene cannot assemble 
fully functional ChAHP complexes. To test whether this could poten-
tially be restored pharmacologically, we treated ADNPPTC718-expressing 
cells with gentamycin or paromomycin, two aminoglycoside antibiotics 
that promote translational read-through5. Indeed, gentamycin treat-
ment promoted read-through of PTC718 (Extended Data Fig. 8e, f) 
and rescued the interaction between ADNPPTC718 and HP1β or HP1γ. 
Although less effectively, HP1γ was also retrieved from samples that 
were treated with paromomycin (Extended Data Fig. 8b). Thus, a ther-
apeutic approach that promotes ribosomal read-through of premature 
stop codons could be of considerable medical benefit. However, the 
discovery of new nonsense suppressors will be inevitable, because the 
clinical utility of aminoglycoside therapy is limited by low efficacy and 
serious toxicities6.
Finally, we set out to investigate the molecular function of ChAHP. 
Inspired by the role of CHD4 in nucleosome remodelling and HP1 in 
heterochromatin assembly, we investigated a possible role of ChAHP 
in regulating local chromatin accessibility by the ATAC-seq method 
(assay for transposase-accessible chromatin using sequencing)23. Many 
transcription factors, such as NRF124, generate local accessible regions 
at their DNA-binding sites (Fig. 4a). Unexpectedly, we did not observe 





























































































































































































Fig. 3 | DNA sequence specifies ChAHP association with euchromatin. 
a, Heat map of HP1γ ChIP–seq enrichment in euchromatic ChAHP-
bound sites (top) or heterochromatic HP1-bound sites (bottom) in 
Adnp+/+ and Adnp−/− mouse ES cells. Each row represents a 6-kb window 
centred on the respective peak signal. Rows are sorted by mean ChIP 
enrichment. Average peak intensity of n = 3 biological replicates (that 
is, three independent ES cell lines). b, Schemes depicting the location of 
ADNP-binding motifs in the Igfbp4 (left) and Bmp1 (right) genes and the 
Igfbp4 locus with the motif deletion Igfbp4Δmotif/Δmotif (middle). c, ChIP–
qPCR measuring ADNP enrichments at Igfbp4 and Bmp1 promoters in 
Igfbp4Δmotif/Δmotif cells compared to the parental line (Igfbp4+/+). n = 3 
biological replicates. d, ChIP–qPCR measuring CHD4 enrichments 
at Igfbp4 and Bmp1 promoters in Igfbp4Δmotif/Δmotif cells compared to 
the parental line. n = 6 biological replicates. e, ChIP–qPCR measuring 
HP1γ enrichments at Igfbp4 and Bmp1 promoters in Igfbp4Δmotif/Δmotif 
cells compared to the parental line. n = 3 biological replicates. f, qRT–
PCR measurement of Igfbp4 and Bmp1 mRNA levels in wild-type and 
Igfbp4Δmotif/Δmotif cells. n = 3 biological replicates. P values in c–f were 
calculated using two-tailed unpaired unequal variances t-tests. Centre 
values denote the mean; error bars denote s.d.
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Fig. 4 | ChAHP obstructs chromatin accessibility. a, Average accessibility 
of loci bound by unrelated transcription factors NRF1 (top) and SOX2 
(bottom) in Adnp+/+ (grey) and Adnp−/− (red) mouse ES cell lines 
measured by ATAC-seq. Profiles represent averaged biological replicates 
(n = 4). b, Average accessibility of loci bound by ADNP and ‘random’ 
control loci (ADNP peaks shifted by 10 kb; dashed lines) in Adnp+/+ (grey) 
and Adnp−/− (red) mouse ES cells. Profiles represent averaged biological 
replicates (n = 4). c, Heat map showing ATAC-seq read coverage in a 2-kb 
window around all ADNP peaks normalized by library depth in Adnp+/+ 
(left) and Adnp−/− (right) ES cells.
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loci was largely devoid of an ATAC-seq signal (Fig. 4b, c). This sug-
gests that ChAHP is bound to chromatin with impaired accessibility, 
or conversely, that the binding of ChAHP renders chromatin inacces-
sible. Notably, all ChAHP-bound sites became readily accessible in the 
absence of ADNP, whereas ChAHP-independent control loci such as 
NRF1- or SOX2-binding sites, as well as a ‘random’ set of genomic loci 
(ADNP peaks shifted by 10 kb) showed no difference in accessibility 
(Fig. 4a–c). Notably, the opening of chromatin in Adnp−/− cells was 
restricted to a few hundred base pairs around ChAHP-binding sites, 
and the surrounding regions remained inaccessible (Fig. 4c). Thus, 
rather than assembling broad, inaccessible domains of chromatin, 
ChAHP denies direct access to its cognate DNA-binding sites.
In summary, we have discovered ChAHP, a gene-regulatory complex 
that consists of the chromatin remodeller CHD4, the DNA-binding 
factor ADNP, and the heterochromatin proteins HP1β and HP1γ. By 
locally restricting access to DNA, ChAHP prevents endodermal gene 
transcription in mouse ES cells and during neuroectodermal differen-
tiation. This stabilizes cellular states and ensures correct lineage spec-
ification. Although ChAHP could directly interfere with transcribing 
RNA polymerase, we favour a model in which ChAHP prevents the 
binding of other regulatory factors, such as transcriptional activators, 
to DNA. Although the exact mode of action of ChAHP remains to be 
determined, such a model would be consistent with the notion that 
ChAHP also binds outside gene bodies and promoters.
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MEthodS
No statistical methods were used to predetermine sample size. The experiments 
were not randomized, and investigators were not blinded to allocation during 
experiments and outcome assessment.
Cell culture and genome editing. Mouse ES cells (129×C57BL/625 were cultured 
on gelatin-coated dishes in ES medium containing DMEM (Gibco 21969-035), 
supplemented with 15% fetal bovine serum (FBS; Gibco), 1× non-essential amino 
acids (Gibco), 1 mM sodium pyruvate (Gibco), 2 mM l-glutamine (Gibco), 0.1 mM 
2-mercaptoethanol (Sigma), 50 mg ml−1 penicillin, 80 mg ml−1 streptomycin, 3 μM 
glycogen synthase kinase (GSK) inhibitor (Calbiochem, D00163483), 10 μM MEK 
inhibitor (Tocris, PD0325901), and homemade LIF, at 37 °C in 5% CO2.
The genome editing was performed as previously published12 in the absence of 
GSK and MEK inhibitors in the above-described ES medium.
Generation of endogenously tagged ES cell lines. For endogenous gene tagging 
using TALENs, Rosa26:BirA-V5-expressing cells (cMB053 or cMB063) were trans-
fected with 400 ng TALEN-EED, 400 ng TALEN-KKR, 100 ng pRRP reporter and 
1,000 ng of donor single-stranded oligodeoxynucleotide encoding the tag sequence. 
The single-stranded oligodeoxynucleotides were synthesized as Ultramers by 
Integrated DNA Technologies and their sequences are listed along with TALEN 
sequences in Supplementary Table 6. All transfections were carried out using 
Lipofectamine 3000 reagent (Invitrogen) at a 3 μl:1 μg DNA ratio in OptiMEM 
medium (Invitrogen). Transfected cells were selected by adding puromycin 
(2 μg ml−1) to the ES medium 24 h after transfection. After 36 h of selection, surviv-
ing cells were sparsely seeded for clonal expansion. The resulting clones were indi-
vidually picked, split and screened by western blot for desired tag integration. See 
Supplementary Information for the list of tagged cell lines generated in this study.
Straight knockout ES cell line generation. Cbx1−/− mouse ES cells were generated 
using TALENs that target the first and last coding exon, resulting in a deletion of 
approximately 6,000 bp (exon 2–exon 6).
Adnp−/− mouse ES cells were generated using Cas9 and TALENs that target the 
first and last coding exon, resulting in a deletion of approximately 7,000 bp (exon 
2–exon 4). The Cas9 sgRNA sequence was cloned into the SpCas9-2A-mCherry 
plasmid26. Sequences of TALENs and Cas9 gRNA can be found in Supplementary 
Table 6. See Supplementary Information for the list of straight knockout cell lines 
generated in this study.
Conditional ES cell line generation. The Cbx3fl/fl cell line was generated as 
described12. For the Cbx5fl/fl conditional cell line, a mouse ES cell line containing 
an integration of the CreERT2 recombinase fusion in the Rosa26 locus (cMB052 
or cMB063) was transfected with TALENs cutting before and after the third 
exon. Single-stranded oligodeoxynucleotides with corresponding homology arms 
and loxP sites for integration were also included in the transfection mix (see 
Supplementary Table 6 for sequences). Clones were screened for homozygous 
integrations for both loxP sites. A cell line with both bi-allelic loxP integrations 
was tested for recombination efficiency by treating the cells with 0.1 μM 
4-hydroxytamoxifen (4-OHT; Sigma) followed by western blot or quantitative 
PCR with reverse transcription (qRT–PCR).
Transient expression experiments in ES cells. The full-length Adnp cDNA was 
cloned into the mammalian expression vector pEFaFB (promoter of elongation 
factor-1 alpha; ATG-3×Flag-Avi-GOI-2A-puromycin), creating pEFaFB-Adnp, 
which was then used as a template to mutate codon 718 (TAT to TAA) using the 
QuikChange Lightning Site-Directed Mutagenesis (SDM) Kit (Agilent), with the 
final construct encoding pEFaFB-ADNPPTC718. Alternatively, AdnpPTC718 cDNA 
was cloned into the pEFaCFB vector (C-terminal 3×Flag-AviTag).
The Cbx3 cDNA was cloned into pEFaFB, and then used as a template for SDM 
mutating chromodomain residues Trp43 and Phe46 to Ala (Cbx3 CDmut)27.
For ChIP experiments, 5 × 106 Adnp−/− (cMB377) cells in a 10-cm dish 
were reverse transfected with 10 μg pEFaFB-Adnp or pEFaFB-AdnpPTC718. 
Alternatively, Cbx1−/−Cbx3−/−Cbx5−/− triple-knockout (4-OHT-treated cMB282) 
cells were transfected with 10 μg pEFaFB-Cbx3 or pEFaFB-Cbx3-CDmut. Cells 
were collected 48 h after transfection, and further processed according to the ChIP 
protocol (below). For affinity purification experiments, 6 × 106 cells in a 15-cm 
dish were reverse transfected with 10 μg pEFaFB-AdnpPTC718 or pEFaCFB- 
AdnpPTC718. Twenty hours after transfection, cells were forward-transfected with 
5 μg pEFaFB-AdnpPTC718. Finally, 48 h from the first transfection, cells were 
treated with 2 mg ml−1 gentamycin (Sigma, G1914) or paromomycin (Sigma, 
P9297) for 24 h. Cells were then collected and processed according to the 
Affinity purification protocol (bellow). Transfections were carried out using 
Lipofectamine 3000 reagent (Invitrogen) at a 3 μl:1 μg DNA ratio in OptiMEM 
medium (Invitrogen), and 10 μM ROCK inhibitor (Tocris, Y27632) for increased 
cell survival.
Differentiation of ES cells to neuronal precursors. The cMB263 (Adnp+/+) and 
cMB267 (Adnp−/−) ES cell lines were differentiated as previously described28, 
except that no feeder cells were used. Instead, cells were grown in ES cell medium 
containing 2i, as described above.
Western blotting. Cells were grown to confluency on 6-well plates, collected in 
PBS, pelleted by 2 min centrifugation at 400g, and pellets were then resuspended 
in 100 μl protein extraction buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% 
Triton X-100, 0.5 mM EDTA, and 5% glycerol) supplemented with protease inhib-
itor cocktail (PIC; Roche), 1 mM PMSF, and 1 mM dithiothreitol (DTT). Proteins 
were extracted for 30 min on ice, the lysates were centrifuged at 16,000g for 20 min 
at 4 °C, and the protein concentration in the supernatant was determined using 
the BioRad protein assay. For western blotting, 20 μg of protein was resolved on 
NuPAGE-Novex Bis-Tris 4–12% gradient gels (Invitrogen), which were semi-dry 
transferred on polyvinylidene fluoride (PVDF) membrane, blocked for 30 min 
in 2.5% non-fat dry milk in TBS plus 0.05% Tween 20 (TBST), and stained with 
primary antibodies at 4 °C overnight. The primary antibodies used for west-
ern blotting were mouse anti-Flag (1:1,000, Sigma clone M2), goat-anti-HP1α 
(1:1,000, Abcam, ab77256), mouse-anti-HP1α (1:1,000, Millipore, mab3446), rat-
anti-HP1β (1:500, Serotec, MCA1946), mouse-anti-HP1γ (1:2,000, Cell Signaling 
Technology), mouse-anti-CHD4 (1:1,000, Abcam, ab70469), rabbit-anti-MTA2 
(1:1,000, Bethyl, A300-395A-T), rabbit-anti-GATAD2B (1:1,000, Bethyl, A301-
283A-T), rabbit-anti-MBD3 (1:1,000, Bethyl, A302-528A-T) and rat-anti-tubulin 
(1:5,000, Abcam clone YL1/2). Signal was detected with corresponding horse-
radish peroxidase (HRP)-conjugated secondary antibodies and Immobilon 
Western Chemiluminiscent HRP Substrate (Millipore). For streptavidin staining, 
membranes were blocked after transfer in 2% bovine serum albumin (BSA) in 
TBST and incubated with streptavidin–HRP (1:20,000, Sigma) for 30 min at room 
temperature, followed by signal development as above.
ChIP. A confluent 10-cm culture dish of ES cells (approximately 2 × 107 cells) were 
cross-linked for 7 min at room temperature, with 1% final formaldehyde solution 
(Sigma, F8775) added directly to the ES medium. Cross-linking was quenched 
by the addition of glycine to a final concentration of 0.125 mM and incubation at 
4 °C for 10 min; cells were then washed twice with PBS. Cells were collected in 1 ml 
PBS with PIC (Roche) and spun at 600g for 5 min at 4 °C. Cells were then resus-
pended in 5 ml wash solution I (10 mM Tris pH 8, 10 mM EDTA, 0.5 mM EGTA, 
0.25% Triton X-100), incubated for 10 min on ice, then spun at 1,200g for 5 min at 
4 °C. The remaining nuclear pellet was then resuspended in 5 ml wash solution II 
(10 mM Tris pH 8, 1 mM EDTA, 0.5 mM EGTA and 200 mM NaCl) and incubated 
for 5 min on ice, then spun at 1,200g for 5 min at 4 °C. Cell pellet was subsequently 
washed in 900 μl sonication buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA and 0.1% 
SDS) without disturbing the pellet, and finally resuspended in the sonication buffer 
supplemented with PIC. Chromatin was then sonicated in Covaris 1-ml tubes for 
15 min with the following settings: duty cycle: 5%, peak incident power: 140 W, 
cycles per burst: 200, temperature (bath): 4 °C.
Beads preparation. For Bio-ChIP (ChIP for proteins tagged with the Flag-Avi 
tag), 40 μl Dynabeads Stepavidin (Thermo Fisher) per sample, or alternatively 40 μl 
Protein-G Dynabeads (Thermo Fisher) per sample for ChIP with protein-specific 
antibodies (Ab-ChIP), were washed twice for 5 min in 0.5 ml blocking buffer (PBS, 
0.5% Tween and 0.5% BSA). Streptavidin Dynabeads were then washed twice with 
immunoprecipitaiton buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 
0.1% SDS, 0.1% sodium deoxycholate and 1% Triton X-100) and stored on ice. 
Protein-G Dynabeads were incubated for 1 h at room temperature in blocking 
buffer with the desired antibody. Beads were then washed twice in blocking buffer 
and stored on ice. For CHD4 ChIP, 10 μg mouse anti-CHD4 (Abcam, ab70469, 
3F2/4) conjugated to Protein G was used.
Immunoprecipitation and washes. For immunoprecipitation analyses, 10 μl (1%) 
was kept as the input sample, and 40 μl pre-blocked Dynabeads were added to 1 ml 
of sonicated chromatin in immunoprecipitation buffer and incubated overnight at 
4 °C on a rotating wheel. Beads were collected on a magnetic rack for 2–3 min to 
remove supernatant between each step, and washed as follows: for Bio-ChIP, twice 
for 10 min with 2% SDS in TE buffer (10 mM Tris, pH 8, 1 mM EDTA), once for 
10 min with high salt buffer (50 mM HEPES pH 7.5, 1 mM EDTA, 1% Triton X-100, 
0.1% sodium deoxycholate and 500 mM NaCl), once for 10 min with DOC buffer 
(250 mM LiCl, 0.5%, NP-40, 0.5% deoxycholate, 1 mM EDTA and 10 mM Tris pH 8) 
and twice for 10 min with 1 ml TE buffer. For Ab-ChIP, beads were washed five 
times with immunoprecipitation buffer, twice with DOC buffer, and twice with TE 
buffer. Beads were then resuspended in 300 μl elution buffer (1% SDS and 100 mM 
NaHCO3) and 6 μl RNaseA (10 mg ml−1 stock) and incubated at 37 °C for 30 min 
while mixing. Elution buffer was adjusted with 6 μl 0.5 M EDTA, 12 μl 1 M Tris 
pH 8 and 2.5 μl Proteinase K (10 mg ml−1, Roche). Beads were incubated for 3 h at 
55 °C and then overnight at 65 °C with mixing to de-crosslink. The same procedure 
was followed for input samples including RNase and proteinase K digestion. DNA 
was purified using AMPure XP beads (Beckman Coulter). Quantification was 
performed with Qubit dsDNA high-sensitivity assay (Thermo Fisher).
ChIP–qPCR and ChIP–seq. DNA was subjected to qPCR analysis (as described 
for qRT–PCR, below) using ChIP primers described in Supplementary 
Information. For ChIP–seq sample preparation, library construction was 
performed using the NEBNext Ultra kit (New England Biolabs) following 
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manufacturer recommendations. Libraries were sequenced on Illumina HiSeq 
2500 machines, with 50-bp single-end sequencing.
qRT–PCR and RNA-seq. For qRT–PCR experiments, total RNA was extracted 
from ES cells with the Absolutely RNA Microprep Kit (Stratagene). Total RNA 
(500 ng) was reverse transcribed with the Primescript RT kit (Clontech). qRT–
PCR was performed on a CFX96 Real-Time PCR System (Bio-Rad) using the 
SsoAdvanced SYBR Green Supermix (Bio-Rad, 172–5264). Relative RNA levels 
were calculated from Ct values according to the ΔCt method and normalized to 
Tbp mRNA levels where applicable. For RNA-seq, total RNA (isolated as above) 
was subjected to ribosomal RNA depletion using the Ribozero kit (Illumina) 
followed by library construction using the ScriptSeq V2 library preparation kit 
(Illumina).
ATAC-seq. ATAC-seq was performed following a previously published protocol23 
using 50,000 Adnp+/+ or Adnp−/− mouse ES cells. The experiment was performed 
in biological replicates using two independent isogenic cell lines for each genotype. 
Libraries were paired-end sequenced (2 × 75 bp) using an Illumina NextSeq 500 
device.
Affinity purification for LC–MS/MS. All affinity purifications in this work were 
performed according to the following protocol with the exception of ADNPPTC718 
affinity purifications (see below). Cells were grown to confluency on 10-cm dishes, 
collected in PBS, and pelleted by centrifugation at 400g for 2 min. All subsequent 
steps were performed on ice or at 4 °C. Pellets were resuspended in 3 ml of nuclear 
extract buffer 1 (NEB1; 20 mM HEPES, 10 mM KCl, 1 mM EDTA, 0.1 mM Na3VO4, 
0.2% NP-40, 10% glycerol, 1 mM DTT and 1× PIC) followed by centrifugation 
at 1,000g for 3 min. Pellets were resuspended in 1 ml NEB1 buffer and incubated 
on ice for 10 min, followed by dounce homogenization. Isolated nuclei were col-
lected by centrifugation at 1,000g for 15 min, and carefully washed twice with 1 ml 
NEB1 without disturbing the pellet. Pellets were then resuspended in 0.5 ml of 
nuclear extract buffer 2 (NEB2; 20 mM HEPES, 10 mM KCl, 1 mM EDTA, 0.1 mM 
Na3VO4, 350 mM NaCl, 20% glycerol, 1 mM DTT and 1× PIC), dounce homog-
enized (20× up and down), incubated for 30 min, and finally spun at 16,000g 
for 30 min. Protein concentration was determined using the Bradford assay, and 
approximately 250 μg of nuclear extract was used per affinity purification. The 
protein lysates were adjusted to affinity purification buffer (350 mM or 500 mM 
NaCl, 20 mM Tris-HCl, pH 7.5, 0.3% NP-40, 1 mM EDTA, 10% glycerol, 1 mM 
DTT and 1× PIC), added to 20 μl anti-Flag-M2 Dynabeads (Sigma), and incu-
bated overnight rotating at 4 °C. Dynabeads were washed the next day in affinity 
purification buffer (4 × 10 min), followed by 3 × 15-min elutions of bound proteins 
with 3×Flag peptide (final concentration 0.3 mg ml−1 in affinity purification buffer, 
Sigma). Next, elutions were pooled and added to the washed Stepavidin Dynabeads 
(Thermo Fisher), and incubated overnight rotating at 4 °C. Streptavidin Dynabeads 
were washed the next day with affinity purification buffer (4 × 10 min), followed 
by a wash with affinity purification buffer without NP40. For single-step affinity 
purification, Flag purification was omitted, and lysates were directly applied to 
the Streptavidin Dynabeads. The enriched proteins were digested directly on the 
Dynabeads with 0.1 mg ml−1 trypsin in digestion buffer (50 mM Tris pH 8.0, 1 mM 
CaCl2 and 1 mM TCEP).
For ADNPPTC718 affinity purification, cells from 2 × 15-cm dishes per replicate 
were used; collection and nuclear lysate isolation were as described above. Next, 
400 μg of nuclear lysates were used for single-step purification with Streptavidin 
Dynabeads in affinity purification buffer (2 h incubation at 4 °C), followed by 
washes (see above). The enriched proteins were digested directly on the Dynabeads 
with 0.2 μg Lys-C in 5 μl digestion buffer (3 M guanidium chloride, 20 mM EPPS, 
pH 8.5, 10 mM CAA and 5 mM TCEP) for 2 h at room temperature. Next, sam-
ples were diluted with 50 mM HEPES, pH 8.5, and digested with 0.2 μg trypsin 
overnight at 37 °C. The next day, 0.2 μg fresh trypsin was added, and samples were 
incubated for an additional 5 h at 37 °C.
Mass spectrometry. Analysis of affinity purification. The generated peptides (see 
‘Affinity purification for LC–MS/MS’) were acidified with TFA to a final concen-
tration of 0.8% and analysed by LC–MS/MS with an EASY-nLC 1000 using the 
two-column set-up (Thermo Scientific). The peptides were loaded with 0.1% 
formic acid, 2% acetonitrile in H2O onto a peptide trap (Acclaim PepMap 100, 
75 μm × 2 cm, C18, 3 μm, 100 Å) at a constant pressure of 80 MPa. Peptides were 
separated, at a flow rate of 150 nl min−1 with a linear gradient of 2–6% buffer 
B in buffer A in 3 min followed by an linear increase from 6 to 22% in 40 min, 
22–28% in 9 min, 28–36% in 8 min, 36–80% in 1 min and the column was finally 
washed for 14 min at 80% buffer B in buffer A (buffer A: 0.1% formic acid; buffer 
B: 0.1% formic acid in acetonitrile) on a 50 μm × 15 cm ES801 C18, 2 μm, 100 Å 
column (Thermo Scientific) mounted on a DPV ion source (New Objective) 
connected to a Orbitrap Fusion (Thermo Scientific). The data were acquired 
using 120,000 resolution for the peptide measurements in the Orbitrap and a 
top T (3 s) method with HCD fragmentation for each precursor and fragment 
measurement in the ion trap according the recommendation of the manufacturer 
(Thermo Scientific).
Protein identification and relative quantification of the proteins was done 
with MaxQuant version 1.5.3.8 using Andromeda as search engine29 and label-
free quantification (LFQ30) as described previously31. The mouse subset of the 
UniProt version 2015_01 combined with the contaminant DB from MaxQuant was 
searched and the protein and peptide FDR values were set to 0.01. All MaxQuant 
parameters can be found in the uploaded parameterfile: mqpar.xml (deposited in 
the PRIDE repository, see Data availability).
Statistical analysis was done in Perseus (version 1.5.2.6)29,30,32. Results were fil-
tered to remove reverse hits, contaminants and peptides found in only one sample. 
Missing values were imputed and potential interactors were determined using t-test 
and visualized by a volcano plot. Significance lines corresponding to a given FDR 
have been determined by a permutation-based method33. Threshold values (FDR) 
were selected between 0.005 and 0.05 and S0 (curve bend) between 0.2 and 2.0 and 
are shown in the corresponding figures. Results were exported from Perseus and 
visualized using statistical computing language R.
iBAQ. Intensity based absolute quantification (iBAQ) was done as described pre-
viously34 to evaluate protein abundances in the ChAHP complexes of the different 
pull-down reactions.
PRM data acquisition. Parallel reaction monitoring (PRM) analyses were 
performed using the same LC–MS system and gradient as described above. 
The acquisition method consisted of acquiring one MS spectrum at 120,000 reso-
lution from 375 to 1,575 Da followed by 21 PRM spectra. An isolation window of 
1.6 Da, a resolution of 240,000, and an automatic gain control value of 105 was used. 
Fragmentation was performed with a stepped HCD collision energy of 30 ± 5, and 
MS/MS scans were acquired with a scan range from 110 to 1,800.
PRM data analysis. The acquired PRM data were processed using Skyline 4.135. 
The transition selection was systematically verified and adjusted when necessary 
to ensure that no co-eluting contaminant distorted quantification based on traces 
co-elution (retention time) and the correlation between the relative intensities 
of the endogenous fragment ion traces, and their counterparts from the library.
MASCOT 2.5 was used in the Decoy mode to search the Swissprot mouse ver-
sion 2015_01 including common contaminants. The enzyme specificity was set to 
trypsin allowing for up to three incomplete cleavage sites. Carbamidomethylation 
of cysteine (+57.0245) was set as a fixed modification, oxidation of methionine 
(+15.9949 Da) and acetylation of the protein N terminus (+42.0106 Da) were set 
as variable modifications. Parent ion mass tolerance was set to 10 p.p.m. and frag-
ment ion mass tolerance to 0.6 Da. The results were validated with the program 
Scaffold Version 4.4 (Proteome Software). Protein identifications were accepted if 
they could be established at greater than 0.1% FDR rate as calculated in Scaffold.
SEC of nuclear lysates. Nuclear lysates were isolated as described above 
(‘Affinity purification for LC–MS/MS’ section) from 3 × 10-cm dishes of 
AdnpFlag-AviTag/Flag-AviTag ES cells (cMB264). Nuclear lysates were then concen-
trated to 250 μl final volume using Amicon Ultra 0.5 ml Centrifugical Filters 
(3 kDa, Millipore), and fractionated by SEC on a Superose 6 HR 10/300 resin by 
fast protein liquid chromatography (AKTA; Amersham-Pharmacia Biotech). The 
predicted size exclusion maximum for this resin is 40 MDa, with a void volume 
of 7.35 ml. The column was equilibrated in 2 column volumes of gel filtration 
(GF) buffer (250 mM NaCl, 50 mM Tris-HCl pH 7.5, 1 mM DTT, 1× PIC) before 
sample loading. A high-molecular-mass protein column standard was used to 
define the column resolution (Sigma). Protein peaks were detected by UV moni-
toring. Thyroglobulin (669,000 Da) peaked in fractions 9 and 10. Before loading, 
each nuclear lysate was adjusted to the appropriate column conditions and cen-
trifuged at 100,000g for 30 min. A 200 μl of lysate was loaded onto the column and 
collected into 350-μl fractions; fractions were then subjected to trichloroacetic acid 
(TCA) precipitation for western blot analysis. For TCA precipitation, the sample 
volume was adjusted to 500 μl with the GF buffer followed by the addition of 
50 μl 0.15% sodium deoxycholate; tubes were vortexed and incubated at room 
temperature for 10 min. Protein was precipitated by the addition of 25 μl of 100% 
TCA (Sigma), followed by a 20-min incubation at −20 °C. Precipitated proteins 
were collected by centrifugation at 10,000 g for 10 min at 4 °C. Protein pellets 
were washed with acetone and air-dried. The protein pellet was solubilized in 
1× sample buffer (62.5 mM Tris, pH 6.8, 0.72 M β-mercaptoethanol or 0.1 M DTT, 
10% glycerol, 2% SDS and 0.05% bromophenol blue) and resolved by NuPAGE-
Novex Bis-Tris 4–12% gradient gels (Invitrogen) and subjected to western blot 
analysis (see ‘Western blotting’ section for further details).
In vitro biochemistry. For cloning, cDNA encoding full-length human ADNP 
(amino acid residues 1–1102) was PCR amplified with primers NotI-ADNP-
forward (5′-AAAAAAGCGGCCGCATGTTCCAACTTCCTGTCAACAA-3′) and 
KpnI-ADNP-reverse (5′-AAAAAAGGTACCCTAGGCCTGTTGGCTGCTC-3′) 
and cloned into a pFast-Bac-derived vector (Invitrogen) in frame with an N-terminal 
His6-tag. Plasmids encoding full-length or N-terminally truncated ADNP 
(amino acid residues 229–1102) with a C-terminal Strep-tag II were generated by 
PCR amplification of ADNP cDNA with primers NotI-ADNP-forward and KpnI-
ADNP-C-reverse (5′-AAAAAAGGTACCGGCCTGTTGGCTGCTCAGTT-3′) 
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or NotI-ADNP(ΔN228)-forward (5 ′-AAAAAAGCGGCCGCATG 
CCAAAGTCCTATGAAGCTTT-3′) and KpnI-ADNP-C-reverse. The 
amplified cDNA was cloned into a pAC8-derived vector36. Expression con-
structs encoding full-length human HP1γ (amino acid residues 1–183) were 
generated by amplification of cDNA using primers NotI-CBX3-forward 
(5′-AAAAAAGCGGCCGCATGGCCTCCAACAAAACTACATT-3′) and KpnI-
CBX3-reverse (5′-AAAAAAGGTACCCTATTGAGCTTCATCTTCTGGA-3′) 
and cloning into pFast-Bac-derived vectors in frame with an N-terminal His6-
tag or Strep-tag II. cDNA for individual chromodomain (amino acid resi-
dues 11–81) or CSD (amino acid residues 109–183) domains of HP1γ was 
amplified with primers NotI-CBX3(11)-forward (5′-AAAAAAGCGGCCGC 
ATGGGAAAAAAACAGAATGGAAAG-3′) and KpnI-CBX3(81)-reverse 
(5′-AAAAAAGGTACCCTATTTCTGAGAGTTAAGAAACGC-3′) or NotI- 
CBX3(109)-forward (5′-AAAAAAGCGGCC GCGATGCTGCTGACAAACCA 
AGAG-3′) and KpnI-CBX3-reverse and cloned into a pAC8-derived vector in 
frame with an N-terminal His6-tag. cDNA encoding for full-length human CHD4 
(amino acid residues 1–1912) was amplified with primers NotI-CHD4-forward 
(5′-AAAAAAGCGGCCGCATGGCCAGCGGCCTGGGAT-3′) and KpnI-
CHD4-reverse (5′-AAAAAAGGTACCCTACTGTTGCTGTGCAACCTG-3′). 
The resulting PCR product was cloned into a pAC8-derived vector in frame with 
an N-terminal His6-tag.
In vitro reconstitution of ChAHP. Full-length and truncated versions of ChAHP 
subunits were subcloned into pAC8 or pFastBac-derived vectors36. The follow-
ing constructs were generated: human ADNP (amino acid residues 1–1102 or 
229–1102) with a C-terminal Strep-tag II, N-terminally His6-tagged human CHD4 
(isoform 1, residues 1–1912) and N-terminally His6-tagged variants of HP1γ 
(residues 11–81 or 109–183) were cloned into pAC8-derived vectors. Full-length 
human ADNP (amino acid residues 1–1102) in frame with an N-terminal His6-tag 
and full-length human HP1γ (residues 1–183) in frame with an N-terminal Strep-
tag II were cloned into pFastBac-derived vectors. Baculoviruses were generated in 
Spodoptera frugiperda Sf9 cells using the Bac-to-Bac method for pFastBac-derived 
vectors or by cotransfection with viral DNA for pAC8-based vectors. After one 
round of virus amplification in Sf9 cells, Trichoplusia ni High5 cells were infected 
with the respective Baculovirus (150 μl of virus per 10 ml of High5 cells at a den-
sity of 2 × 106 cells ml−1) and collected 48 h after infection. Cells were lysed by 
sonication in 50 mM Tris, pH 7.5, 300 mM NaCl, 5 mM β-mercaptoethanol, 0.1% 
Triton X-100, 1 mM PMSF, 1× PIC (Sigma-Aldrich). For pull-down experiments, 
cell lysate of a 15 ml culture was added to 30 μl of Strep-Tactin Sepharose (IBA) 
or 30 μl of His-tag purification resin (Roche) and incubated for 1 h at 4 °C. The 
beads were washed three times with lysis buffer, supplemented with 30 mM imi-
dazole for histidine pull-down reactions. Proteins were eluted by addition of 
2× sample buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 25% glycerol, 0.05% bro-
mophenol blue and 5% β-mercaptoethanol) and analysed by SDS–PAGE and 
Coomassie staining.
For large-scale expression of the ChAHP complex, 1 l of Hi5 cells coinfected 
with Baculoviruses encoding for His6-tagged ADNP and Strep-tagged HP1γ was 
combined with 2 l of Hi5 cells expressing His6-tagged CHD4. Cells were lysed in 
lysis buffer and the cleared lysate was passed over a 50-ml Strep-Tactin Sepharose 
(IBA) column. The bound complex was eluted in 50 mM Tris-HCl, pH 7.5, 100 mM 
NaCl, 5 mM β-mercaptoethanol, 2.5 mM desthiobiotin, and bound to an anion- 
exchange chromatography column (Poros HQ) equilibrated in 50 mM Tris-HCl, 
pH 7.5, 100 mM NaCl, 5 mM β-mercaptoethanol. The bound proteins were eluted 
using a linear NaCl gradient, concentrated and further purified by SEC (HiLoad 
Superdex 200 26/600) in 50 mM HEPES-OH, pH 7.4, 150 mM NaCl and 0.5 mM 
TCEP. Fractions containing the ChAHP complex were concentrated and reinjected 
to a Superdex200 10/300 column equilibrated in the same buffer.
Computational methods. RNA-seq analysis. All sequencing reads were aligned to 
the December 2011 (mm10) mouse genome assembly from UCSC37. HP1-mutant 
RNA-seq data were aligned using STAR 2.5.0a with the following settings to allow 
reporting of one randomly chosen alignment per multi-mapping read: ‘–out-
FilterMultimapNmax 20–outMultimapperOrder Random–outSAMmultNmax 
1–alignSJoverhangMin 8–alignSJDBoverhangMin 1–outFilterMismatchNmax 
999–alignIntronMin 20–alignIntronMax 100000–alignMatesGapMax 100000–out-
SAMtype BAM SortedByCoordinate’. Aligned and sorted reads were indexed using 
SAMtools (version 1.2). ADNP-mutant RNA-seq data were aligned in Galaxy using 
Bowtie with the parameters ‘-m 1–best –strata’38. Aligned Bam files were imported 
in R using QuasR (1.14.0)39. BigWig files normalized for sequencing depth were 
generated using the QuasR qExportWig function. Reads were counted over exons 
using the qCount function and collapsed to yield one value per gene. This count 
table was used for differential expression calling with the EdgeR package40. To 
compare the different Cbx knockout cell lines with Adnp knockouts (Extended 
Data Fig. 7), all biological replicates of the parental/untreated cell lines for Cbx3 
and Adnp were used as control group, whereas the respective knockout replicates 
were considered the treatment group.
Gene Ontology analysis. Gene Ontology term analysis of upregulated gene sets was 
performed using goana from the R limma package41. For the analysis significantly 
upregulated genes (FDR ≤ 0.01, fold change ≥ 4) from EdgeR output were used.
Repeat analysis. RNA-seq libraries were mapped to the genome using STAR 2.5.0a 
with settings optimized for maximum repeat recovery/mappability (–outFilterType 
Normal–alignEndsType Local–winAnchorMultimapNmax 5000–seedPerWin-
dowNmax 1000–alignTranscriptsPerReadNmax 100000–seedNoneLociPerWindow 
100–alignWindowsPerReadNmax 20000–alignTranscriptsPerWindowNmax 
1000–outFilterMultimapNmax 100000–outSAMattributes NH HI NM MD 
AS nM–outMultimapperOrder Random–outSAMmultNmax 1). The resulting 
alignment file was intersected with repeat masker coordinates for mm10 (repeat 
masker 2012-02-07 update, downloaded from UCSC table browser), alignments 
overlapping repeats were counted for all repeat classes and normalized to 1 million 
mapping reads per library.
ChIP–seq read alignment. ChIP–seq data were aligned in R using the qAlign 
function from the QuasR package39 with default settings, which calls the Bowtie 
aligner with parameters ‘-m 1 —best –strata’38. Depth-normalized BigWig files 
were generated using QuasR 1.14.0. For H3K9me3, STAR 2.5.0a (–alignIntronMax 
1–alignEndsType EndToEnd–outFilterType Normal–seedSearchStartLmax 30–
outFilterMultimapNmax 10000–outSAMattributes NH HI NM MD AS nM–out-
MultimapperOrder Random–outSAMmultNmax 1–outSAMunmapped Within) 
was used and non-aligning and multiple mappers were filtered out using samtools. 
BigWig files displaying the full length for uniquely mapping reads were generated 
using bedtools and bedGraphToBigWig (UCSC binary utilities).
Peak finding. ADNP peaks were called on ChIP replicates using the correspond-
ing inputs as background (all BAM files from QuasR alignment). MACS (version 
2.1.1.20160309)42 was run with the default parameters. Peaks detected in at least 
two out of three replicates were kept.
HP1γ peaks were called on both wild-type and knockout ADNP ChIP replicates 
individually, using the corresponding inputs as background (all BAM files from 
QuasR alignment). MACS was run with the following options:–nomodel–shift 
100–extsize 200. Subsequently, peak lists were intersected using bedtools intersect. 
Peaks present in both wild-type and knockout ADNP datasets, which did not 
contain the top scoring ADNP motif, were defined as ADNP-independent HP1γ 
peaks. Note that the number of ADNP-independent HP1γ peaks is an underes-
timate. HP1 proteins, particularly in heterochromatic regions, often cover large 
domains, similar to H3K9me3. However, for consistency reasons and to compile 
an accurate control group for comparison with the sharp ChAHP peaks, we chose 
to use MACS settings that are optimized for identification of transcription-factor 
like, narrow peaks rather than broad peaks. Hence the peaks called here represent 
a stringent set of the most highly enriched loci in the absence of ADNP. Most of 
the broader domains, which are also ADNP-independent, were not considered, as 
their shape is very different compared to ChAHP peaks.
Motif finding. HOMER v.4.8 was used with default settings to identify DNA 
sequence motifs in ADNP peaks43.
Heat maps and meta-plots. Heat maps and meta-plots were generated from aver-
aged replicates using the command line version of deepTools244. Peak centres were 
calculated based on the peak regions identified by MACS (see above). BigWig cov-
erage files for individual replicates were generated by QuasR (see above). For aver-
aging replicates and for calculating log2(ChIP/input) ratios, bigwigCompare from 
deepTools2 was used. To generate histone modification meta-plots for ChAHP-
bound loci (Extended Data Fig. 6), we used the following previously published 
datasets: H3K4me1 (GSE27841)45, H3K4me2 and H3K27me3 (GSE25532)46, 
H3K9ac (GSE31284)47, H3K9me2 (GSE54412)48, H3K9me3 (GSE12241)49.
ATAC-seq analysis. Paired-end reads were aligned using STAR 2.5.0a using default 
parameters except for–alignIntronMax 1 and–alignEndsType EndToEnd. Only 
uniquely mapping reads (alignment score of 255) were kept for further analysis. 
These uniquely mapping reads were used to generate bigwig genome coverage files 
similar to ChIP–seq. Meta-profiles and heat maps were generated using deeptools2. 
For the meta-profiles, the average fragment count per 10-bp bin was normalized 
to the mean fragment count in the first and last five bins. This ensures that the 
background signal is set to one for all experiments.
Reporting summary. Further information on experimental design is available in 
the Nature Research Reporting Summary linked to this paper.
Code availability. All custom codes used to analyse data and generate figures are 
available upon reasonable request.
Data availability. Genome-wide datasets are deposited at the Gene Expression 
Omnibus (GEO) under the accession number GSE97945. The mass spectrometry 
proteomics data have been deposited to the ProteomeXchange Consortium via the 
PRIDE50 partner repository with the dataset identifier PXD006226.
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Extended Data Fig. 1 | Generation of isogenic mouse ES cell lines to 
interrogate protein–protein and protein–chromatin interactions.  
a, Mouse ES cells expressing the BirA biotin ligase from the Rosa26 locus 
were used as a parental cell line for endogenous gene tagging with the 
Flag-AviTag12. For a full list of mouse ES cell lines used in this study 
(cMB#), see Supplementary Information. b, Top, scheme depicting Flag-
AviTag (not drawn to scale) insertion at the endogenous Adnp locus. 
Arrow indicates transcription start site. Boxes represent exons. Bottom, 
scheme depicting ADNP protein. Protein domains as predicted by 
InterPro. Nonsense (NS) and frameshift (FS) mutations found in children 
with Helsmoortel–Van der Aa syndrome are indicated (https://www.
adnpkids.com, dated March 2017). Numbers denote amino acids. c, Sanger 
sequencing of AdnpFlag-AviTag/Flag-AviTag cell lines. d, Distribution of ADNP-
bound genomic sites with respect to protein-coding genes. Peaks were 
called from ChIP–seq data acquired from three independent biological 
replicates (that is, three independent AdnpFlag-AviTag/Flag-AviTag mouse 
ES cell lines). Horizontal bars represent peaks annotated to individual 
categories, and vertical bars represent peaks annotated jointly to specified 
combinations of categories. DIG, distal intergenic; UTR, untranslated 
region. e, ChIP–seq profiles at two lineage-specifying gene loci that were 
generated from three independent AdnpFlag-AviTag/Flag-AviTag ES lines.
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Extended Data Fig. 2 | Generation and analysis of isogenic Adnp 
knockout mouse ES cell lines. a, Scheme depicting CRISPR–Cas9 and 
TALEN-induced double-stranded DNA breaks to delete the Adnp open-
reading frame. TSS, transcription start site. b, PCR genotyping confirming 
homozygous deletion of the Adnp open-reading frame in three different 
mouse ES cell lines used in this study. The experiment was performed 
twice. c, MA plot comparing fold change (FC) in gene expression for 
Adnp−/− versus Adnp+/+ cells (y axis) with mean mRNA abundance  
(x axis). Representative endoderm-specific genes are highlighted in red. 
Dashed red lines indicate fourfold up- or downregulation. CPM, counts 
per million. d, Gene Ontology enrichment analysis of genes upregulated 
in Adnp−/− cells. n = 3 independent biological replicates. e, Scatterplot 
comparing gene expression fold change upon Adnp knockout (y axis) with 
expression changes between extraembryonic endoderm (eXEN) and ES 
cells (x axis). Known key lineage markers are indicated in blue.
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Extended Data Fig. 3 | See next page for caption.
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Extended Data Fig. 3 | The HP1 interactome of mouse ES cells.  
a, Isogenic mouse ES cell lines expressing endogenously tagged CHD4 
and HP1 proteins. Western blot demonstrating expression of FlagAviTag-
tagged proteins. The high molecular mass of CHD4 (218 kDa) does not 
allow discernable separation of tagged from non-tagged protein. See 
Supplementary Information for detailed genotype descriptions of the 
individual ES cell lines. For gel source data, see Supplementary Fig. 1. 
Experiments were performed twice. b, TAP–LC–MS/MS of endogenously 
FlagAviTag-tagged HP1α. Protein purification was performed in the 
presence of 350 mM NaCl. Parental ES cell line serves as background 
control. n = 3 independent biological replicates (that is, three independent 
Cbx5Flag-AviTag/Flag-AviTag mouse ES cell lines). c, TAP–LC–MS/MS of 
endogenously Flag-AviTag-tagged HP1β. Protein purification was 
performed in the presence of 350 mM NaCl. Parental ES cell line serves as 
background control. n = 3 independent biological replicates (that is, three 
independent Cbx1Flag-AviTag/Flag-AviTag mouse ES cell lines). d, TAP–LC–MS/
MS of endogenously Flag-AviTag-tagged HP1γ. Protein purification was 
performed in the presence of 350 mM NaCl. Parental mouse ES cell line 
serves as background control. n = 3 independent biological replicates 
(that is, three independent Cbx1Flag-AviTag/Flag-AviTag mouse ES cell lines) 
e, Heat map showing the variation in co-purifying (Z-score) proteins 
across HP1 isoform-specific TAP–LC–MS/MS experiments. Proteins 
that were significantly enriched in at least one experiment (b–d) were 
included in the analysis. a–e, Validating our approach, all three HP1 
isoforms co-precipitated a large number of proteins. Many of these were 
common to all three HP1 proteins and have previously been described51. 
We also observed several proteins that interacted uniquely with specific 
isoforms, such as the previously identified CAF-1 or SENP7 interactions 
with HP1α52,53. f, Heat map visualization of Pearson’s correlation 
coefficients for the individual HP1 isoform-specific TAP–LC–MS/MS 
experiments. Three independent biological replicates for HP1α and HP1γ, 
two biological and one technical replicate for HP1β, and three technical 
replicates for the parental cell line. g, iBAQ values of ADNP and CHD4 in 
HP1 isoform-specific TAP–LC–MS/MS experiments. Three independent 
biological replicates for HP1α and HP1γ, two biological and one technical 
replicate for HP1β. Centre value denotes the mean; error bars denote s.d. 
b–g, Statistical analysis was performed using Perseus (see Methods). Mass 
spectrometry raw data are deposited with ProteomeXchange.
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Extended Data Fig. 4 | See next page for caption.
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Extended Data Fig. 4 | In vitro characterization of ChAHP complex 
composition. a, Strep-tag pull-down assays with recombinant human 
proteins overexpressed in Hi5 insect cells, revealing that ADNP binds to 
both CHD4 and HP1γ, whereas CHD4 and HP1γ do not interact directly. 
b, SEC of the recombinant ChAHP complex. ChAHP was reconstituted 
from Hi5 insect cells and further purified by separation according to its 
molecular mass on a HiLoad Superdex 300 column. Largest fractions 
eluting first contain ChAHP (1), followed by ADNP–HP1γ (2) and 
HP1γ alone (3). c, Fractions from b were separated on SDS–PAGE and 
visualized by Coomassie staining. d, Pull-down analysis of Strep-tagged 
HP1γ (S-HP1γ) with full-length or N-terminally truncated ADNP 
(ΔΝ228) or CHD4. e, Pull-down analysis of Strep-tagged full-length or 
N-terminally truncated ADNP. b–e, Note that N-terminally truncated 
ADNP does not co-elute with CHD4 on SEC (b, c). This is confirmed by 
pull-down experiments (d, e), which show that ADNP lacking the first 228 
amino acids is only able to bind to HP1γ but no longer to CHD4. Thus, 
ADNP contacts CHD4 through its N terminus. f, Pull-down analysis 
of His-tagged (H) full-length HP1γ, and isolated chromodomain (CD) 
and chromoshadow domain (CSD). Similar to other proteins containing 
the conserved PXVXL pentapeptide54, ADNP directly interacts with the 
CSD of HP1γ. This is consistent with the previously reported interaction 
of ADNP with HP1α17. The chromodomain of HP1γ does not bind to 
ADNP. Experiments in a–f were performed at least twice. S denotes 
the streptavidin tag added to the respective protein; asterisks denote a 
common contaminating protein in streptavidin pull-down assays. For gel 
source data, see Supplementary Fig. 1.
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Extended Data Fig. 5 | HP1 occupancy at ChAHP-binding sites.  
a, Subunit occupancy at ChAHP-bound sites displayed as meta-profile 
integrating signal of all peaks. b, Genome browser screen shot of the 
Igfbp4 locus. ChIP–seq tracks represent depth-normalized read counts of 
averaged replicate experiments. The predicted ADNP DNA-binding motif 
upstream of the Igfbp4 transcription start site is shown. c, Average HP1β 
and HP1γ ChIP–seq enrichment on ChAHP-bound sites in wild-type cells, 
and average HP1β and HP1γ ChIP–seq enrichment on ChAHP-bound 
sites in Cbx3−/− and Cbx1−/− mouse ES cell lines, respectively. n = 2 
biological replicates (that is, independently tagged mouse ES cell lines). 
d, Average HP1α ChIP–seq enrichment on ChAHP-bound sites in wild-
type and Cbx1−/−Cbx3−/− double-knockout ES cell lines. n = 2 biological 
replicates. e, Histone modifications associated with heterochromatin 
are absent at ChAHP-bound sites. f, Histone modifications associated 
with active transcription are absent at ChAHP-bound sites. e, f, Histone 
modification profiles are displayed as meta-profile integrating signal over 
all peaks. g, Binding of wild-type and chromodomain mutant HP1γ to 
ChAHP targets (Igfbp4 and Exd1), an H3K9me3-modified region next 
to an L1 repeat (L1 chr4) and an inactive promoter of an unrelated gene 
(Hoxc5), quantified by ChIP–qPCR. Fold enrichment was normalized to 
an intergenic control region devoid of HP1γ and H3K9me3. Wild-type 
(grey) and mutant (red) HP1γ constructs were transiently transfected into 
HP1 triple-knockout ES cells in biological duplicates. Note the decrease 
of HP1γ binding at the H3K9me3-modified region (L1 chr4), whereas 
ChAHP targets remain unaffected in the chromodomain mutant (CDmut) 
that can no longer bind to H3K9me3. Black lines indicate average 
enrichments.
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Extended Data Fig. 6 | Motif analysis of ADNP-bound loci. a, ADNP 
DNA-binding motifs predicted by HOMER. Frequency of occurrence 
and P values for motif enrichment compared to genomic background 
are indicated. n = 3 independent cell lines. b, Analysis of co-occurrence 
of the top-ten scoring ADNP DNA motifs. The bar graph shows the 
frequency of peaks containing the top-scoring ADNP motif and up to nine 
additional motifs as indicated on the x axis. Note that most peaks besides 
the GCCCCCTGGAG motif also contain more than five other sequence 
motifs out of the top-ten list.
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Extended Data Fig. 7 | See next page for caption.
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Extended Data Fig. 7 | Different HP1 isoforms can functionally 
substitute each other. a, Scatterplots comparing mRNA expression 
changes after deletion of Adnp versus single, double or triple deletions 
of Cbx genes measured by RNA-seq. Green trend lines indicate a loess 
(locally weighted scatterplot smoothing) regression. n = 3 biological 
replicates (that is, three independent Adnp−/−, Cbx1−/−, Cbx3−/−, 
Cbx5−/−, Cbx1−/−Cbx3−/− double knockout, or Cbx1−/−Cbx3−/−Cbx5−/− 
triple knockout mouse ES cell lines). b, MA plot displaying fold changes  
in gene expression for individual Cbx knockout cell lines versus wild type. 
x axis denotes the mean mRNA abundance, log2(counts per million);  
y axis denotes the log2(fold change) between knockout and wild  
type. Dashed red lines indicate fourfold up- or downregulation.  
c, UCSC genome browser shots of three lineage-specifying genes. RNA-
seq profiles normalized by library size of representative wild-type and 
mutant ES cell lines are shown. Experiments were performed three times. 
d, Gene Ontology enrichment analysis of the genes that are upregulated 
in Cbx1−/−Cbx3−/−Cbx5−/− triple-knockout (TKO) and Adnp−/− 
knockout (KO) cells (orange group of genes in a), and of the genes that 
are upregulated in Cbx1−/−Cbx3−/−Cbx5−/− triple-knockout but not 
Adnp−/− knockout cells (grey group of genes in a). See also Supplementary 
Table 5. n = 3 independent cell lines. e, RNA-seq library statistics showing 
fraction of uniquely, multi- and non-mapping reads. Note the increase 
in multi-mappers in the HP1 triple-knockout cells. f, Quantification of 
reads mapping to the major repeat classes in counts per million mappable 
reads. g, Quantification of reads mapping to the different LINE and LTR 
elements in counts per million mappable reads. All mutant cell lines were 
derived from the same parental mouse ES cell line through direct genome 
editing and are therefore isogenic.
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total spectrum count / total unique peptide count / % sequence coverage
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Extended Data Fig. 8 | A patient-specific nonsense mutation in 
Adnp impairs the interaction with HP1 but not with DNA. a, Scheme 
depicting the wild-type and mutant Adnp alleles, which code for Tyr (blue) 
and a patient-specific premature termination codon (red) at amino acid 
position 718, respectively. Full-length and truncated protein products 
are shown on the right. Arrow indicates transcription start site. Boxes 
represent exons. Numbers denote amino acids. b, N-terminally Flag-
AviTag-tagged ADNPPTC718 was streptavidin-purified from cells with 
and without aminoglycoside treatment (gentamycin or paromomycin) 
and subjected to LC–MS/MS analysis. ADNPPTC718-expressing cells were 
treated with 2 mg ml−1 gentamycin (2.9 mM) or paromomycin (3.2 mM) 
for 24 h. The table depicts total spectral counts, unique peptides and 
percentage sequence coverage (derived from Scaffold) for all ChAHP 
components from the different treatments. c, qRT–PCR measurement 
of Bmp1 and Igfbp4 mRNA levels in ES cells expressing full-length Adnp 
(Adnp+/+) or C-terminally truncated Adnp that interacts with CHD4 but 
not with HP1 (AdnpPTC718/PTC718). n = 3 biological replicates (that is, three 
independent RNA isolations). P values were calculated using two-tailed 
unpaired unequal variances t-tests. Centre value denotes the mean; error 
bars denote s.d. d, ChIP–qPCR enrichments for transiently transfected 
Flag-AviTag-tagged wild-type ADNP and ADNPPTC718 constructs on two 
ADNP targets, normalized to an intergenic control. Black lines indicate 
means. e, C-terminally Flag-AviTag-tagged ADNPPTC718 was streptavidin-
purified from cells with or without gentamycin treatment (2.9 mM) and 
subjected to LC–MS/MS analysis. Bold letters indicate unique peptides 
further quantified by parallel reaction monitoring (PRM). C-terminal 
peptides encoded downstream of PTC718 are shown in colour. Dashed 
box denotes the HP1 interaction motif. f, Summed fragment intensities of 
five C-terminal ADNP peptides that are encoded downstream of PTC718 
are shown on the left. Background proteins shown on the right serve as 
loading controls. Intensities were measured by PRM. Total spectrum 
counts were derived from Scaffold. n = 3 biological replicates.
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Extended Data Fig. 9 | ChAHP and NuRD are distinct protein 
complexes. a, Single-step purification followed by LC–MS/MS of 
endogenously Flag-AviTag-tagged CHD4 and ADNP. Protein purification 
was performed in the presence of 350 mM NaCl. Proteins that interact 
predominantly with CHD4 or ADNP are indicated by UniProt names. 
NuRD complex components are labelled in green. n = 3 biological 
replicates (that is, three independent Chd4Flag-AviTag/Flag-AviTag and  
AdnpFlag-AviTag/Flag-AviTag ES cell lines). Statistical analysis was done with 
Perseus (see Methods for details). Mass spectrometry raw data are 
deposited with ProteomeXchange. b, SEC of nuclear protein extracts from 
AdnpFlag-AviTag/Flag-AviTag ES cells. Each fraction (indicated at the bottom) 
was resolved by SDS–PAGE and immunoblotted with the indicated 
antibodies. Molecular mass of individual proteins is indicated on the left. For 
gel source data, see Supplementary Fig. 1. Experiment was performed twice.
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Extended Data Fig. 10 | Isogenic Cbx knockout ES cell lines. a, Western 
blot demonstrating depletion of HP1α protein in Cbx5fl/fl mouse ES 
cell line after treatment with 4-hydroxytamoxifen (4-OHT). b, Western 
blot demonstrating depletion of HP1β protein in three independent 
Cbx1−/− ES cell lines. c, Western blot demonstrating depletion of HP1γ 
protein in Cbx3fl/fl ES cell line after treatment with 4-OHT. d, Western blot 
demonstrating depletion of HP1β and HP1γ proteins in three independent 
Cbx1−/−Cbx3fl/fl double-knockout cell lines after treatment with 4-OHT. 
n = 3 independent 4-OHT treatments. e, qRT–PCR demonstrating 
depletion of Cbx5, Cbx1 and Cbx3 mRNAs in the Cbx1−/−Cbx3fl/flCbx5fl/fl  
triple-knockout cell line upon treatment with 4-OHT. f, Western  
blot demonstrating depletion of HP1γ protein in three independent 
Cbx1Flag-AviTag/Flag-AviTag cell lines. g, Western blot demonstrating depletion 
of HP1β protein in three independent Cbx3Flag-AviTag/Flag-AviTag cell lines. 
For gel source data shown, see Supplementary Fig. 1. Experiments were 
performed twice.
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rabbit polyclonal anti.rat IgG-H&L (Abcam, ab6734, lot: 514318)
Validation Western blot - correct size of the detected bands based on the protein marker;  antibodies used in ChIP were first tested by WB
Eukaryotic cell lines
Policy information about cell lines
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Data access links 
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Files in database submission Adnp_wt_Input_r1.bw, Adnp_wt_Input_r2.bw, Adnp_wt_Input_r3.bw, Adnp_wt_ChIP_r1.bw, Adnp_wt_ChIP_r2.bw, 
Adnp_wt_ChIP_r3.bw, HP1a_wt_Input_r1.bw, HP1a_wt_Input_r2.bw, HP1a_wt_Input_r3.bw, HP1a_wt_ChIP_r1.bw, 
HP1a_wt_ChIP_r2.bw, HP1a_wt_ChIP_r3.bw, HP1b_wt_Input_r1.bw, HP1b_wt_Input_r2.bw, HP1b_wt_Input_r3.bw, 
HP1b_wt_ChIP_r1.bw, HP1b_wt_ChIP_r2.bw, HP1b_wt_ChIP_r3.bw, HP1g_wt_Input_r1.bw, HP1g_wt_Input_r2.bw, 
HP1g_wt_Input_r3.bw, HP1g_wt_ChIP_r1.bw, HP1g_wt_ChIP_r2.bw, HP1g_wt_ChIP_r3.bw, HP1b_Cbx3KO_Input_r1.bw, 
HP1b_Cbx3KO_Input_r2.bw, HP1b_Cbx3KO_ChIP_r1.bw, HP1b_Cbx3KO_ChIP_r2.bw, HP1g_Cbx1KO_Input_r1.bw, 
HP1g_Cbx1KO_Input_r2.bw, HP1g_Cbx1KO_ChIP_r1.bw, HP1g_Cbx1KO_ChIP_r2.bw, HP1g_AdnpKO_Input_r1.bw, 
HP1g_AdnpKO_Input_r2.bw, HP1g_AdnpKO_Input_r3.bw, HP1g_AdnpKO_ChIP_r1.bw, HP1g_AdnpKO_ChIP_r2.bw, 
HP1g_AdnpKO_ChIP_r3.bw, H3K9me3_wt_ChIP.bw, H3K9me3_wt_Input.bw, H3K9me3_wt_ChIP_r2.bw, 
H3K9me3_wt_Input_r2.bw, H3K9me3_wt_ChIP_r3.bw, H3K9me3_wt_Input_r3.bw, HP1a_Cbx1KO_Cbx3KO_r1_input.bw, 
HP1a_Cbx1KO_Cbx3KO_r1_IP.bw, HP1a_Cbx1KO_Cbx3KO_r2_input.bw, HP1a_Cbx1KO_Cbx3KO_r2_IP.bw, 
HP1a_Cbx1KO_r1_input.bw, HP1a_Cbx1KO_r1_IP.bw, HP1a_Cbx1KO_r2_input.bw, HP1a_Cbx1KO_r2_IP.bw, 
Adnp_wt_Input_r1.fastq.gz, Adnp_wt_Input_r2.fastq.gz, Adnp_wt_Input_r3.fastq.gz, Adnp_wt_ChIP_r1.fastq.gz, 
Adnp_wt_ChIP_r2.fastq.gz, Adnp_wt_ChIP_r3.fastq.gz, HP1a_wt_Input_r1.fastq.gz, HP1a_wt_Input_r2.fastq.gz, 
HP1a_wt_Input_r3.fastq.gz, HP1a_wt_ChIP_r1.fastq.gz, HP1a_wt_ChIP_r2.fastq.gz, HP1a_wt_ChIP_r3.fastq.gz, 
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H3K9me3_wt_Input_r3a.fastq.gz, H3K9me3_wt_Input_r3b.fastq.gz, HP1a_Cbx1KO_Cbx3KO_r1_input.fastq.gz, 
HP1a_Cbx1KO_Cbx3KO_r1_IP.fastq.gz, HP1a_Cbx1KO_Cbx3KO_r2_input.fastq.gz, HP1a_Cbx1KO_Cbx3KO_r2_IP.fastq.gz, 
HP1a_Cbx1KO_r1_input.fastq.gz, HP1a_Cbx1KO_r1_IP.fastq.gz, HP1a_Cbx1KO_r2_input.fastq.gz, 
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Replicates All data was generated with 2-3 independently tagged mES cell lines.
Sequencing depth All samples were sequenced single end, reads are 50nt long. 
 
sample total_reads uniquelg_mapped_reads 




Adnp_r1_input 45531949 33260007 
Adnp_r2_input 41040125 29946158 
Adnp_r3_input 41636557 30484917 
Adnp_r1_IP 41661386 29041883 
Adnp_r2_IP 38085206 26541174 
Adnp_r3_IP 48530469 34809813 
HP1g_Adnp-KO_r1_input 45678814 33870008 
HP1g_Adnp-KO_r2_input 42467108 31258583 
HP1g_Adnp-KO_r3_input 43699943 32476799 
HP1g_Adnp-KO_r1_IP 32842004 22321526 
HP1g_Adnp-KO_r2_IP 44889420 29045598 
HP1g_Adnp-KO_r3_IP 35109090 21150753 
HP1a_r1_IP 47043976 31235404 
HP1a_r1_input 52437768 38293017 
HP1a_r2_IP 54535998 37032216 
HP1a_r2_input 51620387 37230624 
HP1a_r3_IP 51671472 33674034 
HP1a_r3_input 51577728 37279754 
HP1b_r1_IP 53002042 34312064 
HP1b_r1_input 68044805 49040528 
HP1b_r2_IP 44585356 29809808 
HP1b_r2_input 55793864 41560084 
HP1b_r3_IP 41795773 28668149 
HP1b_r3_input 64711564 47574471 
HP1b_Cbx3KO_r1_IP 41422135 26755179 
HP1b_Cbx3KO_r1_input 48649519 36300614 
HP1b_Cbx3KO_r2_IP 55593574 34780831 
HP1b_Cbx3KO_r2_input 53412383 39198060 
HP1g_r1_IP 52607556 33568161 
HP1g_r1_input 67240921 48812998 
HP1g_r2_IP 40100424 23783981 
HP1g_r2_input 68715330 49723788 
HP1g_r3_IP 45046950 31042455 
HP1g_r3_input 46085583 34090529 
HP1g_Cbx1KO_r1_IP 60061302 41378985 
HP1g_Cbx1KO_r1_input 66773350 48687798 
HP1g_Cbx1KO_r2_IP 46458292 30007558 
HP1g_Cbx1KO_r2_input 53364441 39299621 
H3K9me3_r1_IP 38739286 20156760 
H3K9me3_r1_input 49519631 41152713 
H3K9me3_r2_IP 86730433 33122220 
H3K9me3_r2_input 98010497 79343833 
H3K9me3_r3_IP 84764823 33502277 
H3K9me3_r3_input 85158611 69629951 
HP1a_Cbx1KO_r1_IP 32771860 19538747 
HP1a_Cbx1KO_r1_input 25703051 20436216 
HP1a_Cbx1KO_r2_IP 36358775 22847351 
HP1a_Cbx1KO_r2_input 27751050 21811944 
HP1a_Cbx1KO_Cbx3KO_r1_IP 35262081 20846058 
HP1a_Cbx1KO_Cbx3KO_r1_input 28576000 22816994 
HP1a_Cbx1KO_Cbx3KO_r2_IP 37494503 22379899 
HP1a_Cbx1KO_Cbx3KO_r2_input 29814815 23576762
Antibodies Dynabeads™ M-280 Streptavidin (11205D, Thermofisher) 
Abcam anti-H3K9me3 (ab8898)
Peak calling parameters MACS2 version 2.1.1.20160309 was used for peak-calling with the parameters " -f BAM -g mm --keep-dup auto". Peaks were 
called for each IP sample vs. its matched input control sample. 
For HP1gamma peaks, the following non-default settings were added: --nomodel --shift 100 --extsize 200.
Data quality A q-value cutoff of 0.05 was applied to all Adnp ChIP replicates separately. 
Plotting -log10 q-values for each replicate against each other showed a good correlation, indicating reproducibility. For the 
final peak set, all peaks present in at least 2 out of 3 replicates were retained.
Software Basic data processing and analysis of enrichments was performed using the R package QuasR. The deepTools suite was used 
to create heatmaps and meta-profiles of binding around peaks.
